²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --]

¿¼²©ÂÛ̳ -> SCI -> ʲôÊÇSCIÆÚ¿¯ [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

kaobook 2011-08-17 22:27

ʲôÊÇSCIÆÚ¿¯

µÚÒ»Õ ʲôÊÇSCIÆÚ¿¯ 7~M<cD  
1£®SCI -R JE6~>'\  
SCIÊÇÃÀ¹úEugene Garfield´´½¨µÄ¿ÆѧÇ鱨Ñо¿Ëù£¨Institute for Scientific Information,ISI£©ÓÚ1960Äê±à¼­³ö°æµÄ¿ÆѧÒýÎÄË÷ÒýÊý¾Ý¿â¡£1992Ä꣬ISI¹éÊôÓÚThomson Scientific and Healthcare,²¢¸ÄΪThomson ISI£¬ÏÖÊôÓÚÌÀÄ·É­¹«Ë¾£¨The Thomson Corporation£©µÄÌÀÄ·É­¿Æ¼¼ÐÅÏ¢¼¯ÍÅ£¨Thomson Scientific£©ÆìÏ¡£ÏêÇé¿É¼û¸Ã¼¯ÍÅÍøÕ¾£ºhttp://scientific.thomson.com. SCIÓбðÓÚ¡¶»¯Ñ§ÎÄÕª¡·£¨Chemical Abstract,CA£©¡¢¡¶ÉúÎïѧÎÄÕª¡·£¨Biological Abstract,BA£©¡¢¡¶¹¤³ÌË÷Òý¡·£¨Engineering Index,EI£©¡¢¡¶¿ÆѧÎÄÕª¡·£¨Scientific Abstract,SA£©¡£Í¨¹ý¼ìË÷SCI¾Í¿ÉÒÔ»ñµÃÒÔÏÂÐÅÏ¢£º `Pc3?~>0HH  
£¨1£©Ïà¹ØÂÛÎÄÊÇ·ñ±»ÒýÓùý£¿  uIMe  
£¨2£©ÂÛÎĵÄÖ÷ÒªÄÚÈÝÊÇʲô£¿ G%u9+XV1#  
£¨3£©Ïà¹Ø¿ÎÌâµÄ×ÛÊöÒÔ¼°×îнøÕ¹ºÍÑÓÉ죿 kcB+_  
£¨4£©Ä³Ò»ÀíÂÛÓÐûÓеõ½½øÒ»²½µÄ֤ʵ£¿ a <X0e>  
£¨5£©Ä³·½·¨ÓÐûÓеõ½¸Ä½ø£¿ bl/,*Wx:4.  
£¨6£©Ä³¸ÅÄîÊÇʲô£¿ÓÉË­Ìá³öÀ´µÄ£¿ {F|48P;J  
£¨7£©Ä³ÎÊÌâÓÐûÓнøÒ»²½¿±ÎóºÍÐÞÕý£¿ ^;F{)bmu+)  
£¨8£©»¹ÓÐË­ÔÚ´ÓÊÂÕâ·½ÃæµÄÑо¿£¿ A\ te*G0:S  
£¨9£©Ä³Ñо¿»ú¹¹»òÕß´óѧ×î½ü·¢±íÁËÄÄЩÎÄÕ£¿ 3kmeD".  
£¨10£©Ä³ÀíÂÛ»ò¸ÅÄîÓÐûÓÐÓ¦Óõ½ÐµÄÁìÓòÖÐÈ¥£¿ u}6v?!  
£¨11£©Ïà¹ØÑо¿ÈËÔ±·¢±í¹ýÄÄЩÂÛÎÄ£¿ )y7_qxwbV  
SCIµÄ¼Ç¼°üÀ¨ÂÛÎÄÓëÒýÎÄ£¬ÆäÒýÎļǼËùÉæ¼°µÄ·¶Î§Ê®·Ö¹ã·º£¬°üÀ¨Êé¼®£¬ÆÚ¿¯ÂÛÎÄ£¬»áÒéÂÛÎÄ£¬×¨ÀûºÍÆäËû¸÷ÖÖÀàÐ͵ÄÎÄÏס£Ëùº­¸ÇµÄѧ¿Æ³¬¹ý100¸ö£¬ËüÊÕ¼ȫÊÀ½ç³ö°æµÄÊýѧ£¬ÎïÀí£¬»¯Ñ§£¬Å©Òµ£¬ÁÖÒµ£¬Ò½Ñ§£¬ÉúÎ»·¾³£¬²ÄÁÏ£¬¹¤³Ì¼¼Êõ£¬ÐÐΪ¿ÆѧµÈ×ÔÈ»¿ÆѧÁìÓòµÄºËÐÄÆÚ¿¯¡£¾­¹ý40¶àÄêµÄ·¢Õ¹ÍêÉÆ£¬ÒÑ´Ó¿ªÊ¼Ê±µÄµ¥Ò»Ó¡Ë¢ÐÍ·¢Õ¹³ÉΪ¹¦ÄÜÇ¿´óµÄµç×Ó»¯£¬¼¯³É»¯£¬ÍøÂ绯µÄ´óÐͶàѧ¿Æ£¬×ÛºÏÐÔ¼ìË÷ϵͳ¡£ ED} 31L  
SCI¸ù¾ÝÆÚ¿¯À´Ô´ÖÖÀà»®·ÖΪSCIºÍSCI-E¡£Web of ScientificµÄÍøվΪhttp://scientific.thomson.com/products/wos/¡£ |dadH 7  
2.Ñ¡¿¯¹ý³Ì |Y_ -  
£¨1£©Ñ¡¿¯ h7qBp300  
ISIÿÖÜ´ÓÊý¾Ý¿âÖÐÔö¼Ó»òɾ³ýÆÚ¿¯£¬Ã¿ÄêISI±à¼­²¿ÆÀÉó½ü2000ÖÖÐÂÆÚ¿¯¡£±»ÆÀÉóµÄÆÚ¿¯Ö»ÓÐ10%----12%±»Ñ¡Óã¬ÍË»ØÂÊ´ï88%¡£´ËÍ⣬ÿÄêÉÐÓÐ150--200ÖÖÒѽøÈëµÄÆÚ¿¯±»ÖÐ;ÌÔÌ­£¬ISIÊý¾Ý¿âµÄÏÖÓÐÆÚ¿¯Ò²ÔÚ²»¶Ïɸѡ¸üС£ +?`b=6e(`  
¼ÆÁ¿Ö¸±ê¸ù¾ÝÖÊÁ¿ÓëÊýÁ¿ÅÅÁУ¬·Ö±ð°üÀ¨ÆÚ¿¯µÄ¸²¸ÇÂÊ¡¢ÆÚ¿¯µÄ»ù±¾³ö°æ±ê×¼¡¢Ñ§ÊõÄÚÈÝ¡¢ÆÚ¿¯×÷ÕߵĹú¼Ê»¯³Ì¶ÈÒÔ¼°Éæ¼°µÄÒýÎÄÊý¾Ý¡£ 8(X0 :  
£¨2£©ÌÔÌ­  wz -)1!  
ISI¶Ôÿһѧ¿ÆµÄÆÀÉóÁ½Äê½øÐÐÒ»´Î¡£ISI»áÁªÂç³ö°æÈ˼ì²éÆÚ¿¯µÄ³ö°æÇé¿ö¡£Ä³Ð©ÆÚ¿¯µÄ¶ÁÕßȺ»áÒòΪ³ö°æʱ¼ä²»¼°Ê±¶ø²»ÔÙÒýÓøÿ¯£¬Ê¹Ó°ÏìÒò×Ó½µµÍ¡£±»ÌÔÌ­ÆÚ¿¯ÉêÇ븴ÒéÒ»°ãÔÚÆÀÉóºó12----18Öܺ󱻿¼ÂÇ£¬´Ó±»ÌÔÌ­ÆÚ¿¯ÖÐÖØÐÂɸѡ³öSCIÆÚ¿¯»¹ÐèÒª3Äêʱ¼ä¡£ xk~Nmb}  
£¨3£©ÒýÎÄ·ÖÎö $M"0BZQ?y!  
ISIʹÓõļ¸ÖÖÒýÎÄ×ÊÁÏ£¬°üÀ¨ÒýÎÄÂÊ¡¢Ó°ÏìÒò×Ó¡¢¼°Ê±Ö¸±ê¡£¶ÔÐÂÆÚ¿¯ISIÒª¼ìË÷ÆÚ¿¯×÷ÕßÓë±àί»á³ÉÔ±µÄ³ö°æ¼Ç¼¡£ISIÕªÒýµÄÎÄÏ×À´×Ô8000ÖÖºËÐÄÆÚ¿¯£¬×î¾ßÓдú±íÐÔ¡£ kReG:  
£¨4£©ÏÖ¿¯Ä¿Â¼ \Mi#{0f+q  
¸ÃÊý¾Ý¿âÆÀÑ¡±ê×¼ÓëÒýÎÄË÷ÒýÏàËÆ£¬ÒýÎÄÁ¿±ÈSCIÉÙ£¬µ«Æ串¸ÇÂÊÏ൱¿É¹Û¡£ e9u@`ZC07  
£¨5£©µç×Ó°æÆÚ¿¯ gp|1?L 54  
1994Äê7ÔÂISIÑ¡ÓÃÁ˵ÚÒ»·Ýµç×ÓÆÚ¿¯£¨The Online Journal of Knowledge Synthesis for Nursing£©¡£1998Äê4ÔÂISIÑ¡ÓÃÁË17ÖÖµç×ÓÆÚ¿¯×÷ΪÆÚ¿¯Ô´¡£´«Í³ÆÚ¿¯ÖÐÊ®·ÖÖØÒªµÄÐÅÏ¢£¬ÈçѧÊõÄÚÈÝ¡¢±àÅŸñʽ¡¢»ù½ð×ÊÖú¡¢Éó¸å»úÖÆ¡¢±à¼­²¿Óë×÷ÕßµÄÏêϸÐÅÏ¢¡¢¹ú¼Ê»¯Ç÷ÊƵȣ¬ÔÚµç×ÓÆÚ¿¯ÖÐͬÑùÖØÒª¡£ %hT4qzJj  
3.ÈçºÎÍƼöÆÚ¿¯ÆÀÉó½ü 7el<5chZ  
ISI¾­³£½øÐÐÓû§µ÷²éºÍÊг¡Ñо¿¡£Èç¹ûÒª¸øISIÍƼöÆÚ¿¯×öÆÀÑ¡£¬¿ÉÒÔÓëEditorial Development DepartmentÁªÏµ£¨Fax£º215--386--6362¡£E-mail£ºJournals@isinet.com£©£¬²¢ÌṩÆÚ¿¯µÄÈ«³Æ¡¢ISSNºÅÂë¡¢Ö÷±àµÄÐÕÃû¡¢µØÖ·ºÍÆÚ¿¯µÄ³ö°æÕß¡£Èç¹û¿ÉÄÜ£¬½«×îÐÂÒ»ÆÚÆÚ¿¯¼ÄÈ¥£¬ËæºóµÄµÚ2°æ¡¢µÚ3°æÒ»µ©³ö°æÒ²ÂíÉϼÄÈ¥¡£Í¬Ê±¸½Ò»·Ý¶ÌÐÅ£¬ËµÃ÷Õâ¸öÆÚ¿¯µÄ¶ÀÌØÖ®´¦ÒÔ¼°ÓëÆäËûÆÚ¿¯µÄ²»Í¬Ö®´¦¡£½«Æ俯Ñù±¾¼ÄÖÁ£º jOtX 60;  
Publication Processing Department r>qA $zD^  
Institute for Scientific Information Jme%  
3501 Market Street !}&" W,,0  
Philadelphia,PA 19104 +AQDD4bu  
USA WO%h"'iJ  
4.SSCI¼ò½é =L 0fZf  
SSCIÊÇSocial Scientific Citation Index<<Éç»á¿ÆѧÒýÎÄË÷Òý>>µÄËõд¡£SSCI´´¿¯ÓÚ1956Ä꣬ÊÇISI´Ó50¶à¸öÁìÓòµÄ3300¶à¸öÖØÒªµÄ¹ú¼ÊÆÚ¿¯ÖУ¬Í¨¹ý¼ÆËã¼°¼ìË÷ÎÄÕÂÖ÷ÌâºÍÒýÎĺó½¨Á¢ÆðµÄ×ÛºÏÐÔÉç¿ÆÎÄÏ×Êý¾Ý¿â£¬ÄÚÈÝÉæ¼°¾­¼Ã¡¢·¨ÂÉ¡¢¹ÜÀí¡¢ÐÄÀíѧ¡¢ÇøÓòÑо¿¡¢Éç»áѧ¡¢ÐÅÏ¢¿ÆѧµÈ50¸öÁìÓò¡£ÊÕ¼ÎÄÏ×ÀàÐÍ°üÀ¨Ñо¿ÂÛÎÄ¡¢ÊéÆÀ¡¢×¨ÌâÌÖÂÛ¡¢ÉçÂÛ¡¢ÈËÎï×Ô´«ºÍÊéÐŵȡ£µ±È»£¬SSCIµÄÊÕ¼ÆÚ¿¯ÓÐÒ»²¿·ÖÄÚÈÝÓëSCIÖظ´¡£2005ÄêµÄSSCIÏÂÔØÍøַΪhttp://scientific.thomson.com/media/pdfs/sourcepub--journals/wos_ssci_a5022_final.pdf¡£ÄϾ©´óѧÒѾ­½¨Á¢¡°ÖÐÎÄÉç»á¿ÆѧÒýÎÄË÷Òý¡±£¨CSSCI£©£¬µÇ½ÍøÖ·http:www.cssci.com.cn²éѯ¡£ -a) T6:e  
5.ISTP¼ò½é _GbE ^  
ISTPÊÇIndex to Scientific and Technical Proceedings<<¿Æѧ»áÒé¼Ë÷Òý>>µÄËõд£¬´´¿¯ÓÚ1978Äê¡£¸ÃË÷ÒýÊÕ¼ÁËÉúÃü¿Æѧ¡¢ÎïÀíÓ뻯ѧ¿Æѧ¡¢Å©Òµ¡¢ÉúÎïºÍ»·¾³¿Æѧ¡¢¹¤³Ì¼¼ÊõÓ¦ÓÃÓëÓ¦ÓÿÆѧµÈѧ¿ÆµÄ»áÒéÎÄÏס£°üÀ¨Ò»°ãÐÔ»áÒé¡¢×ù̸»á¡¢Ñо¿»á¡¢ÌÖÂۻᡢ·¢±í»áµÈµÄ»áÒéÎÄÏס£ÏêÇé²éѯÍøÖ·http://scientific.thomson.com/products/istp¡£ )}X5u%woV  
6.ISR¼ò½é =hX[  
ISRÊÇIndex to Scientific Reviews<<¿ÆѧÆÀÂÛË÷Òý>>µÄËõд£¬´´¿¯ÓÚ1974Äê¡£ÊÕ¼ÊÀ½ç¼°¸÷¹ú2700ÓàÖֿƼ¼ÆÚ¿¯¼°300ÓàÖÖרÖø¡¢´Ô¿¯ÖÐÓмÛÖµµÄÆÀÊöÂÛÎÄ¡£ÏêÇé¿É¼ûÍøÕ¾ c>Z*/>~  
c" Y!$'|Q  
http://scientific.thomson.com/products/isr¡£ {},;-%xE  
7.ÆäËû y' tRANxQ  
PCIÊÇPatent Citation Index<<רÀûÒýÓÃË÷Òý>>µÄËõд£¬ÊÕ¼·¢Ã÷רÀû¡£ÏêÇé¿É¼ûÍøÖ·£ºhttp://scientific.thomson.com/products/pci¡£ |"}4*V_*  
<<ÒÕÊõÓëÈËÎÄÒýÎÄË÷Òý>>£¨Arts and Humanities Citation Index,A and HCI£©ÊÕ¼ÓëÒÕÊõ¡¢ÈËÎÄѧ¿ÆÓйصÄÆÚ¿¯Ä¿Â¼¡£ÏêÇé¿É¼û£º I5pp "*u  
}bfn_ G  
http://scientific.thomson.com/products/ahci¡£

kaobook 2011-08-17 22:27
µÚ¶þÕ SCIÆÚ¿¯Ó°ÏìÒò×Ó " ~n3iNkP  
C@)pmSQ  
SCIÆÚ¿¯Ó°ÏìÒò×Ó #L1>dHhat  
SCIÆÚ¿¯Ó°ÏìÒò×Ó£¨impact factor, IF£©ÊÇÖ¸ÎÄÕÂÔÚÌض¨Äê·Ý»òʱÆÚ±»ÒýÓõÄƵÂÊ£¬ÊǺâÁ¿Ò»¸öѧÊõÆÚ¿¯Ó°ÏìÁ¦µÄÖØÒªÖ¸±êºÍѧÊõ¿¯ÎïµØλµÄÖ÷ÒªÒòËØ£¬ÓÉEugene Garfield ÔÚ20ÊÀ¼Í60Äê´ú´´Á¢£¬ËüµÄ½¨Á¢ÊÇÔÚSCI»ù´¡ÉϵÄÒ»ÖÖͳ¼Æ½á¹û¡£Ä¿Ç°Ëù˵µÄÓ°ÏìÒò×ÓÊÇ´Ó1975Ä꿪ʼ¡£ qhwoV4@f  
Ó°ÏìÒò×Ó=£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄÔÚͳ¼Æµ±Äê±»ÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄ×ÜÊý£© z"av|(?d  
ʾÀý1. =jG?v'X  
2007ÄêÓ°ÏìÒò×Ó¼ÆËã {tmKCG  
Ó°ÏìÒò×Ó£¨2007£©=A¡ÂB ^cb)f_ 90  
ÆäÖУ¬AΪ¸ÃÆÚ¿¯2005-2006ÄêÂÛÎÄÔÚ2007Äê±»ÒýÓõÄ×Ü´ÎÊý£»BΪ¸ÃÆÚ¿¯2005-2006ÄêËùÓÐÂÛÎÄ×ÜÊý¡£ 7%tR&F -u  
ÀýÈ磬2007ÄêNature GeneticsµÄÓ°ÏìÒò×Ó¼ÆËã·½·¨ÈçÏ£º i?W]*V~ply  
2005Äê³ö°æµÄÎÄÏ×ÔÚ2006Äê±»ÒýÓõĴÎÊý=5789£¨´Î£© Q(blW  
2006Äê³ö°æµÄÎÄÏ×ÔÚ2007Äê±»ÒýÓõĴÎÊý=4193£¨´Î£© z1}1*F"  
2005Äê³ö°æµÄÎÄÏ×Êý=203£¨Æª£© 2mLUdx~c  
2006Äê³ö°æµÄÎÄÏ×Êý=210£¨Æª£© OT%V{hD  
¸Ã¿¯2007ÄêµÄÓ°ÏìÒò×Ó=£¨5789+4193£©¡Â£¨203+210£©=24.17£¨´Î/ƪ£©¡£ vh{9'vd3el  
Òò´Ë£¬2007ÄêNature GeneticsµÄÓ°ÏìÒò×ÓÊÇ24.17¡£±íÃ÷¸ÃÆÚ¿¯ÔÚ¹ýÈ¥Á½Äê·¢±íµÄÂÛÎÄÔÚ2007Äêƽ¾ùÊÕµ½24ÌõÒýÎÄ¡£ W7W3DBKtSm  
2.ÆäËû³£ÓõÄÆÚ¿¯ÆÀ¹ÀÖ¸±ê p}f-c  
£¨1£©¼°Ê±Ö¸Êý£¨immediacy index£©ÊǼÆËãijһÆÚ¿¯ÂÛÎĵÄÂÛÎÄÔÚ¸ÃÄê¶È±»ÒýÓõÄËٶȡ£ }"0{zrz  
¼°Ê±Ö¸Êý¼ÆËãµÄ·½·¨£º fo;6huz  
¼°Ê±Ö¸Êý=£¨¸ÃÆÚ¿¯ÎÄÏ×±»µ±ÄêÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸ÃÆÚ¿¯µ±ÄêÎÄÏ××ÜÊý£© 1h{>[ 'L  
ʾÀý (`F|nG=X  
2005Ä꼰ʱָÊý¼ÆËã (>mi!:  
¼°Ê±Ö¸Êý£¨2005Ä꣩=A¡ÂB |a>}9:g,=*  
ÆäÖУ¬AΪ2005Äê³ö°æµÄÎÄÏ×ÔÚ2005Äê±»ÒýÓõĴÎÊý£»BΪ2005Äê³ö°æµÄÎÄÏ×Êý¡£ Q;Q%SI`yT  
£¨2£©±»ÒýÓðëË¥ÆÚ£¨cited halflife£©ÊǼÆËãijһÆÚ¿¯ËùµÇµÄÂÛÎÄƽ¾ù¾­¹ý¶à³¤Ê±¼ä£¬ÈÔÈ»»¹»á±»ÒýÓ᣼ÆËãµÄ·½·¨ÊÇ´Óµ±ÄêÍùÇ°Àۼƣ¬µ±Äê±»ÒýÓõÄÂÛÎÄƪÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄ±»ÒýÓðëË¥ÆÚ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±»ÒýÓÃ×÷Ϊ²Î¿¼ÎÄÏ×µÄʱЧÐÔÔ½¸ß¡£ /'mrDb_ip  
£¨3£©ÒýÓðëË¥ÆÚ£¨citing halflife£©ÊǼÆËãijһÆÚ¿¯Æ½¾ùÒýÓöà¾ÃÒÔÇ°µÄÂÛÎÄ¡£¼ÆËã·½·¨ÊÇ´Óµ±ÄêÍùÇ°Àۼƣ¬µ±ÒýÓõÄÂÛÎÄƪÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄÒýÓðëË¥ÆÚ¡£Èô10ÄêÄÚÒýÓôÎÊýδ´ïµ½50%£¬ÆäÒýÓðëË¥ÆÚÖµÒÔ£¾10.0À´±íʾ¡£µ«¸ÃÆÚ¿¯±ØÐëÒýÓÃÆäËûÂÛÎÄ×ÜÊýÁ¿´ïµ½100´ÎÒÔÉϲÅÁÐÈ룬·ñÔòÔòÒÔ¿Õ°×±íʾ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±íÃ÷¸ÃÆÚ¿¯ËùÒýÓõIJο¼ÎÄÏ×ʵЧÐÔÔ½¸ß¡£ OZa88&  
ͨ¹ýJCR£¨Journal Citation Reports£¬ÆÚ¿¯ÒýÓñ¨µÀ£©¿ÉÒÔµÃÖª£º UDVf@[[hN  
ÄÄЩÊÇ×îÓÐÓ°ÏìÁ¦µÄÆÚ¿¯¡£ CJm.K  
ÄÄЩÊÇ×î³£ÓõÄÆÚ¿¯¡£ T G_bje  
ÄÄЩÊÇ×îÈÈÃŵÄÆÚ¿¯¡£ xM%`K P.8X  
ÄÇЩÆÚ¿¯³ö°æÁ¿×î´ó¡£ 487YaioB$  
ÄÇЩÆÚ¿¯×î³£±»ÒýÓᣠ8.[&wy U  
ÄÇЩÆÚ¿¯µÄÓ°ÏìÒò×Ӹ߻òµÍ¡£ nW~$ (Qnd  
ÄÇЩÆÚ¿¯µÄ¡°Á¢¼´ÒýÓÃÂÊ¡±×î¸ß¡£ ,TEuM|  
ÄÄЩÆÚ¿¯ÒýÓü°±»ÒýÓõÄÇé¿ö¡£ LSSW.Oz2L  
ÊÕ¼ÆÚ¿¯µÄÏêϸ³ö°æÐÅÏ¢¡£ :Jjw"}SfK#  
3.ÆÚ¿¯Ó°ÏìÒò×ӵIJéÕÒ AvyQ4xim+  
·½·¨Ò»£ºµã»÷Á´½Ó£ºhttp://isi3.isiknowledge.comºóÔÙµã»÷Journal Citation Reports£¬½øÈëJCRÊý¾Ý¿â£¬¼´¿É²éÕÒµ±ÄêÆÚ¿¯µÄÓ°ÏìÒò×ÓµÈÖ¸±ê¡£È±µãÊÇÐèÒª¶©¹º²ÅÄܽøÈëJCRÊý¾Ý¿â¡£ C1KfXC*|L  
·½·¨¶þ£º´ò¿ªÓ¢ÎÄÍøÖ·http://www.google.com,ÊäÈëimpact factor,»òÕß´ò¿ªÖÐÎÄÁ´½ÓÍøÖ·http://www.google.com.cn£¬ÊäÈëÆÚ¿¯Ó°ÏìÒò×Ó¡£È±µãÊDz»Äܼ°Ê±²éµ½×îÐÂÐÅÏ¢£¬°üÀ¨ÆÚ¿¯Ó°ÏìÒò×Ó¡£ % Oz$_Xe  
2005Äê£Ó£Ã£ÉÊÕ¼ÆÚ¿¯Ó°ÏìÒò×Ó£º£¯£¯£º£÷£÷£÷£®£ì£é£â£®£å£ã£î£õ£®£å£ä£õ£®£ã£î£¯£ó£ã£é£ê£ï£õ£ò£î£á£ì£²£°£°£µ£®£ø£ì£ó VccM=w% *  
200£³ÄêÖйúÆÚ¿¯Ó°ÏìÒò×Ó£º L+8=P<]  
www.lib.ecnu.edu.cn/sci/jcr.doc Q,D0kS P  
4.ÆÚ¿¯Ó°ÏìÒò×ÓµÄÓ¦ÓüÛÖµ h4tC. i~k  
Ö÷Òª°üÀ¨ÒÔÏÂÄÚÈÝ£º /8=:qIJYA  
¡òͼÊé¹ÝÈËÔ± xLe =d|6  
v#iFQVBq  
¶¨ÆÚ¿¯Òý½øÕþ²ß£¬Ïò¶ÁÕßÍƼöÓÅÐãÆÚ¿¯¡£ : #3OcD4  
¿ª·¢ºÍ¹ÜÀíÆÚ¿¯¹Ý²Ø£¬Ð­Öú×ö³ö¿¯´æµµ¾ö¶¨¡£ 09G9nu;&{  
¡ò±à¼­  dhZ Zb  
¡îÁ˽âºÍÕÆÎÕ×Ô¼ºÕÆÎÕµÄÆÚ¿¯Çé¿ö£¬Öƶ¨ÓÐЧµÄµÄ±à¼­¹æ»®ºÍÄ¿±ê¡£ nDyvX1]  
¡ò³ö°æÉÌ T_uNF8Bh  
¡î²â¶¨ÆÚ¿¯µÄÊг¡Ó°ÏìÁ¦¡£ EbG_43SV  
¡òÂÛÎÄ×÷Õß ,>&?ty9o  
¡îÑ°ÕÒºÍÈ·¶¨Óë×Ô¼º×¨ÒµÏà¹ØµÄÆÚ¿¯¡£ 5LO4P>fq  
¡îÑ°ÕÒ×îÇ¡µ±×îÓÐÓ°ÏìÁ¦µÄµÄÆÚ¿¯·¢±íÆäÎÄÕ¡£ Lwp-2`%  
¡îÈ·ÈÏÆÚ¿¯µÄѧÊõµØλ¡£ 1a5?)D  
¡òÐÅÏ¢Ñо¿·ÖÎöÈËÔ± M`)s>jp@w  
¡î¸ú×ÙÎÄÏ×¼ÆÁ¿Ñ§µÄ·¢Õ¹Ç÷ÊÆ¡£ h0T< :X   
¡îѧϰÑо¿ÒýÎÄģʽ¡£ NR ;q`Xe-  
¡îÑо¿×¨ÒµÑ§¿ÆµÄ·¢Õ¹±ä»¯Ç÷ÊÆ¡£ A(q ~{  
5.ÆÚ¿¯Ó°ÏìÒò×ӵľÖÏÞÐÔ V/`#B$6  
£¨1£©ÓÉÓÚѧ¿ÆµÄ²îÒìµ¼ÖÂÁËÆÚ¿¯Ó°ÏìÒò×ӵĴóСÏà²îÊýÊ®±¶¡£Ä³Ò»Ñ§¿ÆÆÚ¿¯µÄ×ÜÌåˮƽֻÄÜÕë¶Ô×ÔÉíµÄѧ¿ÆÁìÓò£¬ÒòΪÎÞÂÛÓ°ÏìÒò×Ó»¹ÊÇ×ÜÒýÓÃÊýÔÚѧ¿ÆÖ®¼ä¶¼Ã»ÓпɱÈÐÔ¡£ \H,V 9!B  
£¨2£©Ó°ÏìÒò×ÓÊÇÒ»ÖÖͳ¼ÆѧÉϵĸÅÄÊÇ´óÁ¿ÂÛÎIJúÉúµÄ½á¹û¡£Òò´Ë£¬Ó°ÏìÒò×ÓÓÃÓÚÆÀ¼ÛÆÚ¿¯µÄÕûÌåˮƽÊÇ¿ÉÐеġ£  yQ<6p3  
£¨3£©ÆÚ¿¯µÄ·¢Ðмä¸ô¡¢Ã¿ÆÚÊÕ¼µÄÂÛÎÄƪÊý¸÷Óв»Í¬¡£Ã¿ÆÚÊÕ¼ÂÛÎĽ϶àµÄÆÚ¿¯¿ÉÄÜÒòΪ½ÏÈÝÒ×»ñµÃÒýÓôÎÊý£¬¶øÔÚͳ¼Æ×ÜÒýÓôÎÊýÉϾßÓÐÓÅÊÆ¡£ hm*Th  
£¨4£©Â©ÒýºÍÎÄÏ××÷ÕßÒýÓõIJ»¹æ·¶£¬ÖîÈ硰תÒý¡±£¨¶Ô×Ô¼ºÃ»ÓÐÇ××Ô²éÔ½¹ýµÄÎÄÏ×´Ó±ðÈËÂÛÎĵÄÒýÎÄÖмÓÒÔÒýÓã©£»¡°³çÒý¡±£¨Îª×°µãÃÅÃ棬äĿ°áÓá°È¨ÍþÃûÖø¡±£¬»ò¹ÊÒâʹÓÃһЩʱ÷ÖµÄÊõÓïÃû´Ê£©£»²»Ç¡µ±µÄ¡°×ÔÒý¡±£¨×÷ÕßÒýÓÃ×Ô¼ºµÄÎÄÏ×±íÃ÷Ñо¿¹¤×÷µÄÁ¬ÐøÐÔ£¬µ«ÓеÄ×÷ÕßÒýÓÃ×Ô¼ºÒѾ­·¢±íµÄÓëÖøÎÄÖ÷Ìâ¹ØÁª²»´ó»òºÁ²»Ïà¹ØµÄÎÄÕ£¬ÒÔÀ©´ó×Ô¼ºµÄѧÊõÓ°Ï죩¡£ Tq9,c#}&  
Òò´Ë£¬ËäÈ»ÆÚ¿¯µÄÓ°ÏìÒò×ÓÊÇÆÚ¿¯ÆÀ¹À·Ç³£ÓÐÓõŤ¾ß£¬µ«ÓÐÒ»¶¨µÄ¾ÖÏÞÐÔ£¬±ØÐëÕýÈ·¶Ô´ý¡£ 2ZU@>W  
6.ÈçºÎ²é¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý£¬ÒÔ¼°¶¼±»ÄÇЩÂÛÎÄÒýÓà NdM}xh  
·½·¨Ò»£ºÔÚSCIÎÄÏ×¼ìË÷½çÃæhttp:/www.isiknowledge.com£¬µã»÷×ó²à¡¾web of science¡¿,½øÈëÂÛÎļìË÷½çÃæ¡£ÒÔÒ³ÃæÖС¾general search¡¿ÎªÀý£¬Í¨¹ý±êÌâ×÷ÕßÄê·Ý×÷Õßµ¥Î»µÄ²éѯ»òÕß×éºÏ²éѯ¡£ -;sJ25(  
·½·¨¶þ£º´ò¿ªhttp://scholar.google.com,ÍøÒ³£¬ÊäÈëÎÄÏ×µÄÌâÄ¿»ò×÷Õߣ¬È»ºóµã»÷¡¾ËÑË÷¡¿¿ÉÒÔ¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý¡£µã»÷¡¾±»ÒýÓôÎÊý¡¿¿ÉÒÔ¿´µ½¸ÃÎÄÏ×±»ÄÇЩÂÛÎÄÒýÓá£

kaobook 2011-08-17 22:28
µÚÈýÕ SCIÂÛÎĵĻù±¾ÒªÇó +`Q PBj^  
1.¿Æ¼¼ÂÛÎĵĶ¨Òå \B*k_W/r@  
ÃÀ¹úÉúÎïѧ±à¼­Ð­»á°Ñ¿Æ¼¼ÂÛÎĶ¨ÒåΪ£ºÒ»ÆªÄܱ»½ÓÊܵÄԭʼ¿Æѧ³ö°æÎï±ØÐëÊÇÊ×´ÎÅû¶£¬²¢Ìṩ×ã¹»µÄ×ÊÁÏ£¬ÊÇͬÐÐÄܹ»£º¢ÙÆÀ¶¨Ëù¹Û²ìµ½µÄ×ÊÁϵļÛÖµ£»¢ÚÖظ´ÊµÑé½á¹û£»¢ÛÆÀ¼ÛÕû¸öÑо¿¹ý³ÌµÄѧÊõ¡£´ËÍ⣬Ëü±ØÐëÊÇÒ×ÓÚÈËÃǵĸйٽÓÊÜ¡¢±¾ÖÊÉϳ־ᢲ»¼ÓÏÞÖƵØΪ¿Æѧ½çËùʹÓ㬲¢ÇÒÄÜΪһÖÖ»ò¶àÖÖ¹«ÈϵĶþ¼¶Ç鱨ԴËùÑ¡Óá£Öйú¹ú¼Ò±ê×¼GB7713-87ËùÖ¸µÄѧÊõÂÛÎÄÊÇ£º¡°Ä³Ò»Ñ§Êõ¿ÎÌâÔÚʵÑéÐÔ¡¢ÀíÂÛÐÔ»ò¹Û²âÐÔÉϾßÓÐеĿÆѧÑо¿³É¹û»ò´´Ð¼û½âºÍ֪ʶµÄ¿Æѧ¼Ç¼£¬»òÊÇijÖÖÒÑÖªÔ­ÀíÓ¦ÓÃÓÚʵ¼ÊÖÐÈ¡µÃ×îнøÕ¹µÄ¿Æѧ×ܽᡱ¡£ w;lx:j!Vp$  
2.SCIÂÛÎĵÄÌصã " 7l jc  
¡òѧÊõÐÔ 2Som0T<2  
SCIÂÛÎIJ»Í¬Óڽ̲ģ¬Ò²²»Í¬ÓÚ¶ÁÊé±Ê¼Ç£¬ËüÊÇÒ»ÖÖѧÊõÐÔµÄÎÄÕ¡£ËùνѧÊõÊÇָϵͳºÍרÃŵÄѧÎÊ£¬ÊÇÓнÏÉîºñµÄʵ¼ù»ù´¡ºÍÒ»¶¨ÀíÂÛÌåϵµÄ֪ʶ¡£¿Æ¼¼ÂÛÎĵÄѧÊõÐÔÊÇָһƬ¿Æ¼¼ÂÛÎÄÓ¦¾ß±¸Ò»¶¨µÄѧÊõ¼ÛÖµ£¨ÀíÂÛ¼ÛÖµ£©¡£ÔËÓÿÆѧµÄÔ­ÀíºÍ·½·¨£¬Í¨¹ý˼¿¼·ÖÎö»òʵÑ飬×÷³öÅжϣ¬×îºóµÃ³öеļû½â»ò½áÂÛ¡£ÕâÖÖеļû½â»ò½áÂÛ£¬¿ÉÒÔÊÇÍÆ·­¾ÉµÄÀíÂÛ£¬Ò²¿ÉÒÔÊÇÓÃеĹ۵㽫һЩ·ÖÉ¢µÄ²ÄÁÏϵͳ¹á´©ÆðÀ´£¬¾­¹ýÌáÁ¶¼Ó¹¤£¬´ÓÀíÂÛÉϽøÐзûºÏÂß¼­µÄÂÛÖ¤Óë·ÖÎö»ò×÷³ö˵Ã÷¡£Òò´Ë£¬Ñ§ÊõÐÔÊǿƼ¼ÂÛÎĵÄÌØÕ÷¡£ #cw! &  
¡ò´´ÔìÐÔ£¨Ô­´´ÐÔÓë´´ÐÂÐÔ£© 6b-  
SCIÂÛÎÄÊǶԿÆÑй¤×÷µÄÎÄ×ÖÐÔ×ܽᣬǿµ÷Ô­´´ÐÔÓë´´ÐÂÐÔ¡£Ô­´´ÐÔ²»µÈͬÓë´´ÐÂÐÔ£¬´´ÐÂÐÔ¿ÉÒÔÊDZðÈËÑо¿µÄÑÓÐø£¬¶øÔ­´´ÐÔÒâζ×ÅÒ»¸öÐÂÊÂÎï¡¢ÐÂÁìÓò¡¢ÐÂÎÊÌâµÄ¿ª´´¡£¿ÆѧÑо¿µÄÄ¿µÄÔÚÓÚ´´Ô죬Òò´ËºâÁ¿SCIÂÛÎļÛÖµµÄ¸ù±¾±ê×¼¾ÍÔÚÓÚËûµÄ´´ÔìÐÔ¡£ [37f#p  
¡ò¹æ·¶ÐÔ OwNAN  
SCIÂÛÎıØÐë°´Ò»¶¨µÄ¸ñʽºÍÒªÇó½øÐй淶Êéд¡£ÀýÈ磬SCIÂÛÎĵIJο¼ÎÄÏ×Öø¼Ӧ¹æ·¶£¬ÎÄ×Ö±í´ïÓ¦¹æ·¶£¬ÓïÑԺͼ¼Êõϸ½ÚÓ¦²ÉÓùú¼Ê·¨¶¨µÄÃû´ÊÊõÓï¡¢Êý×Ö¡¢·ûºÅ¡¢¼ÆÁ¿µ¥Î»µÈ¡£SCIÂÛÎÄÒªÇó׼ȷ¡¢¼ò½à¡¢Í¨Ë³¡¢ÌõÀíÇå³þ¡£ {%]NpFg#b  
¡ò¿ÆѧÐÔºÍ׼ȷÐÔ &>d:ewM\  
¿ÆѧÐÔÊÇÖ¸SCIÂÛÎÄͬһ°ãÂÛÎÄÒÔ¼°Ò»ÇзǿƼ¼ÎÄÌåµÄ»ù±¾Çø±ð¡£¿ÆѧÐÔÖ÷Òª°üÀ¨Á½·½Ã棺һ·½ÃæÊÇÖ¸ÂÛÎĵÄÄÚÈÝÊÇ¿Æѧ¼¼ÊõÑо¿µÄ³É¹û£»ÁíÒ»·½ÃæÊÇÖ¸ÂÛÎĵıí´ïÐÎʽ½á¹¹ÑϽ÷£¬Ë¼Î¬·ûºÏÂß¼­¹æÂÉ£¬²ÄÁÏÕæʵ£¬·½·¨×¼È·¿É¿¿£¬¹Ûµã׼ȷÎÞÎó¡£×¼È·ÐÔÖ÷ÒªÊÇÖ¸SCIÂÛÎĵÄʵÑé¹ý³Ì¡¢ÊµÑé½á¹û¾ßÓпÉÖظ´ÐÔ¡£ @qg0u#k5  
3.SCIÂÛÎĵĻù±¾ÒªÇó NUi{!<  
¡òÏȽøÐÔ ÏȽøÐÔÖ÷ÒªÌåÏÖÔÚ )OARO  
¨SÀíÂÛ·½ÃæµÄ´´Ð¼û½â£¬ÈçijЩÀíÂÛ·½ÃæµÄ¶ÀÌؼû½âºÍÕâЩ¼û½âµÄÒÀ¾Ý¡£ h1Ke$# $6  
¨SÓ¦Ó÷½ÃæµÄ´´Ð¼û½âµÈ£¬Èçз¢Ã÷¡¢Ð¼¼Êõ¡¢Ð²úÆ·¡¢ÐÂÉ豸»ò½ÒʾԭÓм¼ÊõתÒƵ½ÐµĿÆѧÁìÓòÖеÄЧ¹û¡£ uf{SxEa  
¨SÑо¿·½·¨·½ÃæµÄ´´ÐÂÐÔ£¬ÈçÑо¿·½·¨·½ÃæµÄ´´Ð»òÍ»ÆÆ¡£ d+gk q\  
ҪעÒâ¿ÆÑд´ÐÂÓ¦¸Ã½¨Á¢ÔÚ¹ú¼ÊÑо¿ÒÑ´ïˮƽºÍ³Ì¶ÈµÄ»ù´¡ÉÏ£¬Êǹú¼Ê´´Ð¶ø²»ÊǹúÄÚ´´Ð¡£·ñÔò£¬ºÜÄÑ·¢±í¸ßˮƽµÄSCIÂÛÎÄ¡£µ±È»Òª¼ÇסÁ¢ÌâʱµÄ×îв»µÈÓÚ½áÌâʱµÄ×îС£ 0hH Iz4(  
¡ò¿ÉÐÐÐÔ =2ATqb"$w  
ËùνѡÌâµÄ¿ÉÐÐÐÔ£¬ÊÇÖ¸Äܹ»³ä·Ö·¢»Ó×÷ÕßµÄ×ÛºÏÌõ¼þ£¬¿ÉÒÔʤÈβ¢ÄÜÈçÆÚÍê³É¿ÆѧÂÛÎĵİÑÎճ̶ȡ£Ó°ÏìÑ¡ÌâµÄ¿ÉÐÐÐÔÒòËØ°üÀ¨£º Wh#_9);  
¨S¿ÆѧԭÀíÉÏÊÇ¿ÉÐеģ¬¾ø²»ÄÜÎ¥·´¿ÆѧԭÀíºÍ×ÔÈ»¹æÂÉ¡£ 9`nP(~  
¨SÖ÷¹ÛÌõ¼þ£¬°üÀ¨×÷Õß֪ʶËØÖʽṹ¡¢Ñо¿ÄÜÁ¦¡¢¼¼ÊõˮƽºÍÌس¤¡¢ÐËȤµÈ¡£ i~v@  
¨S¿Í¹ÛÌõ¼þ£¬°üÀ¨ÊµÑéÌõ¼þ¡¢¾­·Ñ×ÊÁÏ¡¢Ê±¼ä¡¢É豸µÈ¡£ UD Iac;vT  
¡òÖØÒªÐÔ zJB+C=]D7H  
׫д¿ÆÑÐÂÛÎĵÄÄ¿µÄÊÇΪÁ˽»Á÷ºÍÓ¦Óá£Òò´Ë£¬Ò»°ãÀ´Ëµ£¬·¢±íÔÚScience¡¢NatureºÍCellµÈ¶¥¼âSCIÆÚ¿¯µÄ¿ÆѧÂÛÎÄÓÚ·¢±íÔÚÆÕͨSCIÆÚ¿¯µÄѧÊõÂÛÎĵIJ»Í¬ÔÚÓÚÇ°Õß½â¾ö»òÕ߻شðÁËÒ»¸ö·Ç³£ÖØÒªµÄÎÊÌ⣬¸ÃÑо¿ÔÚ¿ÆѧÁìÓòÖоßÓÐÉîÔ¶Ó°Ïì»òÕßÓÐÖØ´óµÄ¾­¼Ã¡¢Éç»áЧÒ棬¶øºóÕßÔò½â¾ö»Ø´ðÁËÒ»¸öÆÕͨµÄÎÊÌâ¡£Òò´Ë£¬¿ÆѧÑо¿ºÍ¼¼ÊõÑо¿Ñ¡ÌâµÄÊ×ÒªÔ­ÔòÊÇ£¬ÎªÊ²Ã´ÒªÑо¿¡¢ÓÐʲôʵ¼Ê×÷Óá¢ÆäÀíÂÛºÍѧÊõ¼ÛÖµ¡¢ÀúÊ·ºÍÏÖʵµÄÒâÒåÓÖÊÇʲô¡£ ^L*VW gi9  
¡ò¿ÆѧÐÔ ~2, wI<Nz  
ËùÑ¡µÄ¿ÎÌâ±ØÐëÊôÓÚ¿ÆѧµÄ·¶³ë£¬Êǿ͹۴æÔڵĶø²»ÊÇÐé¹¹µÄ¡£ÅжÏһƪÂÛÎÄÓÐÎÞ¼ÛÖµ»ò¼ÛÖµµÄ´óС£¬Ê×ÏÈÊÇ¿´ÎÄÕµĹ۵ãºÍÄÚÈݵĿÆѧÐÔÈçºÎ¡£Æä´Î£¬ÎÄÕÂÊÇ·ñ¾ßÓпÆѧÐÔ»¹È¡¾öÓë×÷ÕßµÄÀíÂÛ»ù´¡ºÍרҵ֪ʶ¡£Ð´×÷SCIÂÛÎÄÊÇÔÚÇ°È˳ɾ͵Ļù´¡ÉÏ£¬±ØÐëÓ¦ÓÃÇ°ÈËÌá³öµÄ¿ÆѧÀíÂÛȥ̽Ë÷еÄÎÊÌâ¡£Òò´Ë£¬±ØÐë׼ȷµØÀí½âºÍÕÆÎÕÇ°È˵ÄÀíÂÛ£¬¾ßÓй㲩¶ø¼áʵµÄ»ù´¡¡£Èç¹û¶ÔSCIËùÉæ¼°ÁìÓòÖеĿÆÑгɹûÒ»ÎÞËùÖª£¬¾ÍºÜÄÑд³öÓмÛÖµµÄSCIÂÛÎÄ¡£ 18[? dV  
4.Ñ¡ÌâµÄ»ù±¾·½·¨ C%x(`S^/  
Ñ¡ÌâÒª´Óʵ¼Ê³ö·¢£¬Ñ¡ÔñÄÇЩÓмÛÖµ¡¢ÄÜ´Ù½ø¿Æѧ¼¼Êõ·¢Õ¹»òÐèÒªÆÈÇнâ¾öµÄÓÐÖØ´óЧÒæµÄ¿ÎÌâ¡£¿ÆÑÐÂÛÎÄÊÇ·ñÄܹ»ÔÚSCIÆÚ¿¯·¢±í»òÄܹ»ÔÚʲôÑùµÄSCIÆÚ¿¯ÉÏ·¢±í£¬Ôںܴó³Ì¶ÈÉÏÈ¡¾öÓÚ¿ÎÌâµÄÖØÒªÐÔ¡£ x|~D(zo  
5.Ñ¡Ìâ·½Ïò uK"$=v6|  
¡òÑ¡Ôñؽ´ý½â¾öµÄÖØÒªÎÊÌâ ,b2O^tJF#  
¡òÑ¡Ôñ´¦ÓÚÇ°ÑØλÖõĿÎÌ⣬Óë¹ú¼Ê½Ó¹ì ?kT~)k  
6.Ñо¿¿ÎÌâÑ¡ÔñµÄ;¾¶ NO0[`jy(  
¡ò´Ó¿ÆѧÎÄÏ××ÊÁÏÖÐÑ¡Ìâ 6`$,-(J=  
Ò»°ãÀ´Ëµ£¬SCIÆÚ¿¯Ó°ÏìÒò×ÓÔÚ3·ÖÒÔϵÄÎÄÕ¿ÉÄÜÖ»×öÁËÒ»²¿·Ö»úÀí£¨ÖÆ£©Ñо¿£¬¿Ï¶¨Óв»×ã»ò²»È«ÃæÖ®´¦¡£¹Ø¼üÊÇÄã×Ô¼ºÒªÈ¥Ë¼¿¼¡¢È¥·¢ÏÖ¡£°Ñ±ðÈ˵ÄÎÄÕÂÈÏÕ澫¶ÁÁË×ܻᷢÏÖ©¶´»ò²»×ãÖ®´¦¡£×¢Ò⣺ R'1vjDuv  
¨SÏëÏë±ðÈËÕâÎÄÕÂÊÇÔõô×öµÄ¡£ z=8_%r  
¨SÃ÷°×ËûΪʲôҪÕâô×ö¡£ #nMP (ShK  
¨S¸ÃÎÄÕ½â¾öÁËʲôÎÊÌ⣿Òý³öÁËʲôÎÊÌ⣿ #!<+:y'S?  
¨S¿´±¾ÊµÑé½á¹û£¬ÔÚ˼¿¼ÓÐʲôµØ·½²»ÍêÉÆ£¿ÓÐûÓÐÉîÈë»òÍØÕ¹µ½µ×£¿ V, "AG  
¡òÔÚ¿ÆÑйý³ÌÖÐÑ¡Ìâ V)@nRJg  
¡òÔÚʵ¼ùÓëм¼ÊõÓ¦ÓÃÖÐÑ¡Ìâ A )s"h=R  
7.Ñо¿¿ÎÌâÑ¡ÔñµÄÎóÇø +Fy- ~Mq  
£¨1£©Ïë·¨£¨idea£©Ô½¶àÔ½ºÃ¡£ <R]Wy}2-  
£¨2£©Ò»Î¶×·Çó¸ïÐÂÐԵġ¢Í»ÆÆÐԵijɹû¡£ ^/5E773  
£¨3£©Êýѧ¡¢ÀíÂۺ͹«Ê¾Ô½¸´ÔÓÔ½ºÃ¡£ 8Vg`;_-  
£¨4£©×·ÇóÊ·ÎÞÇ°Àý¡£ >P]I&S-.  
8.¿ÎÌâÉè¼Æ³£¼ûµÄ´íÎó ={&TeMMA  
£¨1£©Ñо¿µÄ¿ÎÌâûÓÐÑôÐÔºÍÒõÐÔ¶ÔÕÕ×é¡£ 802]M  
£¨2£©È±·¦Ëæ»ú×é¡£ ogh2kht  
£¨3£©Ñù±¾ÊýÁ¿Ì«Ð¡¡£ jrMGc=KL  
£¨4£©È±·¦Ë«Ã¤µÄÑо¿¡£ 0I AaPz/e  
£¨5£©¹Û²âÖ¸±ê»òÑù±¾´íÎó¡£ p%M(G#gOgP  
£¨6£©´íÎóÎÊÌâ¡£ Zqe[2()  
£¨7£©´íÎó·ÖÎöͳ¼Æ¡£ *b7 ^s,?  
£¨8£©È±·¦Ò»¸ö¾ßÌå¼Ù˵£¬»ò¹ý·ÖÈÈÖÔÓÚÊý¾Ý²É¼¯¡£ s-YV_  
£¨9£©È±·¦ÀíÂÛÒÀ¾Ý¡£ CBgFB-!qpe  
£¨10£©Ã»ÓÐÒýÓùú¼ÊµÄ±ê×¼»òÖ¸±ê½øÐÐÆÀ¹À¡£ & hM,b!R|  
9. SCIÂÛÎĵĸñʽºÍÕûÌ幹˼ B'#gs'fl  
Ò»°ãSCIÂÛÎĵĸñʽΪ£º <pa];k(IQL  
£¨1£©Title£¨±êÌ⣩¡£ SUQ}^gn]  
£¨2£©Authors£¨×÷ÕßÐÕÃû£©ºÍAddress£¨¹¤×÷µ¥Î»Ãû³ÆµØÖ·£©¡£ =<tJAoVV  
£¨3£©Abstract£¨ÕªÒª£©¡£ w]}cB+C+l#  
£¨4£©Introduction£¨ÒýÑÔ£©¡£ E(K$|k_>  
£¨5£©Material and Metheds(²ÄÁϺͷ½·¨)¡£ CEJG=*3  
£¨6£©Results£¨½á¹û£©¡£ $AJy^`E^  
£¨7£©Discussion£¨ÌÖÂÛ£©¡£ w `9GygS  
£¨8£©Acknowledgements(ÖÂл)¡£ }v|[h[cZ  
£¨9£©References£¨²Î¿¼ÎÄÏ×£©¡£ J,2v~Dq  
(fjXp75  
¸½£ºSCIÂÛÎĵĸñʽºÍд×÷Òªµã [}g5Z=l  
SCIÂÛÎĵĸñʽ д×÷Òªµã xVmUmftD  
Abstract£¨ÕªÒª£© What did I do in a nutshell?(¸ÅÂÔ) uX 5B>32  
Introduction£¨ÒýÑÔ£© What is the problem?(´æÔÚµÄÎÊÌâ) 5D@Q1   
Material and Metheds(²ÄÁϺͷ½·¨) How did I solve the problem?(ÎÒÔõô½â¾öÕâ¸öÎÊÌâ) Ra,on&OP`*  
Results£¨½á¹û£© What din I found out?(ÎÒ·¢ÏÖÁËʲô) 0|3B8m  
Discussion£¨ÌÖÂÛ£© What does it mean?(Îҵķ¢ÏÖÒâζ×Åʲô) o~z.7q  
Acknowledgements(ÖÂл) Who helped me out?(Ë­°ïÁËÎÒ) q\b9e&2Y  
References£¨²Î¿¼ÎÄÏ×£© Whose wok did I refer to?(ÎҲο¼ÁËÄÇЩÎÄÏ×) jI pcMN<  
Appendics(¸½Â¼) Extra information£¨¶îÍâÊý¾Ý»ò×ÊÁÏ£©¡£

kaobook 2011-08-17 22:28
µÚËÄÕ ÈçºÎÊéдSCIÂÛÎĵıêÌâ J+Y|# U  
1.SCIÂÛÎıêÌâµÄÖØÒªÐÔ e}@J?tJK.L  
£¨1£©¾ÍÏñÎÒÃÇƽʱ¿´±¨Ö½ÏÈ¿´±êÌâÒ»Ñù£¬Éó¸åÈËÒ»°ãÊ×ÏȲ鿴SCIÂÛÎĵıêÌâºÍ£¨»ò£©×÷Õß¡£Èç¹û¸ÐÐËȤ£¬ÔÙ¿´ÕªÒª¡£Èç¹û»¹ÓÐÐËȤ£¬ËûÃÇ¿´ÂÛÎÄÖеÄͼºÍ±í£¬È»ºóͨ¶ÁÈ«ÎÄ¡£Òò´Ë£¬SCIÂÛÎıêÌâµÄºÃ»µÖ±½ÓÓ°Ïìµ½¶ÔÂÛÎĵĵÚÒ»Ó¡Ïó¡£ (#>5j7i8#  
£¨2£©ÂÛÎıêÌâÊÇһƪÂÛÎĸø³öµÄÉæ¼°ÂÛÎÄ·¶Î§ÓëˮƽµÄµÚÒ»¸öÐÅÏ¢£¬Óл­Áúµã¾¦µÄ×÷Óá£ÓÐÈËÈÏΪSCIÂÛÎıêÌâÊÇÎÄÕµÄÒ»°ë¡£ NxRiE e#m  
£¨3£©SCIÂÛÎĵıêÌâÊÇ·ñ·´Ó³SCIÂÛÎĵÄÄÚÈÝÊÇÉó¸åÆÀ¹À±ê×¼Ö®Ò»¡£ FP cvkXQD  
£¨4£©SCIÂÛÎĵıêÌâÊÇÎÄÕª¡¢Ë÷Òý»òÌá¼µÈÇ鱨×ÊÁϵÄÖØÒª×é³É²¿·Ö¡£Ä¿Ç°£¬ÎÄÏ×»ò×ÊÁϵļìË÷Ö÷ÒªÒÀÀµÓÚ¼ÆËã»úÍøÂçϵͳ¡££¬SCIÂÛÎıêÌâÊDzéѯµÄÒÀ¾Ý¡£Òò´Ë£¬Èç¹ûÄãµÄ±êÌâ²»³ä·Ö£¬ºÜÉÙÓÐÈË»áÕÒµ½ÄãµÄ½á¹û»òÕßÔĶÁÄãµÄÂÛÎÄ¡£Ó°ÏìÄãµÄSCIÂÛÎÄÒýÓôÎÊýºÍ½»Á÷¡£ _!T$|,a  
2. SCIÂÛÎıêÌâµÄÒªÇó Z-=7QK.\{  
×î¼Ñ±êÌâµÄ±ê×¼ÊÇÒýÓÃ×îÉٵıØÐëÊõÓï׼ȷÃèÊöÂÛÎĵÄÄÚÈÝ¡£Ð´×÷ÒªÇó׼ȷ£¨accuracy£©¡¢¼ò½à£¨brevity£©¡¢Çå³þ£¨clarity£©¡¢ÓÐЧ£¨effectiveness£©ºÍÎüÒýÈË£¨attractive£©¡£·´Ó¦Õå×úóÈ·¶¨±êÌâ¡£ KuAGy*:4T  
¡ò׼ȷÍêÕû aQ3vG08L>  
×÷ΪSCIÂÛÎĵġ°±êÇ©¡±£¬ÂÛÎıêÌâÒªÄÜ׼ȷ±í´ïÂÛÎÄÄÚÈÝ£¬Ç¡µ±·´Ó³ËùÑо¿µÄ·¶Î§ºÍÉî¶È£¬Ó¦¸ÃÓëSCIÂÛÎĵÄÄÚÈݷdz£ÌùÇУ¬¼´ÌâÒª¿ÛÎÄ£¬ÎÄÒ²Òª¿ÛÌ⣬ºÁ²»º¬ºý¡£ÕâÊÇ׫дSCIÂÛÎĵĻù±¾Ô­Ôò¡£³£¼ûµÄ´íÎóÖ÷ÒªÓУº I(eR3d:  
¨SÂÛÎıêÌâÌ«´ó»ò̫С¡£ &?6 ~v  
ÀýÈç Hqy>!1 !  
ÂÛÎÄÌâÄ¿Transportation of corneal stem cells cuitured on amniotic membrane for corneal burn: experimental and clinical study(Chinese Medical Journal,2002,115(5):767-769)Ì«´ó¡£¸ÃÂÛÎÄÖ÷ÒªÑо¿ÁËcorneal stem cellsµÄÌåÍâÅàÑøºÍÌåÄÚ¶ÔÍÃÉÕÉ˵ÄÓ°Ïì¡£Òò´Ë£¬Ð´³Éexperimental and clinical studyÊDz»Ç¡µ±µÄ¡£Óá°in vitro and in vivo¡±À´Ìæ´úexperimental and clinical study¸üºÏÊÊ¡£ }C1}T}U  
¨SÂÛÎıêÌâ±í´ï²»ÕýÈ· r/w@Dh]{_  
ÀýÈç {nWtNyJpS  
Experimental study on mechanism and rarity of metastases in skeletal muscle(Chinese Medical Journal,2002,115(11):1645-1649)Õâ¸ö±êÌâ¾ÍûÓаÑÑо¿µÄ¶ÔÏó¡¢ÎÊÌâ˵Çå³þ¡£ lP &%5y;  
¡ò  ¼òÃ÷¶óÒª ;( Va_   
ÂÛÎÄÌâÄ¿Òª¼ò½à£¬²»ÄÜÌ«³¤¡£Ò»°ãÏ£ÍûһƪÂÛÎıêÌâ²»Òª³¬¹ý100¸öÓ¢ÎÄ×Ö·û£¨characters£©£¬°üÀ¨¿Õ¸ñ¡¢±êµã¡£µ±È»²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÀýÈ磬ScienceÒªÇóÂÛÎıêÌâ²»³¬¹ý90¸ö×Ö·û¡£Journal of Biological ChemistryÒªÇóÂÛÎıêÌâ²»³¬³öÁ½ÐС£ W..>Ny;'3  
ÀýÈç U-:Z ^+Y  
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations(Proc Natl Acad Sci USA,2000,97(18):9834-9839) ¡£ÆäÖеĸ±±êÌâÆä²¹³ä¡¢²ûÃ÷×÷Óá£Science¹æ¶¨¸±±êÌâ½öÏÞÓÃÓÚÑо¿ÎÄÕ¡¢ÆÀÂÛ¡¢ÌØÑûÎÄÕ¡£ MA QY/s~F  
¡òÇå³þ Y\F H4}\S  
¾¡¿ÉÄܽ«±í´ïºËÐÄÄÚÈݵÄÖ÷Ìâ´Ê·ÅÔÚ±êÌâµÄ¿ªÍ·¡£ Vc<n6  
¡òÐÑÄ¿ MO+0]uh:  
±êÌâÒª¾ßÓÐÎüÒýÁ¦£¬Ò»Ä¿ÁËÈ»¡£ iC\=U  
ÀýÈç %}MM+1eu  
±êÌâ¡°Identification of human brain tumor initiating cells¡±(Nature,2004-11-18,432(7015):396-401)¸ÃÂÛÎÄÌâÄ¿ÌرðÐÑÄ¿£¬Ò»¿´¾ÍÖªµÀÁËËûÃÇ·¢ÏÖÁËÄÔÖ×Áö¸Éϸ°û¡£Òò´Ë¸ÃÂÛÎľßÓÐÍ»ÆÆÐÔÒâÒå¡£Èç¹û½«ÂÛÎĵıêÌâ¸ÄΪ¡°CD+133 brain tumor fraction contains cells that are capable of tumor initiation in non-obese diabetic severe combined immunodeficient mouse brains ¡±¾ÍÏÔµÃÌ«³¤£¬¶øÇÒ²»¹»ÐÑÄ¿¡£ f;6d/?=~  
µ«Òª×¢Òâ°ÑÎշִ磬²»¿É¹ý·ÖÐÑÄ¿¡£ 1e%Xyqb  
³£¼ûµÄ´íÎó°üÀ¨Ê¡ÂÔ²»µ±ºÍ½é´ÊʹÓò»µ± D*b|(Oi  
[²»ÍƼö]Adhesion kinase controls actin assembly(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ %Q01EjRes  
[ÍƼö]Focal Adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex(Ð޸ĺó) TUCp mj  
[²»ÍƼö]Mouse Behaviour(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ 2(xKE_|  
[ÍƼö]Androgen Administration to Aged Male Mice Increase Anti-Anxiety Behaviour and Enhance Cognitive Performance(Ð޸ĺó)¡£ ,o6:  V]a  
3. SCIÂÛÎıêÌâµÄ¸ñʽ Jk{2!uP  
±êÌâӦλÓÚÊ×Ò³¶¥²¿¡£µ±ÌâÃû½Ï³¤Ê±£¬ÌâÍ·¿Õ4-5¸ñ£¬ÈçÒ»ÐÐд²»Í꣬ÁíÆðÒ»ÐУ¬±ÈÇ°Ò»ÐÐËõ½øÁ½¸ñÊéд¡£ÈçÓи±±êÌâʱ£¬ÁíÆðÒ»ÐУ¬±ÈÖ÷±êÌâÃûËõ½øÁ½¸ñ¼ÓÆÆÕÛºÅÊéдÌâÃû¡£µ±±êÌâ½Ï¶Ìʱ£¬¾ÓÖÐÊéд¡£±êÌâ¿Õ¸ñÁ½ÐÐÔÙд×÷ÕßÃû×ֺ͵¥Î»¡£´ËÍ⻹ҪעÒâÒÔÏÂÊÂÏ 1Ez A@3:{  
£¨1£©±êÌâ²»ÓÃÏ»®Ïß»òб×ÖÌå¡£ {[iQRYD0|  
£¨2£©¾¡¿ÉÄܲ»Ó÷DZê×¼Ëõд¡£ eeZ9 w~<  
£¨3£©±êÌâÒ»°ã²»Óôóд¡£ RGO wm~a  
£¨4£©¾¡Á¿Ê¹±êÌâ³ÉΪһ¸ö¾ä×Ó£¬Ã¿¸ö´ÊµÄµÚÒ»¸ö×Öĸ´óд¡£ $*> _0{<  
4. SCIÂÛÎıêÌâºÍ»ù½ð¿ÎÌâÃû³ÆµÄÇø±ð &WS%sE{p_  
SCIÂÛÎıêÌâÑ¡ÔñÓëÈ·¶¨²»Í¬ÓÚÉêÇë¿ÎÌâÃû³Æ¡£Ç°ÕßÖ÷Òª½«ÄãµÄ½á¹û£¨Äã·¢ÏÖÁËʲô£©£¬ºóÕßÖ÷Òª²àÖØÓÚÄãµÄ¼Æ»®£¨Ä㽫Ñо¿Ê²Ã´£©¡£ 3mpjSL  
ÈçÏÂËùÁÐÊǹú¼Ò×ÔÈ»¿Æѧ»ù½ðÖбêÏîÄ¿±êÌ⣺ CK x}.<_  
£¨1£©¶ÌβºïÖÖȺÉú̬ѧÓëÐÐΪѧÑо¿¡£ wEqCuhZ  
£¨2£©Ä§Ó󲡺¦Éú̬·ÀÖμ¼ÊõµÄ»ù´¡Ñо¿¡£ z81!F'x;  
£¨3£©CPKs¶ÔÑ×Ö¢ÓÕµ¼·Î΢Ѫ¹ÜÄÚƤϸ°û¹Ç¼Ü±ä»¯µÄµ÷¿ØÑо¿¡£ pm|]GkM  
£¨4£©¼¡Çòµ°°×ÇáÁ´¼¤Ã¸ÓëʵÑéÐÔ¶¯ÂöÖàÑùÓ²»¯¹Øϵ¡£ ;trR' ~  
´ÓÖв»ÄÑ·¢ÏÖ£¬±êÌⶼº¬ÓС°¡­¡­Ñо¿¡­¡­¡±¡£µ«ÊÇ£¬ÔÚ1972-2007ÄêNIHÖбê»ù½ð¿â£¬Ö»ÓÐÒ»¸ö»ù½ðº¬ÓÐStudy£º¡°Study of Women¡¯s Heaith Across the Nation¡£¡± $80/ub:R  
ÈçÏÂËùÁÐÊÇNIHÖбêÏîÄ¿µÄÑ¡Ì⣺ HRh".!lxy  
£¨1£©Adult Stem Cells for Repsi Cardiac Damage¡£ 6jA Q  
£¨2£©Biology of Multiple Myeloma Stem Cells¡£ |'#NDFI>}  
£¨3£©Gene Expression Pattern of Liver Stem/Progenitor cells¡£ 0}!lN{m?  
£¨4£©mTert-GFP and Pancreatic Progenitor Cells¡£ efm< bJB2  
£¨5£©The Role of ABC Transporters in Stem Cells¡£ K>~l6  
ºÜ¶à³õѧÕß°ÑSCIÂÛÎĵıêÌâд³É¡°The study of¡­¡­.¡±¡¢¡°The research on¡­¡­.¡±µÈ¡£ÕâÀà±êÌâÔÚSCIÂÛÎÄÖÐÊǺÜÉÙ¼ûµÄ¡£ P@ u%{  
5.±êÌâµÄ¾ä·¨½á¹¹ oyY,uB.|  
±êÌâͨ³£ÓÉÃû´ÊÐÔ¶ÌÓï¹¹³É£¬Èç¹û³öÏÖ¶¯´Ê£¬¶àΪ·Ö´Ê»ò¶¯Ãû´ÊÐÎʽ¡£ÓÉÓÚ³ÂÊö¾äÒ×ʹ±êÌâ¾ßÓÐÅжÏʽµÄÓïÒ壬ͬʱҲ²»¼ò½à£¬Òò´Ë£¬´ó²¿·Ö±à¼­ºÍѧÕ߶¼ÈÏΪ±êÌâ²»Ó¦¸ÃÓɳÂÊö¾ä¹¹³É¡£ÓÉÓÚ±êÌâ¾ä×ӱȽϼòµ¥£¬²¢ÎÞÐèÖ÷¡¢Î½¡¢±ö£¬Òò´Ë£¬´ÊÐòÒ²¾ÍÏÔµÃÓÈΪÖØÒª¡£ÌرðÊÇ£¬Èç¹û´ÊÓï¼äµÄÐÞÊιØϵʹÓò»µ±£¬¾Í»áÓ°Ïì¶ÁÕßÕýÈ·Àí½â±êÌâµÄÕæÕýº¬Òå¡£ A5\S0l$Q  
дSCIÂÛÎĵÄʱºò£¬²»ÒªÏÈд³ÉÖÐÎÄÔÙ·­Òë³ÉÓ¢Óï¡£ h[? 28q$  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S

kaobook 2011-08-17 22:29
µÚ5ÕÂÈçºÎÊðÃû¡¢µ¥Î»Ãû³ÆºÍµØÖ· ,\IZ/1  
1.×÷Õß×ʸñ±ê×¼ )k Uw,F=6  
¹ú¼ÊÉ϶ÔÓÚ×÷ÕßµÄ×ʸñÊÇÓÐÑϸñÒªÇóµÄ¡£ÓÐ×ʸñ³ÉΪSCIÂÛÎÄ×÷ÕßÓ¦·ûºÏÏÂÁÐËùÓбê×¼£¨criteria£©¡£ vhW '2<(  
(1)ÖÁÉÙ²ÎÓ벿·Ö¿ÎÌâµÄ¹¹Ë¼ÓëÉè¼Æ¡¢×ÊÁÏ»òÊý¾Ý·ÖÎöºÍ½âÊÍ¡£ -fv.ByyA  
(2)ÂÛÎĸåµÄÆð²Ý¡¢Ð´×÷»ò¶ÔÆäÖØҪѧÊõÄÚÈÝ×÷ÖØ´óÐ޸ġ£ jrR~V* :k  
(3)ͬÒâ×îºó¶¨¸å¡£ Q)/q h;R u  
Òò´Ë£¬×÷ÕßµÄ×ʸñÓ¦ÒÔÊÇ·ñʵ¼Ê²ÎÓëÒÔÉÏʵ¼Ê¹¤×÷Ϊ»ù´¡¡£½ö½ö³ï¼¯»òÌṩ×ʽð»òÊÕ¼¯×ÊÁÏÕß²¢²»Ó¦µ±³ÉΪ×÷Õߣ¬¶ÔÑо¿Ð¡×é½øÐÐÒ»°ãÐԵعÜÀíÖ¸µ¼ÕßÒ²²»×ãÒÔ³ÉΪ×÷Õß¡£ J(]nPwm=.-  
2.ÊðÃûµÄÄ¿µÄ E'}$'n?:  
£¨1£©Öø×÷ȨӵÓеÄÉêÃ÷¡£ÊðÃû±¾Éí¼´ÏòÉç»áÉêÃ÷×÷Õ߶ԸÃ×÷Æ·ÓµÓÐÁËÖø×÷Ȩ£¬ÈκθöÈ˺͵¥Î»²»ÄÜÇÖ·¸¡£ =W=%!A\g  
£¨2£©ÊðÃû±íʾÎÄÔð×Ô¸ºµÄ³Ðŵ¡£ uVocl,?.L  
£¨3£©ÊðÃû±ãÓÚ¶ÁÕßͬ×÷ÕßÁªÏµ¡£ O1"!'Gk[!L  
3.×÷Õߣ¨Á½ÈËÒÔÉÏ£©ÅÅÐòºÍ±í´ïÐÎʽ ]n_A~Y r  
£¨1£©µÚÒ»×÷ÕßÊÇÖ÷Òª¸ºÔðÊÕ¼¯ºÍ·ÖÎöÊý¾Ý¡¢ÂÛÎĸåµÄÆð²ÝºÍд×÷¡£ ]SI`fja/  
£¨2£©×îºóÒ»¸ö×÷ÕßÒ»°ãÊÇ¿ÎÌ⸺ÔðÈË£¬¶Ô¿ÎÌâºÍÂÛÎÄÈ«Ã渺Ôð¡£ YL+W 4 ld  
£¨3£©ÆäËû×ø×ÅÓ¦¸ù¾ÝÆïÔÚÑо¿ÖеĵűÏ×À´ÅÅÐò¡£ 'n=D$j]X  
ÓÐʱ¿ÎÌâΪºÏ×÷ÏîÄ¿£¬Òò´Ë¿ÉÄÜÓÐÁ½Î»×÷ÕßΪͨÐÅ×÷Õß¡£±í´ïÐÎʽΪ£º P'+*d#*S  
Correspondence author: p#w,+)1!d  
Xxxx,MD,PhD 5sH ee,  
Department of Neurology $ uqlJG#`  
University of San Francisco (~#9KA1A}  
4410 Clement St )Z#7%, o  
San Francisco,CA 94495 B.o &%5dG  
Tel:415-555-xxxx Z,z^[Jz  
Fax:415-555-xxxx 20q T1!j u  
E-mail:kxxx@ucsf.edu 7?4>'  
Or(¿ÉÒÔ²»ÓÃ) ;AaF;zPV  
Xxxx,MD,PhD n~h%K7 c  
Department of Neurology g!8-yri  
Huashan Hospital, Fudan University {_Y\Y&#  
Shanghai 200135,China c~V\,lcI  
Tel:021-555-xxxx TS;MGi0`}  
Fax:021-555-xxxx B\6\QQ;rUo  
E-mail:kxxx@yahoo.com.cn ;tHF$1!J  
4.×÷ÕßÖ°Ôð 5o,82 Kti  
(1)²»ÄÜÒ»¸åÁ½Í¶¡£(2)²»ÄÜÄóÔìºÍÆÛÆ­¡£  mVxS[Gq  
(3)ÂÛÎÄ×÷ÕßÊÇÖ÷ÒªµÄÑо¿Õߣ¬¶ÔÑо¿×÷³öÁËÖØÒª¹±Ï×£¬²¢ÊìϤԭʼÊý¾Ý¡£ Vrnx# j-U  
(4)ËùÓÐ×÷Õß¿´¹ý×îºó¶¨¸å²¢¶ÔÆäÄÚÈݸºÔð¡£Èç¹û¸ÃÂÛÎÄ»òÆ䲿·ÖÄÚÈݱ»·¢ÏÖÓÐÎó»òÆÛÕ©£¬ËûÃÇÓ¦³Ðµ£ÔðÈΡ£ 7-^d4P+|g  
5.ÊðÃû¸ñʽ w$pv  
×÷ÕßµÄÐÕÃûдÔÚÂÛÎıêÌâµÄÏ·½£¬¾ÓÖÐÊéд¡£µ±ÓÐÁ½Î»ÒÔÉÏ×÷Õßʱ£¬Ã¿Ò»×÷ÕßµÄÃû×ÖÓöººÅ·Ö¿ª£¬×îºó×÷ÕßµÄÃû×ÖµÄÇ°Ãæ¸ÄÓÃand·Ö¿ª¡£¹¤×÷µ¥Î»Ãû³ÆºÍµØַӦλÓÚÊðÃûµÄÏ·½¡£µ±×÷ÕßÀ´×Ô²»Í¬µ¥Î»Ê±£¬¿ÉÒÔÓ÷ûºÅ»òÊý×Ö˵Ã÷¡£²»ÒªÔÚ¡°½ÌÊÚ¡±ºóÃæ¼Ó¡°²©Ê¿Éúµ¼Ê¦¡±¡£Ò»°ãÀ´Ëµ×÷Õߣ¨Í¨Ñ¶×÷Õß³ýÍ⣩µ¥Î»µÄÏêϸµØÖ·Èç½ÖµÀÃû»òºÅÂë²»ÐèҪдÃ÷¡£ 7L!k9"X`0F  
6.³£¼ûÎÊÌâºÍ×¢ÒâÊÂÏî y,aASy!Q  
SCIÂÛÎÄÊðÃûÌåÏÖµÄÒâÒå²»½öÊÇÈÙÓþ£¬¸ü¶àµÄÊÇÔðÈΡ£µ«ÊdzÉΪSCIÂÛÎĵÄ×÷Õߣ¬ÓÈÆäÊǵÚÒ»×÷Õߣ¬¿ÉÄÜÓëÕÒ¹¤×÷»ò½úÉý»òÉêÇë»ù½ðÖ±½ÓÏà¹Ø¡£Òò´Ë£¬ÓÐʱºòϵÖ÷Èβ¢Ã»ÓÐÖ±½Ó²ÎÓë¿ÎÌâµÄÑо¿£¬µ«ÓпÉÄܱ»ÄÉÈëΪ×÷Õß¡£Äê×ʱȽϵ͵ÄÑо¿ÈËÔ±Ò²¾­³£°Ñ×ÊÉîÑо¿ÈËÔ±ÁÐΪÂÛÎÄ×÷ÕßÒÔ±íʾ¸ÐлËû£¨ÃÇ£©µÄÖ§³Ö»òÕßÌá¸ßÂÛÎÄ·¢±íµÄ»úÂÊ¡£ÓÐʱ»ù´¡Ñо¿ÕßÁÐÁÙ´²Ò½ÉúΪÂÛÎÄ×÷ÕßÒÔ×÷Ϊ×éÖ¯ÑùÆ·ºÍ²¡ÈËÊý¾ÝµÄ½»»»Ìõ¼þ¡£¸ù¾Ý¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò£¬ËùÓÐÕâЩ·½·¨»òÕßÀíÓɾù±»ÊÓΪ²»Ç¡µ±µÄÐÐΪ¡£ UZyo:*yB  
ÓÐʱ»áÓÐÖø×÷ȨºÍ×÷ÕßÅÅÁоÀ·×¡£±È½Ï¼òµ¥µÄ·½·¨ÊÇ£¬Ê×ÏÈ£¬ÄãºÍÄãµÄºÏ×÷ÕßͬÒâ×ñÑ­¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò¡£Æä´Î£¬ÔÚÑо¿¿ªÊ¼Ö®Ç°£¬È·¶¨×÷ÕßÃûµ¥¡£×îºó£¬ÊÂÏÈ̽ÌÖ×÷ÕßÅÅÐòºÍË­½«ÊÇͨѶ×÷Õß¡£ &0 @2JS/!  
7.ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖеıí´ï +2vcUy  
ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖÐÓв»Í¬µÄ±í´ï·½Ê½¡£¼ûʾÀý N-^\e)ln  
ÖйúÈËÐÕÃû£º½ðУ°²¡£ H)5]K9D  
±í´ï·½Ê½£º VL\6U05Z  
¨SXiaoan Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X 7&X^y+bMe6  
¨SXiaoAn Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X =KX:&GU  
¨SXiao-An Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬XA ]1klfp,`  
¨SJin,Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X ~($h9* \  
¨SJIN£¬Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X XRZmg "  
¨SXiao An Jin£¨An±í´ïΪMiddle name£¬²»ÍƼö£© _W$4Qn+f  
¨SJin Xiao An£¨ÖÐʽ±í´ï£¬²»ÕýÈ·£© 4h-y'&Z  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S GSypdEBj+w  

kaobook 2011-08-17 22:29
µÚ6Õ ÈçºÎSCIÂÛÎĵÄÕªÒª <jxTI%'f59  
1.ÕªÒªµÄ¶¨Òå :=-h'<D  
ÕªÒª£¨abstract»òsummary£©ÊǶÔÂÛÎÄÄÚÈݵĸÅÀ¨£¬ÊÇÒÔÌṩÎÄÏ×ÄÚÈݸü¸ÄΪĿµÄ£¬¼òÃ÷¶óÒª¡¢ÕýÈ·¼ÌÐøÎÄÏ×ÖØÒªµÄÄÚÈݵĶÌÎÄ¡£ÕªÒªÖ÷Ҫ˵Ã÷ÂÛÎĵÄÄ¿µÄ¡¢ËùÓõķ½·¨¼´È¡µÃµÄ½á¹û¼°ÒâÒå¡£ÕªÒªÊÇSCIÂÛÎĵıØÒª¸½¼Ó²¿·Ö£¬Ö»Óн϶̵ÄÎÄÕ²ÅÄÜÊ¡ÂÔ¡£ KX{S8_  
2.ÕªÒªµÄ×÷Óà 9]l7 j\L  
¡ò±¨µÀÂÛÎÄÐÅÏ¢ 'l2`05   
ÕªÒªÓ¦¾ßÓжÀÁ¢ÐÔºÍ×ÔÖ÷ÐÔ£¬²¢ÇÒº­¸ÇÂÛÎĵÄÖ÷ÒªÐÅÏ¢£¬ÒÔ±ã¶ÁÕßѸËÙ×÷³öÅжϣ¬ÊÇ·ñÓбØÒªÔĶÁÈ«ÎÄ¡£Ðí¶à×÷ÕßµÄSCIÂÛÎÄÕªÒª½Ï¼òÂÔ£¬Ã»ÓÐ×¢Ò⽫ÎÄÕÂÖ÷ÒªÄÚÈÝÌåÏÖÔÚÕªÒªÖУ¬´Ó¶øÓ°ÏìÂÛÎĵĽ»Á÷ºÍ·¢±í¡£ qPWYY  
¡òµç×ÓÎÄÏ×¼ìË÷ lrK5q  
ÕªÒªÊǶþ´ÎÎÄÏ×µÄÖø¼ÄÚÈÝ¡£Òò´Ë£¬ÕªÒª±ØÐëÄÉÈë×ã¹»µÄ¹Ø¼üÐÅÏ¢£¬Èç½á¹û¡¢¹Û²ì¡¢Ç÷ÊƵȣ¬Ê¹¶ÁÕ߿ɲο¼ÄãµÄ¹¤×÷¡£  I"r*p?  
¡òÓÃÓÚÉó¸å¹ý³Ì lE /"  
Ò»°ãSCIÆÚ¿¯±à¼­°ÑÂÛÎĵÄÌâÄ¿ºÍÕªÒªË͸øºòÑ¡Éó¸åÈË£¬Éó¸åÈ˸ù¾ÝÕªÒªÄÚÈÝÀ´¾ö¶¨ÊÇ·ñÓÐÐËȤ»òÕßÖµµÃ»¨Ê±¼äÉóÔĴ˸塣 k kY*OA  
3.ÕªÒª½á¹¹ p=T]%k*^h#  
Ò»°ãժҪΪһ¸ö×ÔÈ»¶Î£¨one paragraph£©¡£ÕªÒªµÄÖ÷Òª½á¹¹¿ÉÒÔ¸ÅÀ¨ÎªÒÔÏÂËĸö²¿·Ö£¬°´Ë³ÐòÅÅÁУº oveW)~4  
£¨1£©´æÔÚÎÊÌâºÍÖ÷ÒªÑо¿µÄÄ¿µÄ£¨Motivation/Problem Statement£©¡£ w_6h $"^x  
£¨2£©ÊµÑéÉè¼ÆÓë·½·¨£¨Methods/Procedure/Approach£©¡£ LvB-%@n  
£¨3£©×îÖØÒªµÄ½á¹û£¨Results/Findings/Product£©¡£ >wZ!1Jq  
£¨4£©Ö÷Òª½áÂÛ£¨Conclusion/Implications£©¡£ EFhe``  
4.ÕªÒªµÄ¾ßÌåÄÚÈÝ Wo\NX05-?  
ÕªÒª½á¹¹  ÄÚÈÝ  À´Ô´ D[ny%9 :  
±³¾°×ÊÁÏÎÊÌâÑо¿Ä¿µÄ  What did you investigate and why?  Introduction VDBP]LRF  
ʵÑéÉè¼ÆÓë·½·¨  What did you do?  Methods ji: JLvf]%  
½á¹û  What did you find out?  Results m;k' j@:  
½âÊͺͽáÂÛ  What do you results mean? So what?   Discussion 5yuR[ VU  
5.ÊéдժҪµÄ»ù±¾ÒªÇóºÍ×¢ÒâÊÂÏî 6*Rz}RQ  
£¨1£©ÕªÒªÎªSCIÂÛÎÄÈ«Îĵĸ߶ÈŨËõ¡£È·±£×¼È·¡¢¼ò½à¶ø³ä·ÖµØ±íÊöÂÛÎĵÄÖ÷ҪĿµÄ¡¢·½·¨¼°È¡µÃµÄÖ÷Òª½á¹û¼°ÒâÒå¡£ B]#0]-ua  
£¨2£©¾«¶Ì¼òÃ÷£¬ÄÚÈÝÃ÷È·ÍêÕû¡£Ò»°ãSCIÂÛÎÄÕªÒªÒÔ200-300×ÖΪÒË¡£µ«Ó¦×¢ÒⲻͬµÄSCIÆÚ¿¯ÒªÇóÒ²²»Ò»Ö£¬ÈçScienceÒªÇóÕªÒªÔÚ125×Ö»ò¸üÉÙ¡£ &*r YY\I  
£¨3£©ÕªÒªÖ»ÊÇÎÄ×ÖÃèÊö¡£Ã»ÓÐÈκÎÐÎʽµÄ˵Ã÷£¬Èçͼ¡¢±í¡¢×¢ÊÍ¡£Îª·½±ã¼ìË÷ϵͳת¼£¬Ó¦¾¡Á¿±ÜÃâʹÓû¯Ñ§½á¹¹¡¢Êýѧ±í´ïʽ¡¢½Ç¶ÈºÍÏ£À°ÎĵÈÌØÊâ·ûºÅ¡£ +!CG'qyN>  
£¨4£©ÕªÒªµÄµÚÒ»¾ä»°×îÖØÒª£¬ÄÚÈÝ°üÀ¨ÁËÑо¿¶¯»ú£¨motivation: why do we care about the problem and the results? £©ºÍ´æÔÚµÄÎÊÌ⣨problem statement: what problem are you trying to solve?£©£¬Òò´Ë·´Ó³ÄãÎÄÕÂÑо¿µÄ·½ÏòºÍÖØÒªÐÔ¡£ x%5n &B  
£¨5£©Ó¦²ûÊöÂÛÎĵÄÖ÷ÒªÄÚÈÝ¡£ÄÚÈݱØÐ뾫Ðıàд£¬³¢ÊÔÐí¶à°æ±¾¡£ NbSkauF~b  
£¨6£©ÒªÒýÆð¶ÁÕßµÄÐËȤ£¬ÒªÔ­´´¡£ zq8LQ4@ay  
£¨7£©±ÜÃâ²»±ØÒªµÄ»°£¬Èç¡°In recent years¡­¡±¡¢¡°¡­has received great attention¡­¡±¡¢¡°There has been great interest in¡­¡±¡£ [PdatL2  
£¨8£©±ÜÃâÓÿÉÄܵ¼Ö¶ÁÕß»ìÏýµÄËõÂÔÓï»òÊõÓï¡£ÈçÈ·ÓÐÐèÒª£¬Ó¦ÔÚËõд·ûºÅµÚÒ»´Î³öÏÖʱ¸ø³öÆäÈ«³Æ¡£ uv eTx  
£¨9£©²»Ó¦°üº¬²Î¿¼ÎÄÏס£ d?.ewsC  
£¨10£©²»Ó¦°üº¬Èß³¤µÄ±³¾°×ÊÁÏ¡£ %TP0i#J  
£¨11£©¿ÉÒÔÓÐһЩÊý×Ö£¬µ«²»Òª¹ý¶à¡£ kO+Y5z6=  
£¨12£©ÔÙ´ÎÈ·ÈÏÕªÒªÄÚÈÝ¡£Ò»µ©ÄãÍê³ÉÕªÒª£¬ÐèÒªÔÚ¼ì²é£¬ÒÔÈ·±£ÄÚÈÝÓëÂÛÎÄÍêÈ«Ïà·û¡£ eE '\h  
6.ժҪд×÷µÄÈ˳ƺÍÓï̬ QQj)"XJ29  
ÓÉÓÚÖ÷¶¯Óï̬µÄ±í´ï¸üΪ׼ȷ£¬ÇÒ¸üÒ×ÔĶÁ£¬Òò¶øÄ¿Ç°´ó¶àÊýSCIÆÚ¿¯¶¼ÌᳫʹÓÃÖ÷¶¯Óï̬¡£Nature¡¢CellµÈÆÚ¿¯ÆÕ±éʹÓõÚÒ»È˳ƺÍÖ÷¶¯Óï̬µÄ±í´ï·½Ê½¡£±ÜÃâʹÓõÚÈýÈ˳ƣ¬Èç¡°This paper reported that¡­¡±¡£  (0bv d  
7.ÕªÒªµÄд×÷ʱ̬ g kT`C  
´óÖ¿ÉÒÔ×ñÑ­ÒÔÏÂÔ­Ôò¡£ ~K5eO-  
£¨1£©½éÉܱ³¾°×ÊÁÏ»ò²ûÊÍÑо¿µÄÖ÷ҪĿ±êʱ£¬Èç¹û¾ä×ÓÄÚÈݲ»ÊÜʱ¼äÓ°Ï죬ÊÇÆÕ±éÊÂʵ£¬Ó¦Ê¹ÓÃÏÖÔÚʱ£»Èç¹û¾ä×ÓµÄÄÚÈÝÊǶÔijÖÖÑо¿Ç÷ÊƵĸÅÊö£¬ÔòʹÓÃÏÖÔÚÍê³Éʱ¡£ Vr+X!DeY  
£¨2£©¸ÅÊöʵÑé³ÌÐò¡¢·½·¨ºÍÖ÷Òª½á¹ûʱ£¬Í¨³£Óùýȥʱ¡£ P{ h;2b{  
£¨3£©ÐðÊö½áÂÛ»ò½¨Òéʱ£¬¿ÉʹÓÃÏÖÔÚʱ¡£ }.>( [\ q  
È»¶ø£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÓÉÓÚ¸÷SCIÆÚ¿¯¶¼ÓÐÆä¾ßÌåÒªÇó£¬Òò´ËҪȷ¶¨Ôڵݽ»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßÖ¸ÄÏ£¬°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£ xrs?"]M[  
8.ժҪд×÷¼¼ÇÉ ~xer ZQgc  
¾¡¹ÜÕªÒª³öÏÖÔÚÂÛÎĵÄ×îÇ°Ã棬µ«ÕªÒªÒ»°ãÓ¦¸ÃÔÚÎÄÕ¸÷Ö÷Òª²¿·ÖÍê³ÉºóÔÙд¡£ÒòΪժҪ×ܽáÁËÂÛÎÄ£¬ÕâÑùÓÐÀûÓÚÎÄÕÂÒªµãµÄÌáÁ¶¡£ÓÅÐãµÄÕªÒªÄÜÓÐЧץס¶ÁÕßµÄÐËȤ¡£¿ªÊ¼Ð´×÷ժҪʱ£¬¿ÉÒÔ´ÓIntroduction¡¢Material and Methods¡¢Results and DiscussionÕ½ÚÖÐÑ¡ÔñÕû¸ö¾ä×Ó»ò¹Ø¼ü¶ÌÓ²¢°ÑËûÃÇ°´Âß¼­ÅÅÁС£È»ºó×ÅÊÖÐ޸ĻòÌí¼ÓÎÄ×Ö¡£¼òµ¥µØ˵£¬Ò»°ãÏÈ´ÓһЩ¼òµ¥µÄ±³¾°×ÊÁÏ¿ªÊ¼£¬ÓÃÒ»Á½¾ä»°½âÊÍΪʲôҪ×öÕâÏîÑо¿¼°ÓëÄãÑо¿Ïà¹ØµÄ±³¾°ÌØÉ«¡£Æä´ÎÊǼòÊö×öÁËʲô¡£×îºóÒ»¾äӦΪÑо¿½áÂÛ£¬ÎªÊ²Ã´½á¹ûÊǺÜÖØÒª£¬Ç¿µ÷Ñо¿µÄ´´ÐºÍÒâÒå¡£ .y\j .p  
9.Ëõ¶ÌÕªÒª·½·¨ @G@,)`p4?  
²»Í¬µÄSCIÆÚ¿¯ÆäÕªÒªµÄ³¤¶ÈÓÐËù²»Í¬¡£Ò»°ãËõ¶ÌÕªÒªµÄµÄ·½·¨ÈçÏ£º n6Je5fE  
£¨1£©È¡Ïû²»±ØÒªµÄ×־䣬Èç¡°It is reported¡­¡±¡°Extensive investigations show that¡­¡±¡°The author discusses¡­¡±¡°This paper concerned with¡­¡± N =FX3Z  
£¨2£©¶ÔÎïÀíµ¥Î»¼°Ò»Ð©Í¨ÓôʿÉÒÔÊʵ±½øÐмò»¯¡£ 9~/k25P  
£¨3£©È¡Ïû»ò¼õÉÙ±³¾°½éÉÜ£¨background information£©¡£ 7o_1PwKS6  
£¨4£©Ö»ÃèÊöÐÂÇé¿ö¡¢ÐÂÄÚÈÝ£¬¹ýÈ¥µÄÑо¿Ï¸½Ú¿ÉÒÔÈ¡Ïû¡£ aAhXHsZ|26  
£¨5£©×÷ÕßÔÚÎÄÏ×ÖÐ̸¼°µÄδÀ´¼Æ»®²»ÄÉÈëÕªÒª¡£ [H<![Z1*r  
£¨6£©¾¡Á¿¼ò»¯Ò»Ð©´ë´ÇºÍÖظ´µÄ´ÊÓï¡£ :m#[V7  

kaobook 2011-08-17 22:31
µÚ7Õ ÈçºÎSCIÂÛÎĵĹؼü´Ê VbyGr~t  
1.¹Ø¼ü´Ê T#KF@8'-  
¹Ø¼ü´Ê£¨key word£©ÊÇÕªÒªÄÚÈݵÄŨËõ£¬ÊÇ·´Ó³SCIÂÛÎĵÄÖ÷ÌâÄÚÈݵÄ×îÖØÒªµÄ´Ê¡¢´Ê×éºÍ¶ÌÓһ°ãÑ¡ÓÃ3-6¸ö¡£¹Ø¼ü´ÊÒ²ÊÇSCIÂÛÎĵÄÎÄÏ×¼ìË÷±êʶ£¬±í´ïÎÄÏ×Ö÷Òª¸ÅÄîµÄ×ÔÈ»ÓïÑÔÓôʡ£¹Ø¼ü´ÊÊÇΪ·½±ã¼ÆËã»ú¼ìË÷£¨search engine£©Óõģ¬ÒªÇó´ÊÒåÃ÷È·£¬Ò»´ÊÒ»Òâ¡£ dCc"Qr[k  
2.¹Ø¼ü´ÊµÄåàÑ¡ &\),V1"  
£¨1£©´ÓÌâÄ¿ÖÐÕÒ¡£ÂÛÎĵÄÖ÷ҪŨËõ£¬×îÒ×ÕÒµ½¡£ -!V+>.Oh  
£¨2£©´ÓÕªÒªÖÐÕÒ¡£ÕªÒªÊÇÂÛÎĵÄÄÚÈÝŨËõ£¬°üÀ¨×îÖØÒªµÄ·½·¨¡¢½á¹û¡¢½áÂۺ͹ؼüÊý¾Ý¡£ . 7*k}@k  
£¨3£©´ÓÂÛÎĵÄС±êÌâÖÐÕÒ¡£ËüÊÇ·´Ó³ÂÛÎÄÖ÷ÌâµÄ²ã´Î±êÌâ¡£ <q\OREMsq  
£¨4£©´Ó½áÂÛÖÐÕÒ¡£¿ÉÕÒµ½ÌâÄ¿¡¢ÕªÒª¡¢Ð¡±êÌâÖЩѡµÄ½ÏΪÖØÒªµÄ¹Ø¼ü´Ê¡£ }x!=F<Q!r  
3.¹Ø¼ü´ÊµÄÊéд > n3w'b  
¹Ø¼ü´Ê£º×ó¸ñ¶¥Æ𣬺ó¿ÕÒ»¸ñд¹Ø¼ü´Ê¡£ %EV\nwn6  
4.¹Ø¼ü´ÊµÄλÖà 5^lFksZ  
Ò»°ãÇé¿öÏ£¬¹Ø¼ü´ÊλÓÚÕªÒªÖ®ºó¡£ +5~5BZP  
5.Êéд¹Ø¼ü´ÊӦעÒâÊÂÏî  ja!K2^  
£¨1£©¹Ø¼ü´Ê²»ÒªÈ«²¿À´×ÔÂÛÎĵÄÌâÄ¿¡£ ^#i3JMq  
£¨2£©¹Ø¼ü´Ê²»ÒªÖظ´¡£ } V  *  

kaobook 2011-08-17 22:31
°ËÕÂÈçºÎÊéдSCIÂÛÎĵÄÒýÑÔ£¨Ç°ÑÔ£© 5\!t!FL_  
1.ÒýÎÄ°üÀ¨µÄÄÚÈÝ .kwz$b+h  
£¨1£©¿ÎÌâµÄÌá³ö±³¾°¡£ E3hql3=  
£¨2£©Ç°ÈËÑо¿¾­¹ý¡¢³É¹û¡¢ÏÖʵÇé¿ö¼°´æÔÚµÄÎÊÌâºÍÆÀ¼Û¡£ c+S<U*  
£¨3£©ËµÃ÷Äã×öÕâÏîÑо¿µÄÔ­Òò¡£½éÉÜ¿ÎÌâµÄÐÔÖÊ¡¢·¶³ë¼°ÆäÖØÒªÐÔ£¬Í»³öÑо¿µÄÄ¿µÄ»òÕßÐèÒª½â¾öµÄÎÊÌâ¡£ Lsu_ f'p0  
£¨4£©Ñо¿¹ý³ÌËù²ÉÓõķ½·¨¡¢Ñо¿¹¤×÷µÄз¢ÏÖºÍÒâÒå¡£ J:D{5sE<|  
2.ÒýÎÄд×÷µÄ»ù±¾ÒªÇó \iL{q^Im  
£¨1£©ÑÔ¼òÒâê࣬ÌõÀíÇå³þ¡£ÒÔ×Á·µÄÓïÑÔ£¬±íÊöÑо¿¿ÎÌâµÄÀ´ÁúÈ¥Âö¼°Ñо¿½á¹û¡£Ò»°ãSCIÂÛÎÄÒýÑÔÔÚ450×ÖÒÔÄÚ£¬2-4¸ö×ÔÈ»¶Î¡£ z3Id8G&>  
£¨2£©¾¡Á¿×¼È·¡¢Çå³þÇÒ¼ò½àµØÖ¸³öËù̽Ë÷ÎÊÌâµÄ±¾Öʺͷ¶Î§£¬¶ÔÑо¿±³¾°µÄ²ûÊö×öµ½·±¼òÊʶȡ£ÎÄÏ×ÒýÓúÍÊý¾ÝÌṩһ¶¨Òª×¼È·£¬ÇмDZÜÃâƬÃæժ¼²¿·Ö½á¹û¶ø²»·´Ó¦ÎÄÏ×µÄ×ÜÌå½á¹û¡£ÒýÓõÄÊý¾ÝÒ²ÒªÕýÈ·£¬ÌرðÊǶþ´ÎÒýÓõÄÊý¾Ý¡£ pzr\<U`  
£¨3£©Òª°Ñ¸ÃÁìÓò¹ýÈ¥ºÍÏÖÔÚµÄ×´¿öÈ«Ãæ¸ÅÀ¨×ܽá³öÀ´£¬ÌرðÊÇ×îнøÕ¹µÄÒýÓá£ÔÚ±³¾°½éÉܺÍÎÊÌâµÄÌá³öÖУ¬Ó¦ÒýÓá°×îÏà¹Ø¡±µÄÎÄÏ×ÒÔÖ¸Òý×÷Õß¡£ÒªÓÅÏÈÑ¡ÔñÒýÓõÄÎÄÏ×°üÀ¨Ïà¹ØÑо¿ÖеÄԭʼ¡¢ÖØÒªºÍ×î¾ß˵·þÁ¦µÄÎÄÏס£Á¦½ä²»Ç¡µ±µØ´óÁ¿¡°×ÔÒý¡±¡£ÒýÓÃÎÄÏ×ʱ²»ÒªÔ­Îij­Â¼£¬ÒªÓÃ×Ô¼ºµÄ»°×ܽáÃèÊö¡£ I'h|7y\  
£¨4£©²ÉÈ¡Êʵ±µÄ·½Ê½Ç¿µ÷×÷ÕßÔÚ±¾´ÎÑо¿ÖÐ×îÖØÒªµÄ·¢ÏÖ»ò¹±Ï×£¬ÈöÁÕß˳×ÅÂß¼­µÄÑݽøÔĶÁÂÛÎÄ¡£ v;6O# ta'  
£¨5£©½âÊÍ»ò¶¨ÒåרÃÅÊõÓï»òËõд´Ê£¬ÒÔ°ïÖú±à¼­¡¢Éó¸åÈ˺ͶÁÕßÔĶÁ¸å¼þ¡£ lKVV*RR}  
3.ÒýÑÔµÄд×÷ qe/dWJBa  
£¨1£©´æÔÚʲôÎÊÌ⣿£¨What is the problem?£©ÂÛÎÄÒýÑÔµÄ×÷ÓÃÊÇ¿ª×ÚÃ÷ÒåÌá³ö±¾ÎÄÒª½â¾öµÄÎÊÌâ¡£ÒýÑÔÓ¦¿ªÃżûɽ¡¢¼òÃ÷¶óÒª¡£ÃèÊöÄãÖ¼ÔÚ½â¾öµÄÎÊÌâ¡£×ܽáÏà¹Ø±³¾°Ñо¿¡¢¹Ø¼ü¹ØϵºÍ¸ÅÄʹ¶ÁÕßÄܹ»Àí½âÄãµÄʵÑé¡£ ~?6M4!u   
£¨2£©ÎªÊ²Ã´ÄãµÄÑо¿ÊÇÖØÒªµÄ£¿£¨Why is your proposal important?£©¼òÒª²ûÊöÇ°ÈËÔÚÕâ·½ÃæËù×ö¹ýµÄ¹¤×÷¡£Ê²Ã´ÊÇÒÑÖªµÄ£¬Ä¿Ç°´æÔÚµÄÎÊÌâ»òδ½â¾öµÄÎÊÌâ¡£»Ø´ðºÍ×ܽáÏà¹ØÑо¿£¬Ìá³öÄãÑо¿µÄÀíÓÉ¡£ÔÚ·ÖÎö¹ýÈ¥Ñо¿µÄ¾ÖÏÞÐԺͲûÃ÷×Ô¼ºÑо¿µÄ´´ÐµãʱҪÉ÷ÖØ¡£Ò»¶¨Òª×ñѭʵÊÂÇóÊǵÄÔ­ÔòÀ´¿Í¹Û¹«ÕýÆÀ¼Û±ðÈ˵Ť×÷£¬²»Òª°Ņ̃¸ß×Ô¼ºÑо¿µÄ¼ÛÖµ½¨Á¢ÔÚ±áµÍ±ðÈ˵Ť×÷Ö®ÉÏ¡£¶ÔÇ°È˹¤×÷µÄ¸ÅÀ¨Ò²²»Òª¶ÏÕÂÈ¡ÒåºÍÐîÒâÍáÇú±ðÈ˵ÄÒâ˼¶øÍ»³ö×Ô¼º·½·¨µÄÓŵ㡣ÐðÊöÇ°È˹¤×÷µÄǷȱÒÔÇ¿µ÷×Ô¼ºÑо¿µÄ´´ÐÂʱ£¬Ó¦É÷ÖØÇÒÁôÓÐÓàµØ¡£×î³£Óõıí´ï·½Ê½ÊÇ¡°To the best of our knowledge, we find/ identify for the first time¡­¡±¡£ÔÚһƪÂÛÎÄÖУ¬¶ÔÇ°È˹¤×÷µÄ¸ÅÀ¨Ó¦¾¡¿ÉÄÜ·ÅÔÚÒýÑÔÖС£ÔÚÕýÎÄÖУ¬Èç·ÇºÜ±ØÒª£¬¾Í²»ÒªÔÙÇ¿µ÷ÁË¡£ vM3 b\yp  
£¨3£©ÄãÈçºÎ½â¾öÕâЩÎÊÌ⣿£¨What solution do you propose?£©¼òÊöÄãµÄʵÑ飻һ°ãµÄʵÑéÉè¼ÆºÍ·½·¨£»ÄãµÄз½·¨»òÖØÒª½á¹ûÓÐʲô¹ã·ºµÄÓ°Ïì»òÒâÒå¡£ [k~}Fe) x  
4.ÒýÑÔд×÷ʱ̬ºÍÓï̬µÄÓ¦Óà s2f6;Yc  
£¨1£©ÐðÊöÓйØÏÖÏó»òÆÕ±éÊÂʵʱ£¬³£ÓÃÏÖÔÚʱ¡£ WMi$ATq  
£¨2£©ÃèÊöÌض¨Ñо¿ÁìÓòÖÐ×î½üµÄijÖÖÇ÷ÊÆ£¬»òÕßÇ¿µ÷±íʾijЩ¡°×î½ü¡±·¢ÉúµÄʼþ¶ÔÏÖÔÚµÄÓ°Ïìʱ£¬³£²ÉÓÃÏÖÔÚÍê³Éʱ¡£ ~SzHIVj:6  
£¨3£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿µÄ·½·¨¼°½á¹ûµÄ¾ä×Óʱ£¬¶àʹÓùýȥʽ¡£ Q$bi:EyJXc  
£¨4£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿Ä¿µÄµÄ¾ä×ÓÖÐÓ¦ÓÐÀàËÆ¡°In this study,¡­¡±¡¢¡°The experiment reported here.¡±µÈ´Ê£¬ÒÔ±íʾËùÉæ¼°µÄÄÚÈÝÊÇ×÷ÕßÏÖÔڵŤ×÷£¬¶ø²»ÊÇÖ¸ÆäËûѧÕß»òÕß×÷Õß¹ýÈ¥µÄÑо¿¡£ PP*',D3  
£¨5£©Êǵ±µØʹÓõÚÒ»È˳ÆÈç¡°we¡±»ò¡°our¡±£¬ÒÔÃ÷È·µØÖ¸Ã÷ÊÇ×÷Õß±¾È˵Ť×÷¡£ Ot<vn34mt:  
¡¾ÍƼö¡¿We conducted this study to determine whether ... B+VD53 V  
[²»ÍƼö]This study was conducted to determine whether ¡­ )swu~Wb}U@  
5.ÒýÑÔд×÷Öг£¼ûµÄ´íÎó |YnT;q  
£¨1£©ÒýÑÔ¹ý¼ò¡£ eo [eN.  
£¨2£©Ïà¹Ø±³¾°Ñо¿½»´úº¬ºý¡£ \8^c"%v,:  
£¨3£©Æ̵æÌ«Ô¶£¬ÈÆÁËÒ»¸ö´óȦ×ӲŽøÈëÖ÷Ìâ¡£ ^{}$o#iof  
£¨4£©ÃèÊö¸ÃÑо¿µÄÖØÒªÐÔ£¬µ«ÊÇ¿´Ã»Óн»´úÏà¹ØµÄÀàËÆÑо¿¡£ fW3 awR{  

kaobook 2011-08-17 22:33
µÚ9ÕÂÈçºÎSCIÂÛÎĵÄʵÑé²ÄÁϺͷ½·¨ M "\j7(  
ʵÑé²ÄÁϺͷ½·¨£¨Materials and Methods£©Õ½ÚÃèÊöÄãÊÇÔõÑùÀ´Ñо¿ÎÊÌ⣨How did you study the problem£©£¬°üÀ¨£º¢ÙÄãÓÃÁËʲô£¿£¨What did you use?£©¢ÚʵÑé¹ý³Ì£¿£¨How did you proceed?£© G$oi>zt3  
1.ʵÑé²ÄÁϺͷ½·¨µÄÖØÒªÐÔ MO%kUq|pg  
£¨1£©¿Æѧ³É¹û±ØÐëÊÇ¿ÉÖظ´ÐԵġ£¡°ÊµÑé²ÄÁϺͷ½·¨¡±Õ½ڵĹؼüÊDZ£Ö¤ËûÈË¿ÉÒÔÖظ´ÄãµÄ½á¹û£¬ÒòΪ±¾Õ½ÚÃèÊöÄã×öÁËʲô¡¢Ôõô×öºÍÓÃÁËʲô¡£ vp4NH]fJ  
£¨2£©ÉóºËÕß³£³£×ÐϸÑо¿±¾Õ½ڡ£Éó¸åÕ߸ù¾ÝÄãÌṩµÄʵÑé²ÄÁϺͷ½·¨À´ÅжϺ;ö¶¨ºóÊÇ·ñÂÛÎĵĽá¹û¿ÉÒÔÐÅÈΡ£Èç¹ûÉó¸åÕßÈÏΪʵÑé²ÄÁϺͷ½·¨ÓÐȱÏÝ£¬Ôò¸ÃÂÛÎĵÄÉè¼ÆÒ²ÓÐȱÏÝ¡£Æä½á¹ûÊǸÃÂÛÎı»¾Ü¾ø¡£ nXJG4$G  
Òò´Ë£¬ËäȻʵÑé²ÄÁϺͷ½·¨µÄд×÷Ïà¶Ô½ÏΪ¼òµ¥£¬µ«ÊÇÐèҪעÒâµÄÎÊÌâ²»ÉÙ£¬Öа¡Ó´µÄÔÚÓÚÍêÕûµÄÃèÊö¡£ÍêÕûÐÔ¾ÍÊÇʵÑéµ±ÖеÄÿһ¸ö»·½Ú¶¼Òª×¢Òâµ½£¬²»Òª¹Ë´Ëʧ±Ë£¬ÒÅ©һЩÖØÒªÄÚÈÝ¡£ =im7RgIBo  
2. ʵÑé²ÄÁϺͷ½·¨µÄÖ÷ÒªÄÚÈÝ 1+ib(MJ<:#  
ʵÑé²ÄÁϺͷ½·¨²¿·Ö¿ÉÒÔ°´ÒÔÏÂÈý¸ö·½ÃæÀ´ÃèÊö¡£ 5DS'22GW`  
£¨1£©ÄãÓÃÁËʲô£¬°üÀ¨£º $d\>^Q  
¨SʵÑé¶ÔÏó£¨experimental subjects£©£ºÒ»°ãÊÇÈË¡¢¶¯Îï¡¢Ö²Îï»òÕßһЩ×éÖ¯µÈ£¬ËûÃǵĻù±¾ÐÅÏ¢ÒªÃèÊöÃ÷È·¡£Òª×¢ÒâSCIÂÛÎÄÆÚ¿¯´ó¶à¶ÔÇ£³¶µ½ÈË»ò¶¯ÎïµÄʵÑ鶼ÊÇÒª¶¯ÎïίԱ»á£¨Institutional Animal care and Use Committee, IACUC£©»òÂ×ÀíίԱ»á£¨Institutional review Boards, IRB£©Í¨¹ý¡£ÏêÇéÁ´½ÓÍøÖ·£ºhttp://grants.nih.gov/grants/olaw/GuideBook.pdf¡£ºÍhttp://www.hhs.gov/ohrp/irb/irb_guidebook.htm¡£·½·¨Ñ§Ò»¶¨Òª×öµ½£ºÁÙ´²Ñо¿Óв¡ÈËÖªÇéͬÒâÊ飬ͨ¹ýÂ×ÀíίԱ»áÅú×¼£»¶¯ÎïʵÑé·ûºÏ±¾ÈË´óѧ»òÕßÑо¿µ¥Î»µÄ¶¯Îï¹ÜÀíÓ붯ÎïʵÑéµÄÕ³̵ȡ£Òò´Ë£¬ÈÏÕæÔĶÁͶ¸å¿¯ÎïÖйØÓÚʵÑéµÄÏêϸ¹æ¶¨¡£Èç¹ûÎ¥·´ÕâÒ»¹æ¶¨£¬¿ÉÄܻᱻ²»½ÓÊÜÆÀÉó»ò·¢±í¡£ÒªÃèÊöʵÑ鶯ÎïµÄfull binominal latin names¡¢ÖÖϵºÍÀ´Ô´¡£ U'p-Ko#  
ʾÀýÒ» ¶¯ÎïµÄʵÑéÃèÊö L_ O*?aaZ  
Animal model .^!<cFkCE  
All surgical procedures postoperative care was performed in accordance with guidelines of the Yale Animal Care and Use Committee. Focal cortical ischesia was induced in male mice(8-10 weeks old)weighing 20-25gm by photothrombosis of cortical microvessels as described previously in detail (Boquillon et al.,1992;Schroeter et al.,2002).Each mouse was anesthetized with 25 isoflurane and maintained with 1% isoflurane in an oxygen/air mixture using a gas anesthesia mask in a stereotaxic frame(Stoelting, Wood Dale,IL).The recal temperature was controlled during surgery at 37¡À0.5¡æ with a homeothermic blanket(Harvard Apparatus,Holliston,MA)¡­ m&a 8/5  
ʾÀý¶þ ÈËÌåʵÑéÃèÊö 2Fc>6]:*  
Human samples cnraNq1  
The experiments were carried out in accordance with the Declaration of Helsinki(2000) of the World Medical Association and the protocols approved by the Institutional Research Review Board at ¡Á¡Á¡ÁHospital of Beijing University,with informed consent¡­ jBMGm"NE  
¨SʵÑé²ÄÁÏ£¨experimental materials£©£º¶Ô²ÄÁϵÄÃèÊöÓ¦Çå³þºÍÏêϸ¡£Èç¹û²ÉÓÃͨÓòÄÁϺÍͨÓ÷½·¨£¬Ö»Ðè¼òµ¥Ìá¼°¡£ÀýÈ磬¡°Detail on calculating CBF have been described previously (reference)¡±»òÕß¡°the CBF was calculated based on q+{$"s9v  
The protocol as previously described (reference)¡±¡£Èç¹û²ÉÓÃÓиĽøµÄÌØÊâ²ÄÁϺÍʵÑé·½·¨£¬¾ÍÓ¦¸Ã½ÏÏêϸµÄ¼ÓÒÔ˵Ã÷¡£»¯Ñ§Ò©Æ·ºÍʵ¼ÊµÄÉÌÒµÀ´Ô´Ó¦¸Ã˵Ã÷£¬µ«Êǹ«Ë¾µØÖ·²»±Ø˵Ã÷£¬Èç¡°¡­poly-l-Lysine(Sigma#1309)¡±·ÇÉÌÒµÀ´Ô´µÄ»¯Ñ§Ò©Æ·ºÍÊÔ¼Á±ØÐëÌṩµØÖ·£¬Èç¡°The DCX antibody was kindly provived by Peter A.Rice(Buck Institute La Jolla,CA)¡±¡£ YT~h1<se  
¨SʵÑéÉ豸£¨experimental equipment£©:Òª¶ÔÒÇÆ÷Ðͺš¢Éú²ú³§¼Ò¡¢ÊµÑé¹ý³ÌÖеÄÓÃ;µÈ×÷Ïêϸ˵Ã÷£»É豸ʹÓÃʱһЩ±ØÒªµÄµÄ²½Öè²»¿ÉÊ¡ÂÔ£¬ÓÈÆäÊÇ¿ÉÄܶÔʵÑé½á¹ûÔì³ÉÌض¨Ó°ÏìµÄ²Ù×÷¸üÒªÏêϸ˵Ã÷¡£ÕâÑù×öµÄºÃ´¦ÊÇΪÁËÔÚDiscussionÕ½ÚÖÐÄܹ»½øÐжÔÓ¦µÄ·ÖÎö¡£ÀýÈ磬һЩÉ豸ÔÚʹÓÃǰҪУÕý£¨calibration£©£¬ÓеÄÒªÇóÿ½×¶ÎÊÔÑéÖ®ºó¶¼ÒªÖØÐÂУÕý£¬ÒÔ±£Ö¤½á¹ûµÄÕýÈ·ÐÔ¡£Ò»¶¨ÒªÏêϸ˵Ã÷ÄãµÄ²Ù×÷²½Öè»òУÕý¹ý³Ì£¬±ãÓÚÆÀÉóÈË·ÖÎöÄãµÄ½á¹ûµÄ¿É¿¿ÐÔ¡£ HY2*5 #T  
ʾÀýÈý ʵÑéÉ豸ºÍʵÑé¹ý³ÌµÄ·½·¨Ð´×÷ NbPNcjPL  
Apparatus kHbH{])  
NRI data were acquired at 1.5-T clinical MRI system(Signa,GE Medcial Systems)using the product head coil and foam cushions to minimize head movement. A standard 3D inversion recovery prepped T1-weighted spoiled gradient dcho(GE)sequence (echo time [TE]/repetition time [TR]=8.6/1.6ms;field of view [FOV] of 24mm, 1mm isotropic resolution)was acquire for anatomical localization and a CSF-nulled T2-weighted FLAIR sequence(TE/TR=11002/145ms,FOV 24mm,slice thinkness of 5mm,256x192matrix) was acquired to identify regions of prior cerebral infarction¡­ 8)bqN$*h  
Stroke,2006,37:382-387 d6f+[<<  
£¨2£©ÊµÑé¹ý³Ì£¨experimental procedures£©£º¶ÔʵÑéµÄÕû¸ö²Ù×÷Á÷³ÌÃèÊöÒªÏêÂԵõ±¡¢ÖصãÍ»³ö¡£Ó¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑé¡£Èç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÐèµÄµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£ÐðÊöʱ£¬²»ÒªÂÞÁÐʵÑé¹ý³Ì£¬¶øÖ»ÐðÊöÖ÷ÒªµÄ¡¢¹Ø¼üµÄ¡£²¢ËµÃ÷ʹÓò»Í¬ÓÚÒ»°ãʵÑéµÄµÄÉ豸ºÍ²Ù×÷·½·¨£¬´Ó¶øÊÇÑо¿³É¹ûµÄ¹æ·¶ÐÔ¸ü¼ÓÏÊÃ÷¡£ÐðÊöʵÑé¾­¹ý£¬Í¨³£²ÉÓÃÑо¿¹¤×÷µÄÂß¼­Ë³Ðò£¬¶ø²»°´ÊµÑéÏȺó˳Ðò£¬Òª×¥×¡»·½Ú£¬£¬´Ó¸´ÔÓµÄÊÂÎïÖÐÀí³öÂöÂ磬°´Æä·¢Õ¹±ä»¯¹æÂÉд¡£ +x]3 - s  
£¨3£©½á¹ûµÄͳ¼Æ´¦Àí£¨How the data were analyzed?£©¡£ÊµÑéµÄ½á¹ûÐèÒª½øÐÐͳ¼Æ´¦Àíʱ£¬ÒªÌṩ×ã¹»µÄÐÅÏ¢£¬°üÀ¨£º s"JD,gm$  
¨SʵÑéÖظ´Á˼¸´Î£¬Ò»°ãÀ´ËµÊµÑéÖÁÉÙÖظ´Èý´Î¡£ ~ UNK[  
¨S¾ùÖµ¡£ 4A)@,t9+  
¨S±ê×¼Îó£¨SEM£©»ò±ê×¼²î£¨SD£©¡£ }l7@:ezZZ7  
¨Sͳ¼Æ·ÖÎöµÄ·½·¨¡£ 0b(x@>  
¨SPÖµ£¨P value£©¡£ m[DCA\M o@  
3.²ÄÁϺÍд×÷·½·¨µÄÒªµã 4l'`q+^-  
£¨1£©ÃèÊöʵÑé¹ý³ÌÓ¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑ飬±ÜÃâ»ìÈëÓйؽá¹û»ò·¢ÏÖijЩ·½ÃæµÄÄÚÈÝ¡£ W 9!K~g_  
£¨2£©Ð´×÷ʱҪÏêÂԵõ±¡£×ñÑ­µÄÔ­ÔòÊÇ£ºÈç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÒªµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£Èç¹û¸Ä½ø£¬¿ÉÓá°Briefly¡±¡°In brief¡±½«¸Ä½øµÄ²¿·ÖÁí¼Ó˵Ã÷¡£ ib-H jJ8  
£¨3£©Ò©Æ·ºÍÊÔ¼ÁµÄŨ¶È£¬Ê²Ã´Ê±ºò´¦ÀíµÄ¡¢´¦Àíʱ¼äµÄ³¤¶ÈµÈÐðÊöÒ²ºÜÖØÒª£¬ÌرðÊǵ±Ìõ¼þÓб仯ʱ¡£ %R^*MUTx  
£¨4£©¿ÉÒÔÓÃÁ÷³Ìͼ½øÐÐ˵Ã÷ʵÑé¹ý³Ì¡£Á÷³ÌͼµÄ»­·¨ºÜ¶à£¬ÓÐÎÄ×ÖʽµÄ£¬ÓÐÎÄ×ÖºÍʾÒâͼ½áºÏµÄ£¬²»Í¬ÊµÑéÓв»Í¬×ö·¨¡£Ò»°ãÀ´Ëµ£¬¿ÉÄܺóÕ߶àһЩ£¨ÊµÑéÐÔѧ¿ÆÓÈÆäÈç´Ë£©£¬ÒòΪÕâÑùÄÜʹÆÀÉóÈ˶ÔʵÑé¹ý³ÌһĿÁËÈ»¡£Èç¹ûʾÒâͼ»­µÃƯÁÁ£¬»¹¿ÉÒÔÔö¼ÓһЩӡÏó·Ö¡£ÃèÊöʱҪÓÐÏÊÃ÷µÄ²ã´Î¸Ð£¬¶Ôÿ¸ö²½ÖèÖ®¼äµÄ˳ÐòºÍ¹ØÁªÒªÃèÊöÇå³þ£¬²»ÒªÔì³ÉʵÑé¹ý³Ì»ìÂÒ²»¿°µÄÓ¡Ïó¡£ 7g|EqJ7  
£¨5£©²»ÒªÖظ´ÃèÊö¡£ F1u2SltR  
4.ÂÛÎÄÖг£´æÔÚͳ¼Æ·½·¨Ñ¡Ôñ²»µ±ºÍÓ¦Óò»ÕýÈ·µÈÎÊÌâ }fJLY\  
£¨1£©Í³¼Æ·½·¨ÃèÊö²»Ç壬½áÂÛÇ·¿Æѧ¡£ÎÄÖÐδ½»´ýËùÓÃͳ¼Æ·½·¨»òͳ¼Æ·½·¨½»´ú²»Çå»ò¸ù±¾²»Óè½»´ú£¬Ê¹¶ÁÕ߶ÔÂÛÎĵÄÕýÈ·Óë·ñÎÞ·¨Åжϡ£ÓеÄ×÷ÕßÖ»ÌáÒ»¾ä¡°¾­Í³¼Æѧ´¦Àí¡±ºó£¬¾Íд³ö½áÂÛ¡£ÓеÄÉõÖÁÖ±½ÓÓÃPֵ˵Ã÷ÎÊÌ⣬ÁýͳµØÒÔP£¾0.05»òP£¼0.05¡¢P£¼0.01±ã³Æ½á¹û²îÒìÓÐÎÞÏÔÖøÐÔ£¬PÖµµÄ´óС²»ËµÃ÷²îÖµµÄ´óС£¬Ëü»¹Óë³éÑùÎó²î´óСÓйء£Òò´Ë£¬»¹Ó¦¸ÃдÃ÷¾ßÌåµÄͳ¼Æ·½·¨£¬ÈçÓÐÌØÊâÇé¿ö£¬»¹Ó¦¸Ã˵Ã÷ÊÇ·ñ²ÉÓÃÁËУÕý£¬Ó¦Ð´³öÃèÊöÐÔͳ¼ÆÁ¿µÄ¿ÉÐÅÇø¼ä£¬×¢Ã÷¾«È·Í³¼ÆÖµ£¨ÈçtÖµ¡¢FÖµºÍuÖµµÈ£©ºÍPÖµ£¬È»ºó¸ù¾ÝPÖµ´óС×ö³öͳ¼ÆѧÍƲ⣬²¢×ö³öÏàÓ¦µÄרҵ½áÂÛ¡£ T#GTNk!v  
£¨2£©©~ͳ¼Æ¼ìÑé·½·¨²»ÕýÈ·¡£¾ßÌå±íÏÖÔÚ£º =K <`nF0 w  
¡òtÖµ¼ìÑéÓÃÓÚ¶à×é×ÊÁϱȽϡ£ "A]#KTP  
¡ò³É×ét¼ìÑéÓëÅä¶Ôt¼ìÑéÎóÓᣠx|$|~ 6f=n  
¡ò¶ÔÓÚƫ̬·Ö²¼µÄÊý¾Ý²ÉÓÃt¼ìÑé»ò·½²î·ÖÎö¡£ K05U>151  
¡òËĸñ±íµÄ¼ìÑéÎóÓ㬹¹³É±ÈÓëÂʵÄÎóÓ㬷ÇÕý̬·ÖÎö×ÊÁÏÓáÀSM·½Ê½À´ÃèÊö¡£ eX'U d%  
ÕâЩ´íÎóµÄ·½·¨±ØÈ»µ¼Ö´íÎóµÄ½áÂÛ¡£ÕýÈ·µÄ×ö·¨ÊÇÅä¶ÔÉè¼ÆµÄ¼ÆÁ¿×ÊÁÏÒËÑ¡ÓÃt¼ìÑé¡£t¼ìÑéºÍ·½²î¼ìÑéÖ»ÄÜÓÃÓÚÕý̬·Ö²¼µÄÊý¾ÝÖС£µ±·½²î²»Æëʱ£¬Ó¦Ñ¡ÓýüËƵÄt¼ìÑ飬ÈôΪ´óÑù±¾£¨n£¾50£©£¬¿ÉÑ¡ÓÃu¼ìÑé¡£¶à×é¼ä¾ùÊý±È½Ïʱ£¬Èç¹û×ÊÁϳÊÕý̬·Ö²¼£¬ÇÒ·½²î³ÊÆëÐÔʱ£¬Ó¦¸ÃÓ÷½²î·ÖÎö£¨Ò²½ÐANOVA·ÖÎö£¬»òF¼ìÑ飩¡£ÒªÑо¿Ä³Á½¸ö»òij¼¸¸ö×ÜÌå¾ùÊýÊÇ·ñÏàµÈ£¬»¹ÒªÔÚ·½²î·ÖÎöµÄ»ù´¡ÉÏ£¬½øÒ»²½×öÁ½Á½±È½ÏµÄq¼ìÑ飨Ҳ½ÐStudent-Newman-Keuls¼ìÑé·¨£©¡£µ±¶à¸ö¹Û²ì×éÓëÒ»¸ö¶ÔÕÕ×é½øÐоùÊý¼ä±È½Ïʱ£¬Ó¦×÷Dunnett t¼ìÑé¡£ B  
5.²ÄÁϺͷ½·¨Ð´×÷ʱ̬µÄÓ¦Óà d_ 7hh  
£¨1£©ÈôÃèÊöµÄÄÚÈÝΪ²»ÊÜʱ¼äÓ°ÏìµÄÊÂʵ£¬Ôò²ÅÓÃÒ»°ãÏÖÔÚʱ¡£ ,c,@WQ2:-  
£¨2£©ÈçÃèÊöµÄÄÚÈÝΪÌض¨¡¢¹ýÈ¥µÄÐÐΪ»òʼþ£¬Ôò²ÉÓùýȥʱ¡£ .Ta(v3om%  
£¨3£©·½·¨Õ½ڵĽ¹µãÔÚÓÚÃèÊöʵÑéÖÐËù½øÐеÄÿ¸ö²½ÖèÒÔ¼°Ëù²ÉÓõIJÄÁÏ¡£ÓÉÓÚËùÉæ¼°µÄÐÐΪÓë²ÄÁÏÊÇÌÖÂ۵Ľ¹µã£¬¶øÇÒ¶ÁÕßÒÑÖ¸µ¼½øÐÐÕâЩÐÐΪºÍ²ÉÓÃÕâЩ²ÄÁϵÄÈ˾ÍÊÇ×÷Õß×Ô¼º£¬Òò¶øÒ»°ã¶¼Ï°¹ß²ÉÓñ»¶¯Óï̬¡£ IU;a$  
£¨4£©Èç¹ûÉæ¼°±í´ï×÷ÕߵĹ۵ã»ò¿´·¨£¬ÔòÓ¦²ÉÓÃÖ÷¶¯Óï̬¡£ oA?EJ~%  
£¨5£©Á¦ÇóÓï·¨ÕýÈ·¡¢ÃèÊö׼ȷ¡£ÓÉÓÚ²ÄÁϺͷ½·¨²¿·Öͨ³£ÐèÒª²ÉÓúܼò½àµÄÓïÑÔ£¬Ê¹Óþ«È·µÄÓ¢ÓïÃèÊö²ÄÁϺͷ½·¨ÊÇÊ®·ÖÖØÒªµÄ¡£ÐèҪעÒâµÄ·½Ãæͨ³£ÓУº &B\ sG=  
¨S²»ÒªÒÅ©¶¯×÷µÄÖ´ÐÐÕß¡£ Y@Ur}  
¨SÔÚ¼òµ¥±í´ïµÄͬʱҪעÒâÄÚÈÝ·½ÃæµÄÂß¼­ÐÔ¡£ K3k{q90   
¨SÈç¹ûÓжàÖֿɹ©Ñ¡ÔñµÄ·½·¨ÄܲÉÓã¬ÔÚÒýÓÃÎÄÏ×ʱÌἰһϾßÌåµÄ·½·¨¡£ m/3,;P.6  
¨SÆÕͨ¡¢¼òµ¥µÄ¹ý³Ì²»±ØÏêÊö¡£ saTS8p z  
¨S±ÜÃâʹÓú¬ºý²»ÇåµÄÃèÊö¡£ [ 2PPa9F  

kaobook 2011-08-17 22:34
µÚ10ÕÂÈçºÎÊéдSCIÂÛÎĵÄÑо¿½á¹û ,KCxNdg^#-  
Ñо¿½á¹û£¨Results£©ÊÇһƪÂÛÎĵĺËÐÄ£¨the core of the paper£©,Æäˮƽ±êÖ¾×ÅÂÛÎĵÄѧÊõ»áƽ»ò¼¼Êõ´´Ðµij̶ȣ¬ÊÇÂÛÎĵÄÖ÷Ì岿·Ö¡£×ܵÄÒªÇóÊDZØÐëʵÊÂÇóÊÇ¡¢¿Í¹ÛÕæʵ¡¢×¼È·µÄÓÃ˵Ã÷ÐÔ²ÄÁÏ£¨Í¼ºÍ±í£©ÃèÊöÖ÷Òª³É¹û»òÕß·¢ÏÖ¡£ÎÄ×ÖÃèÊöÒªºÏºõÂß¼­¡¢²ã´Î·ÖÃ÷¡¢¼òÁ·¿É¶Á¡£ÓÐÈË°ÑResultsºÍDiscussion·ÅÔÚÒ»Æðд£¬µ«ÊÇ´ó¶àÊýÂÛÎÄÒªÇó·Ö¿ªÐðÊö¡£ÕâÁ½ÖÖ×ö·¨È¡¾öÓÚÂÛÎĵÄÀàÐÍ£¬±ÈÈçÊÇresearch article»¹ÊÇrapid communication¡£ÓÐһЩSCIÆÚ¿¯µÄrapid communicationÒªÇóresultÓëdiscussionºÏ²¢¡£ [RF6mWQ  
1.Ñо¿½á¹ûµÄд×÷Òªµã <eZ*LK?   
£¨1£©ÑÔ¼òÒâêࣨbe concise£©¡£¶ÔʵÑé»ò¹Û²ì½á¹ûµÄ±í´ïÒª¸ß¶È¸ÅÀ¨ºÍÌáÁ¶¡£²»Äܼòµ¥µØ¶ÔʵÑé¼Ç¼Êý¾Ý»ò¹Û²ìÊÂʵ¶Ñ»ýµ½ÂÛÎÄÖУ¬ÓÈÆäÊÇҪͻ³öÓпÆѧÒâÒåºÍ¾ßÓдú±íÐÔµÄÊý¾Ý¡£ U!(es0rX  
£¨2£©±ÜÃâÖظ´£¨avoid repetition£©¡£¾ö¶¨ÄÄһЩÄÉÈë½á¹ûÕ½ڣ¬ÄÄһЩǨÒƵ½ÌÖÂÛÕ½ڡ£ÔÚ½á¹ûÕ½ڣ¬ÄãÖ»ÃèÊö½á¹û£¬Ò»°ã×ö²»×ö½âÊÍ¡£ÔÚÌÖÂÛÕ½ڽøÐнâÊÍ£¬²¢ÓëÒÑÖªµÄ±¨µÀ±È½Ï£¬²»ÒªÖظ´ËùÓнá¹û¡£ '<s5 4 Cb  
£¨3£©¶ÔʵÑé»ò¹Û²ì½á¹ûÒª¿Í¹ÛµØÆÀ¼Û¡£Äã¹Û²ìµ½Ê²Ã´»òÄã·¢ÏÖÁËʲô£¿¶Ôÿ¸öʵÑé»ò³ÌÐòÒª£º pI_dV44W  
¨S¼òÊöʵÑ飨£©¡£ÀýÈ磬¡°By Western bolt abnaiysis,we found that¡­¡±¡£ &?$mS'P  
¨S±¨¸æµÄÖ÷Òª½á¹û£¨mains results£©°üÀ¨Ô¤ÆÚ½á¹û£¨positive results£©ºÍÒõÐÔ½á¹û£¨negative results£©¡£ 1|m%xX,[  
¨SµäÐÍʵÀý£º×î³£¼ûµÄ£¨most common£©¡£ 3l"8_zLP  
¨S×î¼Ñ°¸Àý£º×îÀíÏëµÄÀýÖ¤£¨best example of ideal or exception£©¡£ n,d)Wwe_`y  
£¨4£©Ñо¿½á¹ûÊDZí´ï×÷Õß˼Ïë¹Ûµã×îÖØÒªµÄ²¿·Ö¡£Îª±í´ïÇå³þ£¬¶àÑо¿¹ý±ØÐë·Ö³ÉÈô¸É¸ö²ã´ÎÀ´Ð´¡£ÓеÄÑо¿½á¹ûÖ»·Ö³ÉÈô¸É¸ö×ÔÈ»¶Î¡£×¢ÒâÒ»¸ö×ÔÈ»¶ÎÖ»Äܱíʾһ¸öÖÐÐÄ˼Ïë¡£Ò²¿ÉÒÔ·Ö³ÉÈô¸É¸öС±êÌâ½øÐзֲã±íÊö£¬¶¼Òª×¢Òâ²ã´ÎÖ®¼äµÄÂß¼­¹Øϵ¡£¶à½á¹ûµÄÂß¼­ÅÅÁУ¬Ó¦×ñÑ­ÒÔÏÂÔ­Ôò£º "n_X4e+18P  
¨S´Ó×îÖØÒªµ½×î²»ÖØÒª£¨from most to least impirtant£©¡£ %/ctt_p0x  
¨S´Ó¼òµ¥µ½¸´ÔÓ£¨from simple to complex£©¡£ SsPZva  
¨S°´ÏàͬÀàÅÅÁУ¬Èçorgan by organ¡¢chemical class by chemical class¡£ TbaZFLr  
¨Sд×÷Ó¦°´Ñо¿ÎÊÌâµÄÂß¼­¹ØϵÀ´Ð´£¬²»Ó¦°´ÊµÑé»òʱ¼ä˳ÐòÀ´Ð´¡£ Y::O*I2  
£¨5£©Êý¾Ý±í´ï¿É²ÉÓÃÎÄ×ÖÓëͼ±íÏà½áºÏµÄÐÎʽ¡£Èç¹ûÖ»ÓÐÒ»¸ö»òÕߺÜÉٵIJⶨ½á¹û£¬ÔÚÕýÎÄÖÐÓÃÎÄ×ÖÃèÊö¼´¿É£»Èç¹ûÊý¾Ý½Ï¶à£¬¿É²ÉÓÃͼ±íÐÎʽÀ´ÍêÕû¡¢ÏêϸµØ±íÊö¡£ÎÄ×Ö²¿·ÖÔòÓÃÀ´Ö¸³öͼ±íÖÐ×ÊÁϵÄÖØÒªÐÔÌØÕ÷»òÇ÷ÊÆ¡£ C57m{RH  
£¨6£©Ò»°ã²»½âÊÍԭʼÊý¾Ý£¨do not interpret the data£©¡£Èç¹ûÂÛÎÄÖл¹°üÀ¨¶ÀÁ¢µÄDiscussionÕ½ڣ¬Ó¦½«¶ÔÓÚÑо¿½á¹ûµÄÏêϸÌÖÂÛÁôµ½¸Ã²¿·Ö¡£ {PR "}x  
ʾÀýÒ» )xiu \rC  
½á¹ûûÓнâÊÍ£º¡°The duration of exposure to running water had a pronounced effect on cumulative seed grermination percentages.Seeds exposured to the 2-day treatment had the highest cumulative germination(84%), 1.25times that of the 12-h or 5-day groups and 4 times that of controls¡±¡£ 0HUylnXf0  
´øÓнâÊÍÐÔ£º¡°The results of the germination experiment suggest that the optimal time for running-water treatment is 2-days.This group showed the highest cumulative germination(84%),with longer(5d) or shorter(12h) exposures producing smaller gains in germination when compared to the control group¡±¡£ l u8*+.V  
£¨7£©ÎÄ×Ö±í´ïӦ׼ȷ¡¢¼ò½à¡¢Çå³þ¡£±ÜÃâʹÓÃÈß³¤µÄ´Ê»ã»ò¾ä×ÓÀ´½éÉÜ»ò½âÊÍͼ±í¡£Îª¼ò½à¡¢Çå³þÆð¼û£¬²»Òª°Ñͼ±íµÄÐòºÅ×÷Ϊ¶ÎÂäµÄÖ÷Ìâ¾ä£¬Ó¦ÔÚ¾ä×ÓÖÐÖ¸³öͼ±êËù½ÒʾµÄÀíÂÛ£¬°Ñͼ±íÖеÄÐòºÅ·ÅÈëÀ¨ºÅÖС£ 7WwE] ^M  
ÈçʾÀý lh[?`+A  
[²»ÍƼö]Figure 2 shows that neurons were distinguished from astrocytes by the selectivelabeling of astrocytes with SR-101. Z/dhp0k  
¡¾ÍƼö¡¿Neurons were distinguished from astrocytes by the selective labeling of astrocytes with SR-101(Fig.2). j8nkNE]&   
[²»ÍƼö]The results are given in Figure 1. @mmnr?_ w  
¡¾ÍƼö¡¿Temperature was directly proportional to metabolic rate(Fig.1). 0)M8Tm0$  
£¨8£©±ÜÃâ׸Êö¡£±ÜÃâͬÑùµÄÊý¾Ý³öÏÖÔÚͼºÍ±íÖС£ 'y=N_/+s  
£¨9£©¾¡Á¿ÓþùÖµ¡¢°Ù·ÖÊýµÈ¸ÅÀ¨Ô­Ê¼Êý¾ÝÖµ£¨raw data£©¡£ uovv">Uw  
£¨10£©°üÀ¨Êý¾Ý»òͳ¼Æ×ÊÁÏʱ£¬Ó¦¸Ã¸³ÓèÊʵ±µÄµ¥Î»£¨appropriate units£©¡£ %~y>9K  
ʾÀýÈçÏ£º OQ- Hn -H  
µ¥¸öÊý¾Ý¡°The maximum time was 140 min¡±¡£ ""Da 2Md  
¶àλÊý¾ÝÐèÒª¼ÓÉÏÎó²î£¨error value£©Èç¡°¡­was 10¡À2.3h¡±. #n}~u@,o_  
һϵÁеÄÊý×Ö¶¼ÓÐÏàͬµÄµ¥Î»£¬ÔÚβÊý¼Óµ¥Î»£¨units£©£¬Èç¡°No differences were observed after 2,4,6,or 8h of incubation¡±¡£ L7d1)mV  
2.Ñо¿½á¹ûд×÷ʱ̬µÄÓ¦Óà L SP p  
£¨1£©ÐðÊöÑо¿½á¹ûµÄÄÚÈÝ£¬Í¨³£²ÉÓùýȥʽ¡£ 9}u,`&  
£¨2£©Í¼¡¢±íΪÖ÷Óïʱ£¬³£ÓÃÒ»°ãÏÖÔÚʱ¡£ DY 9]$h*y  
£¨3£©¶ÔÑо¿½á¹û½øÐÐ˵Ã÷»òÓÉÆäµÃ³öÒ»°ãÐÔÍÆÂÛʱ£¬¶àÓÃÏÖÔÚʱ¡£ +[<YE  
£¨4£©²»Í¬½á¹ûÖ®¼ä»òʵÑéÊý¾ÝÓëÀíÂÛÄ£ÐÍÖ®¼ä½øÐбȽÏʱ£¬¶à²ÉÓÃÒ»°ãÏÖÔÚʱ£¨ÕâÖֱȽϹØϵ¶àΪ²»ÊÜʱ¼äÓ°ÏìµÄÂß¼­ÉϵÄÊÂʵ£©¡£ u*TC8! n  
3.Ñо¿½á¹ûµÄд×÷Óï̬ Xl$, f`f~  
½á¹û²¿·ÖÒÔ±»¶¯Óï̬ΪÖ÷¡£¿ÉÒԲβåÖ÷¶¯Óï̬¡£ }f]Y^>-Ux  

kaobook 2011-08-17 22:34
µÚ11Õ ÈçºÎÕýÈ·±í´ïSCIÂÛÎÄÖеÄͼºÍ±í 4,e'B-.  
ËäÈ»ÎÄ×ÖÊÇSCIÆÚ¿¯±í´ïµÄÖ÷ÒªÊֶΣ¬µ«ÔÚ±í´ï½á¹û·½Ã棬ͼºÍ±í£¨figures and tables£©±ÈÎÄ×Ö¸ü¾ßÓÐÖ±¹ÛÐÔ£¬ÇÒ¼òµ¥Ã÷ÁË£¬±ÜÃâÁËÈß³¤µÄÎÄ×ÖÐðÊö¡£ËüÄܹ»ÒÔ½ÏСµÄ¿Õ¼ä³ÐÔØ׎϶àµÄÐÅÏ¢£¬Ö±¹Û¡¢¸ßЧµØ±í´ï¸´ÔÓµÄÊý¾ÝºÍ¹Ûµã£¬Ê¹¶ÁÕßÀí½âÎÄÕÂËùÐðÊöÊÂÎïµÄÐÎ̬¼°±ä»¯¹æÂÉ£¬²¹³äÎÄ×ÖÐðÊöµÄ²»×ã¡£ÓÈÆäÊÇÔÚÃèÊö±äÁ¿¼äµÄÏ໥×÷Óûò·ÇÏßÐÔ¹Øϵʱ£¬ËüÒ²Äܹ»°ÑÓÃÎÄ×ÖÓïÑÔÄÑÒÔ±íÊöÇå³þµÄÄÚÈÝ£¬¼òÃ÷µØ³ÊÏÖ³öÀ´£¬Ê¹ÂÛÎĵÄÄÚÈݱí´ïµÄ¸üºÏÀí¡¢¸üÍêÉÆ¡£Òª¼Çס£º¡°A picture is worth a thousand words¡±¡£ n^Ca?|} ,  
1.²åͼµÄÀàÐÍ SCIÂÛÎÄÖеIJåͼÖÖÀàºÜ¶à£¬³£ÓõÄÓУº |oi+|r  
£¨1£©ÏßÐÎͼ£¨line graphs£©¡£ÓÃÓÚ˵Ã÷Á½¸ö±äÁ¿£¨two variables£©Ö®¼äµÄ¹ØϵºÍÇ÷ÊÆ(trends and relationships between data)¡£×Ô±äÁ¿£¨independent variable£©±êÔÚX-ÖáÉÏ£¨X-axis£©£¬Òò±äÁ¿(dependents variable)±êÔÚY-ÖáÉÏ(Y-axis)¡£³£ÓÃÓÚÏÔʾÁ¬ÐøÐԱ仯¡£ÏßÐÎͼÖеÄÏßÌõÊýÄ¿Ò»°ã²»³¬¹ý5Ìõ£¬µ«ÎÞÂÛ¼¸Ìõ£¬¶¼Ó¦ÒÔÄܹ»ÇåÎú·Ö±æΪԭÔò¡£ÏßÐÎͼҪÇó£º LE\=Y;%  
¨SÏßÌõÇåÎú¼ò½à¡£ Yv5H41o"  
¨SͼÐÎÖеÄÎÄ×Ö¡¢±êÖµÓ¦Ò×ÓÚ±æÈÏ¡£ U!aM63F3  
¨S×ø±êÖáÅԵıêÄ¿Ó¦°üº¬²âÁ¿µ¥Î»¡£ .eR1\IAm  
¨S±íʾ²»Í¬±äÁ¿µÄ·ûºÅÈÝÒ×Çø·Ö¡£ K*SgEkb'l  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏò´¹Ö±¡£ x b"z%.j  
£¨2£©ÌõÐÎͼ»òÖ±·½Í¼£¨bar graphs or histograms£©¡£ :&IHdf0+  
µ±×Ô±äÁ¿ÊÇ·ÖÀàÊý¾Ýʱ£¬¿ÉÒÔ²ÉÓÃÌõÐÎͼ»òÖ±·½Í¼À´ËµÃ÷×Ô±äÁ¿µÄ¹ØÁª¡£ÌõÐÎͼ»òÖ±·½Í¼Ö÷ÒªÓÃÓÚ½ÒʾÁ˱仯·ù¶È£¨change in magnitude£©£¬¶øÏßÐÎͼÖ÷ÒªÊÇÓÃÀ´ÏÔʾ¸Ä±ä·½Ïò»òÕßÇ÷ÊÆ£¨change in direction£©¡£ÌõÐÎͼ»òÖ±·½Í¼¿ÉÒÔÊÇ×ÝÏò»òºáÏò¡£Ã¿Ìõ´ú±íÒ»ÀàÊý¾Ý£¬ÌõµÄ³¤¶Ì±íʾÊý¾ÝµÄ´óС¡£ÓÐʱһÀà±äÁ¿ÓÖ·ÖΪ¼¸¸öˮƽ£¬¾ÍÐèÒªÓÃÏàÓ¦ÊýÁ¿µÄÌõÀ´±íʾ¡£³£¼ûÌõÐÎͼ¾ßÓÐÏÂÁÐÀàÐÍ£º *n CA6i  
¨SÊúʽÌõÐÎͼ£¨vertical bar graphs£©¡£ H<(F$7Q!\  
¨SµþʽÌõÐÎͼ£¨stacked bar graphs£©¡£ %S`& R5  
¨SµãʽÌõÐÎͼ£¨dot graphs£©¡£ <RY =y?%z  
ÌõÐÎͼ»òÖ±·½Í¼ÒªÇó£º K(EJ`2]:r  
¨S²»Í¬µÄÌõÓÐÃ÷ÏÔÇø·Ö¡£ b=,B Le\  
¨SÖáÉϵĿ̶ÈÒ×ÓÚ±æÈÏ£¬×Ý×ø±êµÄ±êÄ¿°üº¬²âÁ¿µ¥Î»¡£ R2,9%!iiX  
¨S×Ý×ø±êµÄ³¤¶ÈÖÁÉÙºÍ×µÄÌõµÄ³¤¶ÈÏàµÈ¡£ #\0m(v  
¨SͼÖеÄÎÄ×Ö¡¢Êý×ÖÓ¦Ò×ÓÚ±æÈÏ¡£ =AIFu\9#a`  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏà´¹Ö±¡£ Vu:ZG*^  
£¨3£©±ýÐÎͼ»ò°Ù·Ö±Èͼ£¨pie or percentage graphs£©¡£ u? =mh`  
ÓÃÀ´ÏÔʾ¸÷ÖÖÊý×Ö±ÈÀý¹ØϵµÄͳ¼Æͼ¡£°Ñµ¥Î»Ô²ÊÓΪ100%£¬¸÷ÖֳɷֵÄÊýÁ¿°´ÔÚÕûÌåÖÐËùÕ¼µÄ·Ý¶îÔÚÔ²ÐÎÖÐÏÔʾ¡£ÔÚÓÃÓڶԱȼ¸¸öÊý¾ÝÔÚÆäÐγɵÄ×ÛºÏÖÐËùÕ¼°Ù·Ö±Èֵʱ×îÓÐÓ᣾¡¹Ü±ýÐÎͼÒ×ѧºÃÓ㬵«ÔÚʵ¼Ê¹¤×÷ÖÐʹÓñȽÏÉÙ¡£ÆäÔ­Òò£ºÊ×ÏÈ£¬±È½ÏµÄÏîÄ¿Ò»°ã²»Äܳ¬¹ý6¸ö¡£·ñÔòͼÐλáÌ«¸´ÔÓÄÑÒÔÀí½â¡£Æä´Î£¬µµ±È½ÏµÄÊý¾ÝºÜ½Ó½üʱ£¬¾ÍºÜÄÑ¿´µ½¸÷²¿·ÖµÄ²îÒ졣ͻ³ö¸÷²¿·Ö½ÏºÃµÄ·½·¨Ö®Ò»ÊÇ´ÓÃ÷µ½°µÓò»Í¬µÄÑÕÉ«»òµã¸ø¸÷¸ö²¿·ÖͼÉÏÒõÓ°£¬×îСµÄ²¿·Ö×îºÚ¡£»òÕßÓò»Í¬µÄÑÕÉ«À´±íʾ¡£ÖÆͼµÄ¼ÆËã·½·¨£º°Ù·Ö±È¡Â100¡Á360¡ã=¡Á¡Á¡Á¡ã LwC?t3n  
£¨4£©É¢µãͼ£¨scatter graphs, scatterplot£©¡£ÓÉÈô¸É¸öµã×é³É£¬ÕâЩµã¶ÔÓ¦ÓÚƽÃæÖ±½Ç×ø±êϵÖеÄ×ݺáÖáÁ½¸ö±äÁ¿£¬±íʾij¸öʼþµÄÊýÖµ¡£Í¨³£ÓÃÓڱȽϿçÀà±ðµÄ·ÇÖظ´Öµ¡£¿É´ÓµãµÄλÖÃÅжϲâÁ¿ÖµµÄ¸ßµÍ¡¢´óС¡¢±ä¶¯Ç÷ÊÆ»ò±ä»¯·¶Î§¡£É¢µãͼ¼ÓÈëÇúÏߣ¬¿ÉÒÔ¿´µ½Ç÷ÊÆ¡£Èç¹ûËùÓеĵ㹹³ÉÒ»¸öÌõÐΣ¬Ôò˵Ã÷´æÔÚÏà¹Ø¹Øϵ¡£ÀýÈ磬ÑØ×ÅбÏßÉϵÄÒ»µãÒâζ×ÅÏßÐÔÏà¹Ø£¬Èç¹ûËùÓе㶼ÂäÔÚÒ»ÌõбÏßÉÏ£¬ÄÇôÆäÏà¹ØϵÊýΪ1.00¡£ n<.7tr0f\  
£¨5£©½á¹¹Í¼»òÁ÷³Ìͼ£¨structure graph or flow chart£©Äܹ»ÃèÊö²Ù×÷¹ý³ÌµÄ²½ÖèÖ®¼ä¡¢Ð¡×éÄÚ¸÷²¿·ÖÖ®¼äµÄ¹Øϵ¡£½á¹¹Í¼¾­³£ÊÇ·½¿é»òԲȦÓëÏßÁ¬Óá£ÀýÈ磬×éÖ¯½á¹¹Í¼¿ÉÒÔÏÔʾ³ö³ÉÔ±¼äµÄµÈ¼¶£»Á÷³Ì½á¹¹Í¼ÏÔʾһ¸ö¹ý³ÌÖеĸ÷¸ö²½Ö裻ģÐͽṹͼ¿ÉÒÔÏÔʾ²»Í¬±äÁ¿Ö®¼äµÄ¹Øϵ¡£ ZnEgU}g<2  
½á¹¹Í¼ÒªÇó£º X:GRjoa  
¨SͬһÐÔÖʱäÁ¿ËùÓõķ½¿ò»òԲȦӦ´óСÏàͬ£¬ÏßÐÎÒ»Ö¡£ B\J[O5},  
¨SËùÓеÄÏßÌõµÄ´Öϸ¡¢¼ýÍ·µÄÐÎ×´Ó¦Ò»Ö¡£ 6}^x#9\  
£¨6£©ÕÕƬͼ£¨£©ÓÃÓÚÏÔʾÏÔ΢¾µÏÂ×éÖ¯ÇÐƬÏà¡¢·ÅÉäÓ°Ïñ¡¢´óÌå±ê±¾¼°ÐÎ̬ѧÌØÕ÷£¬ÕæÊÇ¡¢Ö±¹Û¡¢ÐÅÏ¢Á¿´ó¡£ÕÕƬͼÖÊÁ¿µÄºÃ»µÊǾö¶¨ÂÛÎÄÄÜ·ñ·¢±íµÄÒ»¸öÖØÒªÒòËØ¡£ ]9oj,k  
ÕÕƬͼҪÇó£º ;_,jy7lf  
¨SÇåÎú¶È¸ß£¬¶Ô±È¶ÈºÃ¡£ *k{Llq  
¨S×éÖ¯ÇÐƬÕÕƬӦ±êÃ÷±ÈÀý³ßºÍȾɫ·½·¨¡£ gP% <<yl  
¨SʵÎïÕÕƬΪ±íÃ÷ʵÎï´óС£¬²¢½«±ÈÀý³ßͬʱÅÄÔÚÕÕƬÉÏ¡£ !>sA.L&=  
¨SÒª¶Ô±ÈÇ¿ÁÒ¡¢ÖصãÍ»³ö¡£ 9q`Ewj R  
2.²åͼµÄÌØÕ÷ /5,6 {R9  
SCIÂÛÎĵIJåͼÆäÌØÕ÷ÓУº y\FQt];z)  
¨SͼÐεÄʾÒâÐÔ¡£´ÓͼÖеóö¸÷Á¿ÖµÖ®¼äµÄ¾«È·¹Øϵ¡£ [k7( t|Q{  
¨SÄÚÈݵÄдʵÐÔ¡£·´Ó¦±ä»¯¹æÂÉ£¬¸÷Á¿ÖµÖ®¼äµÄÏ໥±ä»¯¹Øϵ¡£ F*k =JL  
¨S±í´ïµÄ¹æ·¶ÐÔ¡£Í¼ÖеÄÏßÐΡ¢ÎÄ×Ö¡¢·ûºÅµÈÓ¦·ûºÏÓйرê×¼µÄ¹æ¶¨ºÍ¹«ÈϵÄÏ°¹ß¡£ÔÚͬһƪÎÄÕÂÖУ¬Í¬Ò»ÐÔÖʲåͼµÄ×ÖÌå¡¢×ֺš¢Ö÷¸¨ÏßÌõ´Öϸ¡¢µ¥Î»·ûºÅµÈÒªÏàͬ¡£ 'V&g"Pb  
3.²åͼҪÇó T9yI%;D  
ͼÒ×ÓڱȽϡ¢ËµÃ÷ÎÊÌâ¡£²àÖرíÏÖ¹ØÁª¡¢Ç÷ÊÆ¡¢Òò¹û¹ØϵµÈ¡£Ê¹ÓÃʱӦÉÙ¶ø¾«£¬Òª»æÖƵÄÇåÎú¡¢¼òÃ÷¡¢´ó·½¡¢ÃÀ¹Û£¬Ê¹ÈËͨ¹ý¿´Í¼Äܹ»¼ÓÉî¶ÔÄÚÈݵÄÀí½â¡£ $DDO9  
£¨1£©Í¼±íÓ¦¾ßÓÐ×ÔÃ÷ÐÔ£¨£©£¬¼´Ö»¿´Í¼¡¢Í¼½âºÍͼÀý¡¢²»ÔĶÁÕýÎÄ£¬¾Í¿ÉÒÔÀí½âͼÒâ¡£ `oxBIn*BD  
£¨2£©²¹³ä¶ø²»ÊÇÖظ´ÎÄ×ÖµÄÃèÊö¡£ rEa(1(I  
£¨3£©ÃèÊö×î»ù±¾¡¢×îÖØÒªµÄÊÂʵ¡£ YEv\!%B  
£¨4£©¼òÃ÷£¬Ê¡ÂÔ²»±ØÒªµÄϸ½Ú¡£ h% -=8l,  
£¨5£©²åͼӦ¸ÃÓÐͼÐòºÍͼÌ⡣һƪÎÄÕÂÖ»ÓÐÒ»¸ö²åͼÕßÒ²Ó¦ÓÐÐòºÅ£¬ÈçFigure 1(Fig 1)¡£Í¼ÌâÓ¦¼ò¶Ì¡¢×¼È·¡£ zJXZ0yRT  
£¨6£©ÏßÌõͼӦÏßÌõÇåÎú£¬´Öϸ¾ùÔÈ£¬±ÈÀýÊʵ±¡£ $ .tT  
£¨7£©ÕÕƬͼӦͼÏñÇåÎú£¬²ã´Î·ÖÃ÷£¬·´²îÊʶȡ£ g2f"tu_/%  
£¨8£©²åͼ¾ùÁíÖ½¸½ÓÚÎĺó£¨submission by mail£©»òÕßÁí´æΪJPEG»òÕßTIFFÎļþ£¨online submission£©£¬²¢ÔÚÎÄÕÂÖÐÏàÓ¦¶ÎÂäºó±êʾÆäλÖᣠqsj$u-xhX  
4.²åͼµÄÉè¼Æ  gW~YB2 $  
ÀûÓòåͼÀ´±í´ï½á¹û£¬Ó¦¶Ô²åͼ½øÐо«ÐÄÉè¼Æ£¬Ê¹Í¼ÃæµÄ±ÈÀýÊʵ±£¬ÇåÎúÃÀ¹Û¡£ rCo}^M4Pb  
£¨1£©±êÄ¿ÊÇÓÃÀ´ËµÃ÷×ø±êÖáµÄº¬ÒåµÄ£¬Ó¦¸ÃÓë±»±ê×¢µÄ×ø±êÖáƽÐУ¬¾ÓÖÐÅÅÓ¦ÔÚ×ø±êÖáºÍ±êÖµµÄÍâ²à£¬ÎÄ×Ö·½ÏòÓ¦¸ÃÓë×ø±êÖá·½Ïò´¹Ö±¡£Í¼ÖеÄ×Ö£¨±ê¼ÇÖáµÈ£©Ó¦¸ÃÊÇСдÀàÐÍ£¬µÚÒ»×Öĸ´óд£¬Ã»ÓоäºÅ¡£ R ~=c1bpdq  
£¨2£©±êÖµÊÇ×ø±ê¶¨Á¿±íÊöµÄ³ß¶È¡£±êÖµÓ¦·ÀÖ¹±ê×¢¹ý·ÖÃܼ¯ÒÔÖÁÓÚÊýÂëÇ°ºóÁ¬½Ó£¬±æʶ²»Çå¡£±êÖµÅÅÓ¦ÔÚ×ø±êÖáÍâ²à£¬½ô¿¿±êÖµ¶ÌÏߵĵط½¡£ÎªÁËÇåÎú£¬±êÖµµÄÊý×ÖÓ¦¾¡Á¿²»³¬¹ý3λÊý¡£Òò´Ë£¬ÒªÈÏÕæÑ¡È¡±êÄ¿Öеĵ¥Î»£¬ÈçÓÃ3kg´úÌæ3000g¡¢ÓÃ5ug´úÌæ0.005mgµÈ¡£×ø±êÖáÉϵıêÖµ·¶Î§ÊǸù¾ÝͼÐεÄÊý¾ÝÈ·¶¨£¬µ«×ø±êÖáÉϱêÖµµÄ¼ä¾àÔòÊÇÈÎÑ¡µÄ£¬²»Í¬µÄÑ¡Ôñ½«Ê¹Í¬Ò»ÌõÇúÏßÓв»Í¬µÄÐÎ×´¡£Òò´Ë£¬±êÖµµÄÈ·¶¨Ó¦¿¼ÂÇÒÔϼ¸µã£º qjRbsD>  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄܺ­¸ÇÕû¸öÊý¾Ý¡£ "-:H$  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ¼ä¾à£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄÜÕýÈ·µØ·´Ó³Êý¾Ý¡£ÒòΪÁ½×ø±êÖáµÄ±êÖµ¼ä¾à²»Êʵ±½«»áŤÇúÊý¾ÝµÄÏÔʾ¡£ Y~Uf2(7b5  
¨SÈç¹ûÔÚ×ø±êÖáÉϵIJâÁ¿µ¥Î»²»ÊÇ´Ó0¿ªÊ¼£¬ÄÇôÓá°//¡±·ûºÅÔÚ×ø±êÖáÉÏ·Ö¼¸¶Î¡£ p W[TufTa  
£¨3£©±äÁ¿ÏàͬµÄ¼¸ÌõÇúÏßÓ¦»æÖÆÔÚͬһ·ùͼÄÚ¡£ R*6TS"aL  
£¨4£©¶ÔÓÚͬһƪÂÛÎÄÖеĶà·ù²åͼÀ´Ëµ£¬Ó¦¾¡Á¿Ê¹ÓòåͼµÄ¸÷ÒªËØÏ໥ͳһ£¬ÓÈÆäÊÇʹÓÃÏàͬ±äÁ¿µÄ±êÄ¿¡¢±êÖµ¡¢Í¼ÀýµÈÓ¦Ï໥һÖ¡£ =sW K;`  
£¨5£©ÕÕƬͼ»òÉè¼Æͼ£¬Ó¦×¢Ã÷³ß´ç´óС¼°³¤¶Èµ¥Î»¡£ myo4`oH  
£¨6£©Í¼Æ¬ÖеÄËõÂÔÓï¡¢·ûºÅ±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ <8(q .  
£¨7£©ÂÛÎĵIJåͼÓ븽±í²»ÒËÌ«¶à£¬Ö»¸½×î±ØÒªµÄ¡£ @0@WklA JA  
£¨8£©Í¼·ùµÄ´óСÓëͼÄÚËùÌṩµÄÐÅÏ¢Á¿ÏàÆ¥Å䣬²»ÖÁÓÚʹͼÃæ¸Ðµ½¿Õ¿õ»òÓµ¼·¡£ |K. I%B  
£¨9£©²åͼµÄ´óСºÍ±ÈÀý¡£ IfH/~EtX  
¨S²åͼҪ°´ÔÓÖ¾µÄ°æÃæ´óС±ÈÀý½øÐÐѹËõ¡£³ýÌØÊâÒªÇóÍ⣬ͼµÄ´óС±ØÐëÒªÏÞ¶¨ÔÚÆÚ¿¯µÄ°æÐÄÖ®ÄÚ¡£ z^wod  
¨SͬÀàÐÍ»òͬµÈÖØÒªµÄͼµÄ´óСӦ¸Ã¾¡¿ÉÄܵر£³ÖÒ»Ö£¬µ¥Î»¿Ì¶ÈÏàͬ¡£ U>n[R/~]  
¨S¿ÉÒÔ°ÑÀàËƵÄͼ£¨ÈçÁ½¸öͼµÄ×ø±êÖáÏàͬ£©ºÏ²¢ÆðÀ´¡£ ^4IJL",  
£¨10£©Í¼ÄÚµÄÏßÐÎÓë·ûºÅ¡¢Êý×ֵȱÈÀýÊʵ±¡£ -[*y{K@dh  
£¨11£©Í¼»­Ïß²»Ò˹ýϸ»ò¹ý´Ö£¬¹ýϸÈÝÒ×ÔÚÖÆ°æ¹ý³ÌÖжÏÏߣ¬¹ý´ÖÏԵñ¿´ÖÄÑ¿´¡£ rX^uHq 8  
£¨12£©Í¼Ó¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬Ã¿Ò»Í¼Ó¦Óмò¶ÌÈ·ÇеÄÌâÃû¡£ ce$ [H}rDB  
£¨13£©»æÖƲåͼʱ£¬³ý·ÇÌØÊâÐèÒª£¬²»ÒªÎªÁË×·ÇóЧ¹û¶øÔö¼ÓһЩÎÞÒâÒåµÄϸ½Ú£¬Èç°Ñ¶þάµÄÌõÐÎͼ»­³ÉÈýάµÄÖùÐÎͼ¡£ NP3 e^  
£¨14£©ÓзûºÏͼʱ£¬Ã¿Ò»Í¼Ó¦¸ÃÇå³þµØ±»±ê¼ÇΪA(a)¡¢B(b)¡¢C(c)µÈ¡£ SOPair <r  
£¨15£©°±»ùËáºÍºËÜÕËáÐòÁÐÓ¦¸Ã¿¼ÂÇÓÃFigure,¶ø²»ÊÇTable¡£ $mT)<N ;w  
5.±í¸ñ [VX5r1-F  
±í¸ñÊǼǼÊý¾Ý»òÊÂÎï·ÖÀàµÄµÈµÄÒ»ÖÖÓÐЧ±í´ï·½Ê½£¬¾ßÓмò½à¡¢ÇåÎú¡¢×¼È·µÄÌص㡣Âß¼­ÐԺͶԱÈÐÔÓÖºÜÇ¿£¬Òò¶ø±í¸ñÔÚSCIÂÛÎÄÖб»¹ã·º²ÉÓᣱíµÄÖÖÀà½Ï¶à£¬Ö÷ÒªÓÐʾÒâ±í¡¢Í³¼Æ±í¡¢ËµÃ÷¶ÔÕÕ±íµÈ¡£ÊÊÓÃÓÚ³ÊÏֽ϶àµÄ¾«È·ÊýÖµ»òÎÞÃ÷ÏÔ¹æÂɵĸ´ÔÓ·ÖÀàÊý¾ÝºÍƽÐС¢¶Ô±È¡¢Ïà¹Ø¹ØϵµÄÃèÊö£¬µ«È±·¦Ç÷ÊÆ¡£ _k}Qe ;  
¡ò±í¸ñµÄ»ù±¾½á¹¹  `\##M=  
SCIÆÚ¿¯³£Ê¹ÓÃÈýÏß±í£¨£©£¬¼´Ö»Óбí¸ñ¶¥Ïß¡¢À¸Ä¿ºÍµ×Ïß¡£±íÖÆ°æÈÝÒ×£¬ÏÔʾ¼òÁ·¡£ g\B ? |%  
¨S±íÐòºÍ±íÌ⣺±íÐò¼°±í¸ñµÄÐòºÅ¡£±íÌâ¼´±í¸ñµÄÃû³Æ£¬Ó¦×¼È·µÃÌ壬¼ò¶Ì¾«Á¶µÄÎÄ×ÖÓÃÀ´±í´ï±íÌ⣬Á¬Í¬±íºÅÖÃÓÚ±í¸ñ¶¥ÏßÉÏ·½¡£±íÐòºÍ±íÌâ³£ÓúÚÌå×Ö¡£ \hBzQ%0  
¨S±íÍ·£ºÖ¸±í¸ñ¶¥ÏßÓëÀ¸Ä¿ÏßÖ®¼äµÄ²¿·Ö£¬±íÃ÷±í¸ñÄÚµÄÏîÄ¿»ò·´Ó³Á˱íÉíÖиÃÀ¸Ä¿ÐÅÏ¢µÄÌØÕ÷¼°ÊôÐÔ¡£ jcC"vr'u|  
¨S±íÉí£ºÀ¸Ä¿ÏßÓëµ×ÏßÖ®¼äΪ±íÉí£¬ÊDZí¸ñµÄÖ÷Ìâ¡£  zv"NbN  
¨S±í×¢£º±ØҪʱ£¬Ó¦½«±íÖеķûºÅ¡¢±ê¼Ç¡¢´úÂ룬ÒÔ¼°ÐèҪ˵Ã÷µÄÊÂÏÒÔ×î¼òÁ·µÄÎÄ×Ö£¬×÷Ϊ±í×¢ºáÅŵ×ÏßÏ·½¡£ X#by Dg  
¡ò±í¸ñÒªÇó 8@doKOA~T  
¨SһƪÎÄÕÂÖв»ÊDZí¸ñÔ½¶àÔ½ºÃ£¬¶øÊÇÒª¸ù¾ÝÆä±ØÒªÐÔ½øÐо«Ñ¡¡£Èç¹ûÓÃÒ»Á½¾ä»°¼´¿É˵Ã÷µÄÄÚÈݾͲ»±ØÁбí¸ñ£»Èç¹û²ÉÓöà×éÊý¾Ý±í˵Ã÷ͬһÏÖÏó£¬Ôì³ÉÁ˱í¸ñ±¾ÉíµÄÖظ´£¬Ó¦¸ÃÑ¡ÔñÒ»×é×î׼ȷ¡¢×îÓÐ˵·þÁ¦µÄ±í¸ñ£¬¶ø½«Öظ´µÄ±í¸ñɾ³ý¡£Èç¹ûÎÄ×ÖÐðÊöÓëͼºÍ±íÏàÖظ´£¬Ò²Ó¦¸ÃÖ»±£ÁôÈýÕâÖÖ×îºÏÊʵÄÒ»ÖÖ±íÊö·½Ê½£¬ÕâÑù²ÅÄÜʹÎÄÕ¼ò½à¡¢¾«Á·¡£ {^Q,G x(  
¨S±í¸ñµÄÉè¼ÆÓ¦¸Ã¿Æѧ¡¢Ã÷È·¡¢¼ò½à¡¢ÖصãÍ»³ö¡¢±í´ï¹æ·¶¡£±í¸ñÓ¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬ÐòºÅÓð¢À­²®Êý×Ö±íʾ£¬ÈçTable1,Table2¡£¼´Ê¹Ö»ÓÐÒ»·Ý±í¸ñÒ²Òª±êTable1¡£ ,+d8   
¨S±í¸ñÖеÄËõÂÔ´ÊÓë·ûºÅ£¬±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ ml2/ }}  
¨S±íÄÚͬһÀ¸µÄÊý×Ö±ØÐëÉÏÏ߶ÔÆë¡£±íÄÚ²»ÒËʹÓá°¡±ºÍÀàËÆ´Ê£¬Ò»ÂÉÌîÈë¾ßÌåÊý×Ö»òÎÄ×Ö¡£Èç¡°N/A¡±´ú±íδ²â»òÎÞ´ËÏ¡°¡ª¡±´ú±íδ·¢ÏÖ£¬¡°0¡±´ú±íʵ²â½á¹ûȷΪÁã¡£ ~[F7M{LS  
¨S±í¸ñÖеIJÎÊýÓ¦±êÃ÷Á¿ºÍµ¥Î»·ûºÅ¡£ÈôËùÓÐÀ¸Ä¿»ò´ó²¿·ÖÀ¸Ä¿µÄµ¥Î»Ïàͬ£¬¿É½«¸Ãµ¥Î»±ê×¢ÔÚÏàÓ¦µÄÀ¸ÄÚ¡£ P];0,;nF  
¨S±í¸ñÄÚ£¬Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£ÀýÈç3.4ºÍ2.56ºÍ1µÄÕýÈ·±í´ïÓ¦¸ÃÊÇ3.40¡¢2.56ºÍ1.00¡£¡ò±í¸ñ±à¼­ J3'q.Pc  
±í¸ñÒª×÷Ϊһ¸ö¶ÀÁ¢µÄÐÅÏ¢µ¥Î»ÁîÒ³´òÓ¡¡£ÔÚÕýÎÄÄÚ£¬Ã¿·ùͼ»ò±í¸ñÓ¦°´ÆÚ³öÏÖµÄ˳Ðò±êºÅ¡£ x44V 9-o  
6.Figure LegendsÒªÇó Cj}H'k<B  
£¨1£©Figure LegendsÒªÁíҳ˫ÐдòÓ¡¡£ÅÅÔÚ±í¸ñ»ò²Î¿¼ÎÄÏ׺óÃæ¡£Ò²¾ÍÊÇ˵Figure LegendsÅÅÂÛÎĵÄ×îºó¡£.Figure Legends²»ÒªÅÅÔÚ²åͼÏÂÃæ¡£ tYgHJ~1L*  
£¨2£©Í¼Ðò¼´²åͼµÄÐòºÅ¡£¸ù¾Ý²åͼÔÚÕýÎÄÖб»Ìá¼°µÄ˳Ðò£¬Óð¢À­²®Êý×Ö½øÐÐÅÅÐò£¬ÈçFigure 1¡¢Figure 2µÈ¡£²¢¾¡Á¿°Ñͼ°²ÅÅÔÚ¿¿½üµÚÒ»´ÎÌá¼°ËüµÄλÖᣠo; 6^:  
£¨3£©Figure Legends²»Ó¦¸Ã°üº¬·½·¨Ï¸½Ú£¬»òÕß²»³¬³ö100¸ö×Ö¡£Èç¹ûSCIÂÛÎÄûÓз½·¨²¿·Ö£¬Figure LegendsÓ¦¸ÃÉÙÓÚ300¸ö×Ö¡£ KL!cPnAUu  
£¨4£©Í¼Ìâ¼´²åͼµÄ±êÌ⣬ҪÇó¼òÃ÷׼ȷ£¬ÒªÓнϺõÄ˵Ã÷ÐÔºÍרָÐÔ£¬²»ÒªÎª×·ÇóÐÎʽÉϵļò½à¶øÑ¡ÓùýÓÚ·ºÖ¸µÄͼÌâ¡£ T++q.oFc  
£¨5£©Í¼ÖÐδÄܱí´ïÓÖ±ØÐëÒªÇó±í´ïµÄÐÅÏ¢Ó¦¸ÃÔÚͼעÖÐ˵Ã÷£¬ÈçÐèÒª½âÊ͵ĶÈÁ¿µ¥Î»¡¢·ûºÅÒÔ¼°ËõÂԴʵȡ£²»Ó¦¸ÃÈöÁÕßÈ¥²Î¿¼Õ÷ÎIJÅÄÜÀí½â²åͼµÄÐÅÏ¢¡£Èç¹ûÄãµÄ²åͼ°üÀ¨Îó²îÏߣ¬ÄÇô»¹ÐèҪ˵Ã÷ËûÃÇÊDZê×¼Îó¡¢±ê×¼²î¡¢ÐŶȱ߽绹ÊÇÊýÖµ·¶Î§£¬ÕâÓÐÖúÓÚ¶¨ÒåËù²ÉÓõÄÑù±¾´óС¡£Èç¹ûÔÚͼÖбê³öÁËÏÔÖøÐÔµÄÖµ£¬ÄÇôÔÚͼעÖоÍҪ˵Ã÷¡£ "Uf1;;b  
£¨6£©µ±²åͼÖÐÓмýÍ·£¨arrow£©¡¢·ûºÅ£¨symbol£©¡¢Êý×Ö£¨number£©»ò×Öĸ£¨letter£©Ê±£¬ÒªÔÚÕⲿ·Ö£¨²»ÊÇÔÚ²åͼҳÉÏ£©¶ÔÆä·½Ïò¡¢Î»ÖõÈ×ö³ö·Ç³£Ã÷È·µÄ˵Ã÷¡£ s;l"'6:_  
7.ÔõÑùÕýÈ·µØʹÓÃͼºÍ±í mcidA%  
ÄãÐèҪעÒ⼸¸ö·½ÃæµÄÎÊÌ⣺ ;,uATd|  
£¨1£©Í¼¡¢±í»¹ÊÇÎÄ×ÖÄĸöʹÓøüÓÐЧ?Èç¹ûÓëÎÄ×Ö²ÄÁÏÖظ´£¬ÄÇô¾ÍûÓбØҪʹÓÃͼºÍ±í¡£Èç¹ûÄܹ»²¹³ä˵Ã÷ÎÄ×Ö²ÄÁÏ»òÕßÄܹ»Ëõ¶ÌÌÖÂ۵ij¤¶È£¬ÄÇô²åͼ¾ÍÊdzÊÏÖÐÅÏ¢µÄÓÐЧ·½Ê½¡£ }%c>Hh  
£¨2£©ÄÄÖÖͼ¡¢±í×îÊʺÏÄãµÄÄ¿µÄ£¿ÊÇ·ñÐèÒªÖÆ×÷ÏêϸµÄ¡¢¸ß·Ö±æÂʵIJåͼ£¿ÄÜ·ñÓÃÒ»·ù¼òµ¥µÄ½öÓÃÏßÌõ»òµã¾ÍÄܱíʾµÄ²åͼ£¿Á½Õß±í´ïµÄÐÅÏ¢ÊÇ·ñÒ»Ñù£¿ `gC J[  
£¨3£©Í¼¡¢±íÊÇ·ñÕæʵ¡¢ÓÐЧ¡¢¿Í¹ÛµØչʾÁËÊý¾Ý£¿ g [O  
£¨4£©Í¼¡¢±íÊÇ·ñչʾÁËÊý¾ÝµÄ±¾Öʺ͹æÂÉ£¿ @@-TW`G7  
£¨5£©Í¼¡¢±íÊÇ·ñ±í´ïÁËÂÛÎĵÄÖ÷Ìâ»ò¹Ûµã£¿ 86cnEj=   
8.²åͼµÄºË²éÇåµ¥ $e4N4e2x/  
£¨1£©Õâ¸ö²åͼÓбØÒªÂð£¿Óë±í¸ñ»òÕýÎÄÊÇ·ñÖظ´£¿ vgDpo@fz8  
£¨2£©ÓÐͼÐòºÍͼÌâÂ𣿠F/1 m&1t  
£¨3£©Õâ¸ö²åͼ¼ò½àÂ𣿻¹ÓÐûÓÐɾȥµÄÎÞ¹Øϸ½Ú£¿ 2yFT` 5+H4  
£¨4£©×ø±êÖáµÄ±êÖµÊÇ·ñºÏÊÊ£¿ :.=j)ljTx  
£¨5£©ÀàËƵIJåͼ»òÕßÖØÒªÐÔÏà·ÂµÄ²åͼÊÇÒÔͬÑùµÄ×ø±êϵ»­µÄÂ𣿠@(*A<2;N  
£¨6£©ËùÓеÄÊõÓïƴдÊÇ·ñÕýÈ·£¿ Dk$<fMS,7c  
£¨7£©²åͼÖеķûºÅ¼°Ëõд¶¼ÔÚͼעÖÐÓÐËù˵Ã÷Âð£¿ÕâЩ·ûºÅ¡¢ËõдÓë±êÌâÊÇ·ñÒ»Ö£¿ÔÚÆäËû²åͼ»òÕýÎÄÖÐÊÇ·ñ±£³ÖÒ»Ö£¿ R i,_x  
£¨8£©ËùÓеIJåͼÔÚÕýÎĵÄÏàӦλÖô¦ÊÇ·ñ±»Ìá¼°£¿ hbr3.<o1lY  
ÔÚÒ»°ãÇé¿öÏ£¬Ðí¶àSCIÆÚ¿¯¶Ô²åͼºÍ±í¸ñÒªÇóÓÐÃ÷È·µÄ˵Ã÷¡£²»Í¬µÄÆÚ¿¯¶Ô²åͼºÍ±í¸ñÓв»Í¬µÄÒªÇó¡£Òò´ËҪȷ¶¨ÔÙ½»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßµÄÖ¸ÄÏ¡£°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£ ]t&^o**  
9.ͼ±íÔÚÂÛÎÄÊÖ¸åÖеÄλÖà z6;hFcO  
¨Sͼ£ºÔÚͼעºóÃ棬ÿ¸öͼһҳ£¨submission by mail£©¡£Èç¹ûon line submission,ÔòͼΪÁí´æ¡£ 8D@Jd  
¨Sͼע£ºÍ¼×¢ÅÅÔÚ±í¸ñºóÃ棬ÁíÆðÒ»Ò³¡£ 0WKS  
¨S±í¸ñ£ºÅÅÔÚÕýÎÄÖвο¼ÎÄÏ׵ĺóÃ棬ÿ¸ö±í¸ñÒ»Ò³¡£ Bxw(pACf  
10.SCIÂÛÎÄͼ±íÉè¼ÆÖг£¼ûµÄ´íÎó F#) bGi  
£¨1£©Í¼¡¢±í¸ñÄÚÈÝÓëÎÄ×ÖÖظ´¡£ÔÚSCIÂÛÎÄÖУ¬ÏàͬÄÚÈݲ»ÒËÓÃÎÄ×Ö¡¢±í¸ñºÍͳ¼ÆͼÖظ´±í´ï£¬Ó¦¸ù¾ÝÄÚÈݵÄÐèҪѡÔñÒ»ÖÖ±í´ï·½Ê½¼´¿É¡£Õâ·½ÃæµÄÔ­ÔòÓ¦ÊÇ£º·²ÊÇÓüò½àµÄÎÄ×ÖÄܹ»±í´ïÇå³þµÄ¾Í²»ÓÃͼºÍ±í¸ñ±í´ï£¬£»·²ÊÇÓñíÄܹ»Ò»Ä¿ÁËÈ»±íʾµÄ¾Í²»ÓÃͼ¡£ÎªÊ¹¶ÁÕß±ãÓÚ¶ÔÕձȽϺÍÁ˽⾫ȷ½á¹ûʱ£¬ÒÔ±í¸ñÐÎʽΪÒË¡£ L A A(2  
£¨2£©±í¸ñÖÐÊý¾Ý¼ÆËã²»¾«È·£¬±£ÁôλÊý²»Ò»Ö¡£±íÖÐÊýÖµ¾«È·Óë·ñÊǾö¶¨Í³¼Æ±íÖÊÁ¿µÄ¹Ø¼üÒòËØ£¬Ò²ÊÇ¿ÆѧʵÑé½á¹ûÊÇ·ñÑÏÃܵľßÌåÌåÏÖ¡£ÓÉÓÚ±í¸ñÖеÄÊý¾ÝÊǾ­¹ýԭʼÊý¾Ý¼ÆËãµÃ³ö£¬Òò´ËÍùÍù²»ÊÇÕûÊý¡£Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£±í¸ñÖÐͬһָ±êÊý×ÖµÄÓÐЧλÊýÓ¦Ò»Ö£¬²»×ãÕßÒÔ¡°0¡±²¹×ã¡£¼ÆËã°Ù·Ö±Èʱ£¬Ó¦×¢Òâ¸÷°Ù·Ö±ÈÏà¼ÓӦΪ100%¡£ C4gES"T  
£¨3£©ËõÂÔÓï¼°Á¿ºÍµ¥Î»²»¹æ·¶¡£±í¸ñÖÐËùÁеÄÖ¸±êÃû³Æ²»ÒËËæÒâ¶ø¶¨£¬Ó¦Ê¹Óù̶¨µÄËõÂÔÓï¡£ÌØÊâÇé¿öÏÂʹÓò»³£Óõĵ¥Î»ºÍËõд´Êʱ£¬ÐèÔÚ±í×¢ÖÐ˵Ã÷¡£µ¥Î»Ó¦¸Ã×ñÑ­¹ú¼Ê±ê×¼ÃüÃûÔ­Ôò¡£ÔÚÊý×ֺ͵¥Î»Ö®¼äÓ¦¸ÃÓÐÒ»¸öµ¥Ò»¿Õ¸ñ¡£Ç§¼Æµ¥Î»Ó¦¸ÃÓöººÅ·ÖÀ루1,000£©¡£ \X! NoF  
£¨4£©±íÖзÖ×é±äÁ¿Óë¹Û²âÖ¸±êµÄλÖõߵ¹¼°Êý¾ÝÅÅÁв»µ±¡£±íÖÐÊý¾ÝµÄÅÅÁÐÓ¦°´Í¬ÀàÊý¾Ý×ÝÅŵÄÔ­Ôò°²ÅÅ£¬ÅÅÁв»µ±Ôòµ¼Ö¶Á±í·ÑÁ¦£¬²»Ò׶ÔÕձȽϺʹÓÖÐÁ˽â±ä»¯¹æÂÉ¡£ Ac*J;fI  
£¨5£©±íע˵Ã÷¹ý·±¡£±í×¢ÊǶԱíÖÐÓйØÄÚÈݵıØÒª²¹³äºÍ˵Ã÷£¬Ó¦¼òÃ÷¶óÒª¡£ÈçÐèҪ˵Ã÷µÄÄÚÈݽ϶àʱ£¬Ó¦ÒÆÈë±íÇ°µÄÕýÎÄÖÐÓÃÎÄ×Ö½éÉܱíÖÐÊý¾ÝµÄ¼ÆË㹫ʽ£¬Ó¦ÔÚÂÛÎĵġ°Materials and Methods¡±²¿·Ö½éÉÜ£¬²»ÒËÁÐÈë±í×¢¡£ Ol h{<~Fv  
£¨6£©ÂÞÁÐԭʼ¼Ç¼Êý¾Ý¡£µäÐ͵ıíºÍͼʾ¶Ô½á¹ûµÄ×ܽᣬÑо¿¹ý³ÌÖеÄԭʼÊý¾Ý£¬²»±ØÈ«²¿ÂÞÁÐÓÚ±íÖС£±í¸ñÖеÄÊý¾ÝÒ»°ãÓ¦ÊǾ­¹ýͳ¼Æѧ´¦ÀíµÄ¡£ QS\wtTXj  
£¨7£©ÎÞ±íÌâ»ò±íÌⲻȷÇлòÖص㲻ͻ³ö¡£±íÌâÊDZí¸ñµÄÖØÒª×é³É²¿·Ö£¬ÊǶԱíÖÐÄÚÈݵĸÅÀ¨£¬±íÌâÓ¦¸ÃÖ÷νÓÐÐò£¬¼ò½à¡¢×¼È·¡£ )[M:#;,L  
£¨8£©Í¼¡¢±íÖеÄÊõÓï¡¢·ûºÅ¡¢µ¥Î»ÓëÎÄÖÐÎÄ×ÖÐðÊö²»Ò»Ö»òÕßÕýÎÄûÓÐÌἰͼºÍ±í¡£Í¼±íÖгöÏÖµÄÊõÓï¡¢·ûºÅ¡¢µ¥¡¢Ó¦ÓëÎÄ×ÖÐðÊöÏàÒ»Ö£¬ÒÔÏÔʾÕû¸öÂÛÎĵÄÍêÕûÓëͳһ¡£ WcM\4q@  
£¨9£©Í³¼Æͼ±íÉè¼Æ²»¹æ·¶¡£Èç±íÖÐÏßÌõ¹ý¶à¡£ _/%,cYVc8!  
11.³£¼ûµÄ´íÎóÇé¿ö "lt5gu!`u  
¨S×ø±êÖáÉϱêÖµ²»µ± 4$ihnb`DQN  
¨Sȱµ¥Î»£¬×ø±êÖáµßµ¹£¬¾â³ÝÐÎÏßµÄÁ¬½ÓûÓиù¾Ý£¬Í¼Ìå²»Ã÷È·£¨¸ü¶àÄÚÈÝ¿ÉÒÔ¼ûhttp//:www.ruf.rice.edu/~bioslabs/tools/tools.html£© $?k]KD  
¨S´æÔÚÎÊÌ⣺Ñù±¾Ì«ÉÙ `F&~SU,  
¨S´æÔÚÎÊÌ⣺×ÊÁÏûÓÐåàÑ¡ `]@=Hx(  
¨S´æÔÚÎÊÌ⣺±í¸ñ²»¹æ·¶£¬Ã»Óбí¸ñ±êÌâ 9 6#]P  

kaobook 2011-08-17 22:35
µÚ12 ÕÂÈçºÎÊéдSCIÂÛÎĵÄÌÖÂÛ ?Y S 3)  
ÌÖÂÛ£¨Discussion£©ÊÇһƪÎÄÕµľ«»ª¡¢È«ÎĵÄÁé»ê£¬Ò²ÊÇ×îÄÑдµÄ²¿·Ö¡£DiscussionÖ®ËùÒÔÄÑд£¬ÊÇÒòΪÌÖÂÛ²¿·Ö×îÄÜ·´Ó³×÷Õߵĸ´Ï°µÄÎÄÏ×Á¿ºÍ¶Ôij¸öѧÊõÎÊÌâÁ˽âÒÔ¼°Àí½âµÄÉî¶ÈºÍ¹ã¶È¡£Éî¶È¾ÍÊÇÂÛÎĶÔÓÚÌá³öÎÊÌâµÄÑо¿µ½ÁËÒ»¸öʲôÑùµÄ³Ì¶È£¬¹ã¶ÈÖ¸ÊÇ·ñÄܹ»´Ó¶à¸ö½Ç¶ÈÀ´·ÖÎö½âÊÍʵÑé½á¹û¡£ M;OMsRCVO  
1.ÌÖÂÛ²¿·ÖµÄÖØÒªÐÔ Sl^PELU  
ÒªÈÃÉó¸åÈ˺ͶÁÕßÁ˽âÄãµÄÂÛÎÄΪʲôֵµÃÒýÆðÖØÊÓ£º hLk6Hqr7  
£¨1£©ÄãµÄ½á¹ûÓÖÓÐʲôÀíÂÛÒâÒ壿 ,5ZQPICF  
£¨2£©ÄãµÄ½á¹ûÓÐʲôʵ¼ÊÓ¦ÓüÛÖµ£¿ 0jjtx'F  
£¨3£©ÄãµÄ·¢ÏÖÊÇ·ñ¿ÉÒÔÀ©Õ¹µ½ÆäËûÁìÓò£¿ g|$;jQ\_  
£¨4£©ÄãµÄ½á¹ûÊÇ·ñÓÐÖúÓÚÎÒÃÇÀí½â¸ü¹ã·ºÁìÓò£¨a broader topic£©£¿ ybJwFZ80  
2.ÌÖÂÛµÄÄÚÈÝ 5dE=M};v  
ÔÚDiscussionÕâÒ»Õ½ڣ¬ÄãÓ¦¸Ã½âÊÍÄãµÄ½á¹û¡£Òò´Ë£¬ÌÖÂÛµÄÄÚÈÝÖ÷ÒªÓУº IOuqC.RJ}o  
£¨1£©¸ÅÊö×îÖØÒªµÄ½á¹û¡£ÄãµÄ½á¹ûÓÐʲôÒâ˼£¿Êý¾ÝÊÇ·ñ·ûºÏÄãµÄ×î³õ¼ÙÉ裿Èç¹ûûÓеĻ°£¬ÎªÊ²Ã´£¿ÄãÊÇ·ñÐèÒªÐ޸ļÙ˵£¿ vW vu&3tx  
£¨2£©Ö¸³öÆäÊÇ·ñÄܹ»Ö§³ÖÏÈÇ°µÄ¼ÙÉèÒÔ¼°ÊÇ·ñÓëÆäËûѧÕߵĽá¹ûÏ໥һÖ£»Èç¹û²»ÊǵĻ°£¬ÎªÊ²Ã´£¿ÊÇ·ñËûÃǵÄÉè¼ÆÓÐȱÏÝ£¿ a\}MJ5]  
£¨3£©¶Ô½á¹ûÌá³ö˵Ã÷¡¢½âÊÍ»ò²Â²â£¬¸ù¾ÝÕâЩ½á¹û£¬ÄܵóöºÎÖÖ½áÂÛºÍÍƶϣ¿ zUv#%Q8vw  
£¨4£©ËµÃ÷Ñо¿µÄ¾ÖÏÞÐÔÒÔ¼°ÕâЩÏÞÖƶÔÑо¿½á¹ûµÄÓ°Ïì¡£ÓÐʲô½øÒ»²½µÄʵÑéÐèÒª½øÐУ¿Èç¹ûÄãµÄ½á¹ûÄ£ÀâÁ½¿É£¬»¹ÐèҪʲôʵÑéÄÜʹ½á¹û¸ü¼ÓÃ÷È·£¿ /}L2LMIm  
£¨5£©Ö¸³ö½á¹ûµÄÀíÂÛÒâÒåºÍʵ¼ÊÓ¦ÓüÛÖµ¡£ ]Zc|<f;  
3.ÌÖÂÛ²¿·Öд×÷µÄ»ù±¾ÒªÇó ^IIy>  
DiscussionµÄÖصãÔÚÓÚ¶ÔÑо¿µÄ½á¹ûµÄ½âÊͺÍÍƶϣ¬²¢ËµÃ÷×÷ÕߵĽá¹ûÊÇ·ñÖ§³Ö»òÕß·´¶ÔijÖֹ۵㣬ÊÇ·ñÌá³öÁËеÄÎÊÌâ»ò¹ÛµãµÈ¡£Òò´Ë׫дÌÖÂÛʱҪ±ÜÃ⺬Ð¾¡Á¿Ö±½Ó¡¢Ã÷È·µØ×ö³öÍêÕûµÄ½âÊÍ¡£ËµÀíÒªÓиù¾Ý£¬ÎÊÌâÒª½²Çå³þ¡¢½²Í¸³¹¡£Òò´Ë£¬Ã¿¸ö½áÂÛ¶¼ÒªÓÐÖ¤¾Ý¡£×ÜÊǾ۽¹ÔÚÄãµÄ½á¹ûÉÏ£¬²»ÒªÌÖÂÛÓëÄãÏÖÔڵŤ×÷Î޹صĻ°Ìâ¡£ h"0)spF"d  
4.ÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ h ! R=t  
Ò»°ãʵÑéÐÔSCIÂÛÎĵÄÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ÈçÏ£º ,#&7+e!]>P  
µÚÒ»¶Î£¨first paragraph£© 25{_x3t^  
²ûÊö·¢ÏÖ¡£¿ÉÒÔ´ÓÕªÒª¸Äд£¬ÀýÈ磺 Z f\~Cl  
In this study, we have shown that tumor cells organize a mitochondrial chaperone network,, which involves Hsp90, its related molecule, TRAP-1, and the immunophilin CypD. This complex maintains mitochondrial homeostasis and antagonizes the function of CypD in permeability transition. Conversely, inhibition of mitochondrial Hsp90 chaperones with a novel class of mitochondria-directed ATPase antagonists cause sudden loss of mitochondrial membrane potential, release of cytochrome c, and massive death of tumor but not normal cells. foQo`}"5  
Öмä¶ÎÂ䣨middle paragraph£© ?&~q^t?u  
¶ÎÂäµÄ¶àÉÙ¸ù¾Ý½á¹û¶àÉÙ¶ø¶¨£¬¿ÉÒÔÊDz¢ÁйØϵ»òÕßÊǵݽø¹Øϵ¡£µ«Òª±£Ö¤Ã¿Ò»¶Î¶¼Ò»¸öÖ÷Ìâ¡£¶øÇÒÿһ¶ÎÖÐҪ˵Ã÷ÒÔϼ¸µã£º G--X)h-  
£¨1£©ÄãµÄÑо¿½á¹ûÊÇʲô£¿ÓÐʲôÒâÒ壿ÀýÈ磺 xHJkzI  
The results presented here demonstrate an involvement of Shh signaling in the regulation of SVZ stem cells, leading to sustained neurogenesis, in the postnatal and adult mouse brain. Taken together , the gene expression and analyses and the in vitro and in vivo experiment indicate that Shh signaling is critical for the proliferation of the number of cells with stem cell properties, for the proliferation of early precursors and consequently !@8i(!xb  
for the production of new neurons. T:Klr=&V  
£¨2£©ÄãµÄÑо¿½á¹ûºÍ±ðÈ˵ĵÄÀàËÆÑо¿ÓÐʲôÒìͬ£¿Èç¹û²»Í¬£¬¿ÉÒÔÌÖÂÛһЩ²úÉú²îÒìµÄ¿ÉÄÜÔ­Òò¡£ÀýÈ磺 9N}\>L)_  
In contrast to other data(ref), we show that Shh is sufficient to increase the number of neurospheres derived from SVZ cultures grown over quiescent astrocytes. This difference might relate to the method used:it is possible that the astrocytes in the in the feeder layer produce enough cofactors but at low enough levels for Shh to act, whereas saturating levels of EGF mask the effects of Shh(ref). 'EAskA] *  
£¨3£©Èç¹ûÄãÔÚÑо¿½á¹ûÖгöÏַdz£ÐµĶ«Î÷£¬ÓÃÒÔÇ°±ðÈ˵ÄÀíÂÛºÜÄѽâÊÍ£¬ÄÇôÄã¿ÉÒÔÌá³öÄãµÄ¼ÙÉèÀíÂÛÀ´½âÊÍÊÇÑÏÖØÀ´½âÊÍʵÑéÖзdz£ÐµĶ«Î÷£¬Ò»¶¨Òª×öµ½ÄÜ×ÔÔ²Æä˵¡£ U{hu7  
Ä©¶Î£¨last paragraph£© D5?8`U m=  
ÔÚDiscussion µÄ×îºóÒª×ܽáһϣ¬¸æËß±ðÈËÄãÕâ¸öÑо¿µÄ¼¸¸öÖ÷Òª½á¹û£¨Á½Èý¾ä»°£©¡£ÀýÈ磺 BrwC9:  
In summary, Hsp90-directed protein folding/refolding functions as a novel regulatory mechanism of mitochondrial permeability transition (reference).Although this pathway is selectively exploited in tumor cells to elevate an antiapoptotic threshold, the development of Hsp90 antagonists competent to accumulate in mitochondria may provide a new class of potent and selective anticancer agents,potentially devoid of side effects for normal tissues. %sr- xE  
5.ÌÖÂÛ²¿·Öд×÷µÄ³£¼ûÎÊÌâ RE%f'y  
£¨1£©Ã»ÓÐÑ¡ÔñÉîÈëÌÖÂÛµÄÎÊÌ⡣ѡÔñºÏÊʵĽá¹ûÔÚDiscussion²¿·Ö½øÐÐÉîÈëÌÖÂÛ£¬ÊÇдºÃ¸Ã²¿·ÖÊ×ÏÈÒªÃæÁÙµÄÎÊÌâ¡£ÒªÒÔÿһ¸öÖØ´ó½á¹ûΪ»ùµã¡£Ò»°ãÀ´Ëµ£¬¿É¸ù¾ÝÒÔÏÂÔ­ÔòÀ´ÅжϣºÈç¹ûÄãµÄ½á¹ûÌåÑéÁËʵÑéµÄ¶ÀÌØÐÔ£¬ÊÇÆäËûÑо¿¾ÍÖÐûÓеõ½µÄ£¬ÄÇôÕâ¸öÑо¿½á¹û¾ÍÊÇÒªÖصãÌÖÂÛµÄÎÊÌ⣻ÓÐЩ½á¹ûºÍÇ°È˵ÄÑо¿½á¹ûÒ»Ö£¬²¢Ã»ÓÐÏÔÖøÐÔ²îÒ죬¾ÍÓ¦¸ÃÒ»±Ê´ø¹ýÎÞÐèÉîÈëÌÖÂÛ¡£DiscussionµÄÒ»¸öÖØÒª×÷ÓþÍÊÇҪͻ³ö×Ô¼ºÑо¿µÄ´´ÐÂÐÔ£¬²¢ÌåÏÖ³öÏÔÖøÇø±ðÓÚËûÈ˵ÄÌص㣬Çø±ð´óºÍСÊÇÁíÍâÒ»¸öÎÊÌ⣬ÖØÒªµÄÊÇÓÐÇø±ð£¬Çø±ð¾ÍÊÇ´´Ð¡£ \?^2 }K/  
£¨2£©Ã»ÓжÔÑ¡ÖеÄÎÊÌâ°´Ò»¶¨²ã´Î´Ó¶à¸ö½Ç¶È½øÐÐÌÖÂÛ¡£Ñ¡ÔñµÄÎÊÌâÓÐʱ²»Ö¹Ò»¸ö£¨¶àÊýÇé¿öÊÇÁ½¸öÒÔÉÏ£©£¬Òò´Ë£¬Òª°´Ò»¶¨²ã´ÎÃèÊöÇå³þ¡£ÎÊÌâÎÞÂÛ´óС¡¢ÊÇ·ñÖØÒª£¬¶¼Òª´Ó¶à¸ö½Ç¶ÈÕ¹¿ªÉîÈëÌÖÂÛ¡£ e:9EP,  
¨SÊ×ÏÈÒªÓÐÀàËƽá¹ûµÄ¶Ô±È£¬ËµÃ÷×Ô¼º½áÂ۵ĶÀÌØÐÔ¡£ $P0q!  
¨SÆä´ÎҪϵͳ²ûÊöΪʲô»áÓÐÒìͬ¡£·½·¨ÓжàÖÖ£¨´ÓʵÑéÉè¼Æ½Ç¶È¡¢´ÓÀíÂÛÔ­Àí½Ç¶È¡¢´Ó·ÖÎö·½·¨½Ç¶È»ò½è¼ø±ðÈË·ÖÎö·½·¨µÈ£©¡£ÖØÒªµÄÊǽ«ÕâÎÊÌâÉîÈë²ûÊöÇå³þ£¬²»ÄÜÈÃÈËÓÐÒâÓÌδ¾¡Ö®¸Ð£¨So What£¿£©¡££¨3£©ÓëResultsµÄ²»Ò»ÖÂÐÔ¡£¾ÍÊǽá¹ûºÍÌÖÂÛûÓÐÒ»Ò»¶ÔÓ¦¡£ÉÙÊý³öÏÖÌÖÂÛµÄÄÚÈÝ¿ÉÒÔÍƳöÓëʵÑéÏà·´µÄ½áÂÛ¡£ 6,3o_"J!  
£¨4£©×÷ÕßÔÚÌÖÂÛʱ²»ÒýÓûòûÓÐϵͳÒýÓÃÏà¹ØÎÄÏס£·¢ÉúÕâÖÖÇé¿öµÄÖ÷ÒªÔ­ÒòΪ£º×÷ÕßûÓÐÒâʶµ½²éÕÒºÍÒýÓÃÏà¹ØÎÄÏ׵ıØÒªÐÔ£»×÷ÕßÒòÌõ¼þËùÏÞ£¬ÎÞ·¨²éµ½»ò²éÈ«Ïà¹ØÎÄÏ×£»ÉÙÊý×÷Õß¹ÊÒâ²»ÒýÓÃÏà¹ØÎÄÏ×£¬ÒÔÍ»ÏÔ×Ô¼ºÑо¿µÄ"ÐÂÓ±"Óë"¼ÛÖµ"¡£ >dt*^}*  
£¨5£©×÷ÕßËäÒýÓÃÏà¹ØÎÄÏ×£¬µ«Ã»ÓнáºÏ×ÔÉíµÄÑо¿ÌÖÂÛ£¬Ò²¾ÍÊÇ˵£¬×÷ÕßËäÈ»²éµ½²¢ÒýÓÃÁËÏà¹ØÎÄÏ×£¬µ«Ã»ÓаÑÒÔÇ°µÄ½á¹ûºÍ×Ô¼ºµÄ½á¹ûÈÚºÏÔÚÒ»ÆðÌÖÂÛ¡£ÕâÁ½ÖÖÂÛÎÄ·Ö¸îµÄ½á¹û¶¼Ò»Ñù£¬¾ÍÊÇʹ¶ÁÕß¿´ÍêÂÛÎĺó£¬ÈÔ¶Ô¸ÃÑо¿È±·¦ÏµÍ³¡¢ÍêÕû¡¢ÉîÈëµÄÁ˽âºÍÀí½â¡£ gK[;"R)4o@  
£¨6£©¼òµ¥Öظ´IntroductionµÄÄÚÈÝ¡£ËäÈ»ÌÖÂÛ×ÜÓëIntroductionÖÐÄúÔ®ÒýµÄÎÊÌâ»ò¼Ù˵ÏàÁ¬¡£µ«²»ÊǼòµ¥µÄÖظ´£¬¶øÊÇIntroductionµÄÕ¹¿ª¡£ mSxn7LG  
£¨7£©Öظ´ResultsµÄÄÚÈÝ¡£²»ÒªÔÚÌÖÂÛÖÐÖظ´ÉêÃ÷ÄãµÄ½á¹û¡£ËäÈ»Äã¿ÉÒÔż¶ûÔÚDiscussion²¿·ÖÀïÌἰͼºÍ±í¸ñ°ïÖú½âÊÍijÊ£¬µ«²»ÄÜ°üº¬ÐµÄÊý¾Ý¡£¿ÉÒÔÓÃÁ÷³Ìͼ˵Ã÷¡£Èç¹ûÄãÐèÒªÌáÐѶÁÕßÌÖÂ۵Ľá¹û£¬¿ÉÒÔÓÃbridge sentenceÀ´½øÐÐÁ¬½Ó¡£ÀýÈ磬The increased expression of neuroglobin in the damaged region after focal isechemia suggests that¡­(½âÊÍ)¡£ TD}<U8I8_  
6.ÌÖÂÛ²¿·Öд×÷µÄÈ˳ƺÍÓï̬ _q27 3QG/"  
ÔÚÕâÒ»½Ú¾¡¿ÉÄÜʹÓÃÖ÷¶¯Óï̬¡£É÷·ÀÂÞà´ʾ䣬Ҫ¼ò½à¡£¿ÉÒÔʹÓõÚÒ»È˳ÆÃèÊö×Ô¼ºµÄ½á¹û¡£ÏÖÔÚʱºÍ¼òµ¥µÄ¹ýȥʱ¿ÉÒÔÓÃÓÚÌÖÂۺͽáÂÛÕ½ڣ¨Present and simple past tenses may both be correct for results discussion and conclusions£©¡£

kaobook 2011-08-17 22:35
µÚ13ÕÂÈçºÎÊéдSCIÂÛÎĵĽáÂÛ @9gZH_ur>E  
½áÂÛ£¨Conclusion»òSummary£©ÓֳƽáÊøÓï¡¢½áÓï¡£ËüÊÇÕû¸ö¿ÎÌâÑо¿µÄ×ܽᣬȫƪÎÄÕµĹé½á¡£Ò»°ãÀ´Ëµ£¬½áÂÛÖгöÏÖµÄÎÊÌⲻ̫¶à¡£ÓÐЩSCIÆÚ¿¯ÒªÇóÓнáÂÛÎÄÕ£¨¶ÎÂ䣩£¬Î»ÓÚÂÛÎĽáÂÛ½áÊøʱ¡£ |0y#} |/  
1.½áÂÛд×÷µÄÄÚÈÝ xZ9:9/Vg  
£¨1£©½á¹ûÒªµã¡£±¾Ñо¿½á¹ûÓÐʲôз¢ÏÖ£¬µÃ³öÁËʲô¹æÂÉÐÔ½áÂÛ£¬½â¾ö»òÍêÉÆÁËʲôÀíÂÛ£¬ÊÊÓÃÓÚʲôÑùµÄ·¶Î§¡£¶ÔÇ°ÈËÓйر¾ÎÊÌâµÄÀíÂÛ¡¢·½·¨»ò¼¼Êõ×öÁËÄÄЩ¼ìÑ飬ÄÄЩÓë±¾Ñо¿½á¹ûÒ»Ö£¬ÄÇЩÓë±¾Ñо¿²»Ò»Ö£¬×÷³öÁËÄÄЩÐÞÕý¡¢²¹³ä¡¢·¢Õ¹»ò·ñ¶¨¡£ ? W'p&(;  
£¨2£©ÒâÒå»òʵÓÃÐÔ¼ÛÖµ¡¢ÍƹãÇ°¾°¡£ XZM3zlg*  
2.½áÂÛд×÷ÒªÇó sV  
£¨1£©¸ÅÀ¨×¼È·£¬´ë´ÇÑϽ÷¡£×¼È·¡¢ÍêÕûµØ¸ÅÀ¨ÂÛÎÄÖд´ÐµÄÄÚÈÝ¡£ )O~[4xV~  
£¨2£©Ã÷È·¾ßÌå¡¢¼ò¶Ì¾«Á¶¡£½áÂÛÓ¦ÌṩÃ÷È·¡¢¾ßÌåµÄ¶¨ÐÔÓ붨Á¿µÄÐÅÏ¢¡£¶ÔÒªµãÒª¾ßÌåÂÛÊö£¬²»ÄÜÓóéÏóºÍÁýͳµÄÓïÑÔ¡£ G:1'}RC :  
£¨3£©×ۺϷÖÎö£¬¿Í¹ÛÆÀ¹À£¬Å¨Ëõ±í´ï¡£±ÜÃâÒÔ¼ÙÉèÀ´¡°Ö¤Ã÷¡±¼ÙÉ裬ÒÔδ֪À´ËµÃ÷δ֪£¬²¢ÒÀ´ÎÑ­»·ÍÆÂÛ¡£²»Òª°ÑÇ°ÑÔ²¿·ÖµÄÄÚÈÝ£¬ÈçÁ¢ÌâÒÀ¾Ý¡¢Ñо¿Ä¿µÄµÈдÔÚ½áβ²¿·ÖÀ´ÌÖÂÛ¡£ Mn.,?IF`K  
3.½áÂÛд×÷·½·¨ ssi7)0  
£¨1£©ÓÉÓÚMS Word µÈÎÄ×Ö´¦ÀíÈí¼þÌṩµÄ¿½±´£¨copy£©¡¢Õ³Ìù£¨paste£©¹¦ÄÜ£¬ÂÛÎÄÕªÒªÖеÄһЩ»°¿É±»¿½±´µ½½áÂÛÖС£µ«Òª×¢Òâ¸Ä±äʱ̬¡£ $>XeC}"x68  
£¨2£©½áÂÛÒ»°ã¿ÉÒÔÓü¸¾ä»°À´±íÊö¡£ÓÐʱҲ¿ÉÒ԰ѽáÂÛ·Ö³ÉÈô¸ÉÌõÀ´Ð´£¬µ«²»³£¼û¡£ `@h|+`h  
£¨3£©½áÂÛҪǡÈçÆä·Ö¡£ 85GIEUvH/  
£¨4£©±¾Ñо¿ÉÐδ½â¾öµÄÎÊÌâ¼°½ñºóÑо¿·½ÏòµÄÉèÏë»ò½¨ÒéºÍÓ¦Óü¼ÊõÓÐÄÄЩ¸Ä½øµÄ½¨ÒéÒ»°ã²»·ÅÔÚ½áÂÛÖС£µ«ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚ½áÂÛÖмÓÈëÕâЩÉèÏë»ò½¨Òé¡£ËùÒÔͨ¶ÁSCIÆÚ¿¯µÄ×÷ÕßÖ¸ÄÏÊ®·ÖÖØÒª¡£ !LI<%P)  
4.½áÂÛÈ˳ƺÍд×÷ʱ̬µÄд×÷ q!5:M\  
дËûÈËÑо¿½á¹ûÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£»ÃèÊö±¾ÎĵÄÑо¿½á¹ûÓùýȥʱ£»ÆÕͨʵÓõĽáÂÛÊÇÏÖÔÚʱ¡£½áÂÛÖв»Ê¹ÓõÚÒ»È˳Ƶ¥ÊýÖ÷¸ñ¡°I¡±£¬¶ø½Ï¶àʵÓõÚÒ»È˳Ƹ´ÊýÖ÷¸ñ¡°We¡±£¬ÒÔ˵Ã÷¸Ã¹¤×÷ÊÇÓɶàÈËÍê³ÉµÄ¡£

kaobook 2011-08-17 22:36
µÚ14ÕÂÈçºÎÊéдSCIÂÛÎĵÄÖÂл wcHk]mLM  
1.ÖÂлÄÚÈÝ Z0|5VLk,<{  
ÖÂлÄÚÈÝÖ÷Òª·ÖΪÁ½·½Ã棺 {1GJ,['qL  
£¨1£©±íÃ÷¸ÃÑо¿ÊÇʲô×ʽð»ò»ù½ð×ÊÖúµÄÇé¿öÏÂÍê³ÉµÄ¡£ÖйúÒ»°ã¶¼Êǹú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨Nature Science Foundation of China, NSFC£©¡£ÃÀ¹ú´ó¶àÊÇÃÀ¹ú¹ú¼ÒÎÀÉúÑо¿Ôº£¨National Institute of Health, NIH£©ºÍÃÀ¹ú¹ú¼Ò¿Æѧ»ù½ð£¨National Science Foundation, NSF£©¡£Ð´»ù½ðʱһ°ãÒª±ê×¢Çå³þ»ù½ðºÅÂë£*****rant number£©£¬Ö»ÓÐÕâÑù²ÅËãÊǸÃÏî»ù½ðµÄÑо¿³É¹û£¬Ò²¿ÉÒÔËã×÷ʵÑéÊÒµÄÑо¿³É¹û¡£ 8&QST!JGSX  
£¨2£©¶Ô²ÎÓëÈËÔ±ºÍµ¥Î»±íʾ¸Ðл¡£Ó¦¶ÔÕû¸öÑо¿¹ý³ÌÖУ¬ÓÈÆäÊDzÎÓ벿·ÖÑо¿¹¤×÷£¬°üÀ¨ÌṩʵÑéÉè¼Æ»òʵÑé²ÄÁÏ£¬µ«Ã»ÓÐÁÐÔÚ×÷ÕßÖеÄÑо¿ÈËÔ±£¬Òª¿Ï¶¨ËûµÄ¹±Ï×£¬ÓèÒÔÖÂл¡£ÓÐЩÉó¸åÈËÒ²ºÜ¿´ÖØÕâЩ·½Ãæ¡£Òò´Ë£¬ÒªÒýÆðÖØÊÓ¡£  <,.$U\W  
µ«ÊÇ£¬Èç¹ûÌṩ°ïÖúµÄ¹ý¶à£¬¾Í²»±ØÒ»Ò»ÌáÃû£¬³ýÖ±½Ó²ÎÓ빤×÷¡¢°ïÖúºÜ´óµÄÈËÔ±ÁÐÃûÖÂл£¬Ò»°ãÈ˾ùÁýͳ±íʾлÒâ¡£Èç¹ûÓеĵ¥Î»»ò¸öÈËȷʵ¸øÓè°ïÖúºÍÖ¸µ¼£¬ÉõÖÁÑо¿·½·¨¶¼ÊÇ´ÓÈ˼ÒÄÇÀïѧµ½µÄ£¬Ò²Ö»×ÖδÌᣬÊDz»Ó¦¸ÃµÄ¡£Èç¹ûдÉÏһЩ´Óδ¸øÓè°ïÖúºÍÖ¸µ¼µÄÈË£¬ÎªÕչ˹Øϵ£¬Ìá³öÖÂлҲÊDz»Ö÷ÕÅ¡£ J,a&"eOZ  
2.ÖÂлÔÚÂÛÎÄÊÖ¸åÖеÄλÖà G  hM  
ÖÂлͨ³£Î»ÓÚÂÛÎĽáÊøÖ®ºó»ò½áÊøʱ¡£µ«ÉÙÊýSCIÆÚ¿¯ÒªÇó°ÑÂÞÁÐÖÂл·ÅÔڲο¼×ÊÁÏ֮ǰ£¬»òÕßÔÚµÚÒ»½Ú¡£ c '|*{%<e2  
3.ÀûÒæ³åÍ» G,8mFH  
ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚÖÂлÕ½ÚÄÚ˵Ã÷¡°Any clarification regarding conflicts of interest of the authors¡±¡£Èç¹ûûÓУ¬Äã¿ÉÒÔдÉÏ¡°The authors indicate no potential conflicts of interest¡±»òÕß¡°The authors declare that they have no competing financial interests¡±¡£ OqGp|`  
4.ÊéдÖÂл³£¼ûµÄ´íÎó 2j\_svw'  
£¨1£©Êéд»ù½ðÀ´Ô´Ê±£¬Ã»Óбê×¢»ù½ðºÅÂë¡£µ±È»£¬ÓÐЩ»ù½ðûÓлù½ðºÅÂë¡£ :4AQhn^;"  
£¨2£©ÓÐÈË»ùÓÚÀñò£¬ÌíÉ϶ÔeditorºÍanonymous reviewersµÄ¸Ðл£¬ÕâÊÇûÓбØÒªµÄ¡£ aRd~T6I  
£¨3£©ÓÐЩÃû¼Ò¡¢Ñ§Õß»ò½ÌÊÚ£¬´Óδָµ¼£¬Ò²Ã»ÓÐÔĶÁ¹ýÂÛÎÄ£¬½è¡°ÖÂл¡±À´Ôö¼ÓÂÛÎÄ·¢±íµÄ¿ÉÄÜÐÔ£¬ÊDz»¶ÔµÄ¡£ÖÂл´ÊºÍÖÂл·½Ê½±ØÐëÕ÷µÃÊÜлÈ˺͵¥Î»µÄͬÒâ¡£

kaobook 2011-08-17 22:36
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× +]l?JKV  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ +Z#=z,.^  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õ߶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëδÔøÔĶÁµÄÎÄÕ¡£ EPo)7<|>  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò >}k*!J|  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ #83   
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© =dm9+ff  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© o)Q4+njT@  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© 3 9 8)\3o  
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ Z;+,hR((  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ g$(Y\`zw  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî (>`_N%_  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠe9acI>^w  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åÇ°£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ s>9I#_4]  
£¨3£©¾¡Á¿²»ÒªÒÅ©ÖØÒª²Î¿¼ÎÄÏס£ K^{j$  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ vuQA-w7  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£ ;NP-tA)  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æʱ£¬¿ÉÒÔд³Éin press¡£ AArLNXzVW  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ 3h bHS~  
4.²Î¿¼ÎÄÏ׵ĸñʽ {/[@uMS_6]  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚÇ°£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 ;Q ZG<  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ o!xCM:+J  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ s'O%@/;J  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚÇ°£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ @Y ~gd K  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊÇ°´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊÇ°´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ 'O%*:'5k  

kaobook 2011-08-17 22:37
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× /.:1Da  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ s$y_(oU,D  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õ߶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëδÔøÔĶÁµÄÎÄÕ¡£ cG E{dWz  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò PvKGB01_  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ c(( 3B  
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© (4Db%Iw  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© hu-]SGb6  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© Dw=L]i :0v  
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ TjpyU:R,&|  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ '[r:pwE  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî zDg*ds\  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠWjBml'^RY  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åÇ°£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ &4E|c[HN  
£¨3£©¾¡Á¿²»ÒªÒÅ©ÖØÒª²Î¿¼ÎÄÏס£ \] Y<d  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ :M6|V_Yp  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£ k r$)nf  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æʱ£¬¿ÉÒÔд³Éin press¡£ n6[shXH  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ gvVy0nJI~  
4.²Î¿¼ÎÄÏ׵ĸñʽ {F_>cyR  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚÇ°£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 ~vP_c(8f  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ YBY;$&9  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ 9u~C?w  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚÇ°£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ K*^'t ltJ  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊÇ°´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊÇ°´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ wgDA b#Zuk  

kaobook 2011-08-17 22:37
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ 2 SU'lh\E  
1.¸½Â¼µÄÄÚÈÝ }P=FMme{F(  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ lBn<\Y!^  
2.¸½Â¼µÄÓ¦Óà EQnU:a  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖƵÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠ6n:X p_yO  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ uP7|#>1%  
3.×¢ÒâÊÂÏî y 2k's  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ &2@"zD  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ "= s dn  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ 0$XrtnM  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ yR F+  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓƵ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøʹÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓƵ¡£ _2k<MiqCD[  
4.¸½Â¼µÄ¸ñʽ 57 Vn-  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ zv1,DnkqF  
1.¸½Â¼µÄÄÚÈÝ 4&]NC2I  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ a"+/fC`  
2.¸½Â¼µÄÓ¦Óà yl<=_Q  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖƵÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠz:n JN%Qb  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ q9(O=7O]-  
3.×¢ÒâÊÂÏî Nf~B 1vkp  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ Mc  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ _qit$#wK;  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ L8;`*H  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ +SRM?av  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓƵ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøʹÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓƵ¡£ F7p`zf@O]  
4.¸½Â¼µÄ¸ñʽ -r_Pp}s  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ19ÕÂÈçºÎÏòSCIÆÚ¿¯Í¶¸å *SZ*S %oS3  
1.×¼±¸Í¶¸åÐÅ hE/y"SP3  
SCIÆÚ¿¯µÄ±à¼­ÍùÍùÐèҪһЩÓйØ×÷Õß¼°ÆäÂÛÎĵÄÐÅÏ¢£¬¶ø×÷ÕßҲϣÍû¸ø±à¼­ÌṩһЩÓÐÖúÓÚÆäÈ«ÎÄËÍÉó¼°¾ö²ßµÄÐÅÏ¢¡£ÕâЩÐÅÏ¢¶¼Ó¦¸Ã°üÀ¨ÔÚͶ¸åÐÅ£¨covering letter£©ÖС£Í¶¸åÐÅÓ¦°üÀ¨ÒÔϼ¸·½ÃæµÄÄÚÈÝ£º Vi>kK|\b  
£¨1£©ÂÛÎĵÄÌâÄ¿ºÍËùÓÐ×÷ÕßµÄÐÕÃûÒÔ¼°µØÖ·¡£ KH&xu,I  
£¨2£©ÉêÃ÷ÎĸåȨתÈᣠ~ # ~Kxh  
£¨3£©ÎÞÒ»¸å¶àͶ¡£ K`1\3J)  
£¨4£©ËùÓÐÁгö×÷Õß¾ù¶ÔÎĸåÓÐÈ·Çй±Ïס£ 9X{aU)"omQ  
£¨5£©ÎĸåÄÚÈÝÕæʵ£¬ÎÞαÔì¡£ STB=#z  
£¨6£©ËùÓÐ×÷Õß¾ùÒÑÔĶÁÎĸ壬ÇÒͬÒâË͸塣 4d3PF`,H`  
£¨7£©½¨ÒéÉó¸åÈ˼°Òò´æÔÚ¾ºÕù¹Øϵ¶ø²»ÒË×öÉó¸åÈ˵ÄÃûµ¥¡£ MgLz:2 :F  
£¨8£©Í¨ÐÅ×÷Õߣ¨corresponding author£©µÄÐÕÃû£¬ÏêϸµØÖ·£¬µç»°ºÍ´«ÕæºÅÂ룬E-mailµØÖ·¡£  /m*vY`  
£¨9£©Í¨ÐÅ×÷ÕßÇ©Ãû¡£ uEuK1f`  
Science¶ÔͶ¸åÐÅÒªÇó¹ý¶à£º !-4pr[C  
¡òThe title of paper and a statement of its main point. L*VGdZ  
¡òAny information needed to ensure a fair review process. 'bg%9}  
¡òNames of colleagues who have reviewed the paper. SR S~s  
¡òAlso required for submission are the following: Names, telephone, and E-mail addresses for all authors. 6q8qq/h)  
¡òA statement that none of the material has been published or is under consideration elsewhere, including the Internet. U=%S6uL\bx  
¡òNames, affiliations, and E-mail addresses of five potential referees. ,k@fX oW  
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. p<6pmW3  
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. TaB35glLY  
¡òFor authors using experimental animals, a statement that the animals¡¯ care was in accordance with institutional guidelines. .x1EdfHed/  
¡òCopies of any paper by you or your coauthors that is in press or under consideration elsewhere that relates to the work submitted to sciences, or of any paper that is cited in your paper as in press. These materials should be sent as attached PDF files in an E-mail to science_editors@aass.org. (F7!&]8%  
¡òWritten permissions from any authors who is not an author of your manuscript but whose work is cited as a personal communication or in press. Permission must allow distribution of in press manuscripts or relevant data to reviewers or any interested reader upon publication. n4CzReG  
Ͷ¸åÐÅʾÀý1 c{#lKD<7  
Dear Editor: eA_1?j]E3  
Enclosed for your consideration is an original research article, entitled ¡°X X X X X¡±. 2Sb~tTGz79  
1.All authors of this research paper have directly participated in the planning, execution, or analysis of this study. q@u$I'`Bs  
2.All authors of this research paper have read and approved the final version submitted. nS'0i&<{1  
3.The contents of this manuscript are not been copyrighted or published previously. iygdX2  
4.The contents of this manuscript are not now under consideration for publication elsewhere. ">voi$Kzey  
5.The contents of this manuscript will not be copyrighted, submitted ,or published elsewhere ,while acceptance by the Journal is under consideration. |g 4!Yd  
6.There are no directly related manuscripts or abstracts ,published or unpublished, by any authors of this paper. y)#Ib*?  
We believe the paper may be of particular interest to the readers of your Journal because the study reports that ¡­. J/wot,j^  
Correspondence and phone calls about the paper should be directed to X X X X X at the following address, phone and fax number ,and E-mail address: 6576 RT  
(your name and address here) /5r[M=_ihr  
Thanks very much for your attention to our paper. I[<C)IG  
Sincerely yours, sOLo[5y'  
(your name here) #.tF&$ik  
Ðí¶àÂÛÎÄÒòSCIÆÚ¿¯±à¼­²¿ÍùÍùÕÒ²»µ½ºÏÊʵÄÉó¸åÈË£¬ÖÂʹ¸å¼þÒ»ÔÙÍÏÑÓ¡£ÌṩÉó¸åÈËÃûµ¥ºÍÏêϸͨѶµØÖ·£¬»á¼Ó¿ìÉó¸åÈËËٶȡ£Òò´Ë£¬ÔÚͶ¸åµÄͬʱ£¬ÌṩһЩÊìϤÂÛÎÄÄÚÈݵÄÉó¸åÈËÊDZØÐèµÄ¡£ xb_35'$M  
Ͷ¸åÐÅʾÀý2 Pd^ilRB  
Dear Dr. XXX, ";",r^vr\  
I would like to submit the attached manuscript,¡°XXX¡±,for consideration for possible publication in the Research Articles section of JCI. 0VsrAV0  
My two nominees for associate editor are Dr. Smith and Dr. XXX.. Dr. Smith is well versed in the topic of the paper, while Dr. XXX has used a methodology in his own research that is related to the methodology in the paper being submitted. "W:'cIw  
Reguarding the option of nominating up to four reviewers, my nominees are: bEy j8=P;  
Name-1,E-mail adderess-1 p#J}@a  
Name-2,E-mail adderess-2 Q} f=Ye(&}  
Name-3,E-mail adderess-3 d:=5y)  
Name-4,E-mail adderess-4 O-bC+vB]M  
The nominees for associate editor and reviewers have no conflict of interest with any of the authors of the paper being submitted. Sjj &n S  
This paper (or closely related research) has not been published or accepted for publication. It is not under consideration at another journal. No other papers using the same data set have been published.(NONE: If other papers using the data set have been published, please indicate the differences between the submitted paper and the other published papers.) Ge[N5N>  
Sincerely, q^goi 1  
(your name and address here) )0RH"#, 2L  
2.ÔĶÁͶ¸åÐëÖª zj`!ZY?fv  
´ÓÏàÓ¦µÄSCIÆÚ¿¯ÍøÕ¾µÄhomepageÏÂÔØInstruction for Author,²¢ÇÒ°´ÕÕÒªÇó×¼±¸ºÃÔ­¸åËùÓÐÎļþ£¬ÈçͶ¸å·ÝÊý¡¢ÂÛÎĸñʽ¡¢³¤¶È¡¢Í¼±í¡¢²Î¿¼ÎÄÏ׸ñʽ¡¢Åäͼ˵Ã÷£¨Figure legends£©µÈ£¬ÖðÌõ×ñÑ­¡£Ò»°ãSCIÂÛÎÄ¿É·ÖΪ»Ø¹ËÐÔÎÄÕ£¨review article£©¡¢ÆÕͨÂÛÎÄ£¨regular/research article£©¡¢¿ìѶ£¨short communication£©µÈ¡£²»Í¬µÄѧ¿Æ£¬ÕýÎĵÄÄÚÈݺÍÐÎʽ»áÓÐËùÔö¼õ£»Í¼±í¡¢¹«Ê½µÄÊýÁ¿Ò²»áÓÐËù²»Í¬¡£´ËÍ⣬²»µ«Ô­¸æµÄÄÚÈÝÒª·ûºÏSCIÆÚ¿¯µÄµÄÒªÇ󣬶øÇÒÔÚÊý×Ö¡¢Ò³Êý¡¢¸ñʽ¡¢Îļþ´¢´æÐÎʽµÈ·½Ã棬¾ùÐèÓëͶ¸åµÄµÄSCIÆÚ¿¯ÒªÇóÒ»Ö¡£·ñÔò£¬ÂÛÎÄÔÚ³õÑ¡½×¶Î»áºÜ¿ìÂäÑ¡¡£ jcOxtDTSW  
3.ÏòSCIÆÚ¿¯Í¶¸åµÄ·½Ê½ ,T jd  
£¨1£©ÓʼÄÐÎʽ¡£¼´Í¨¹ý¹ú¼Ê¿ì¼þ»òº½¿Õ½«ÂÛÎĵÄÔ­¸åÓʼĸøÆÚ¿¯µÄÖ÷±à»ò±à¼­²¿¡£ hMeE@Q0  
a£©¸å¼þ°ü×°£ºÒ»°ãÓ¦°´ÒÔÏÂ˳Ðò±¸Æë×ÊÁÏ£º {o5E#<)  
¨SͶ¸åÐÅ¡£ !lL21C6g+  
¨SÂÛÎĸ忽±´·ÝÊý¡£ÒÔ´òÓ¡¸å£¨hard copy£©Í¶¸å¡£ #$X_,P|D  
¨S°æȨתÈÃÉêÃ÷£¨¿ÉÒÔÔÚÂÛÎĽÓÊܺó×·¼Ó£©¡£ HRje4=:  
b£©¸å¼þÓʼġ£Óʼĸå¼þӦעÒ⣺ JyYg)f  
¨SÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¼û¡°Í¶¸åÐëÖª¡±£©¡£ÓеÄSCIÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÌرðÖ¸³öͶ¸åµØÖ·Ó붨¿¯»ò¶©µ¥Ðб¾µØÖ·²»Ò»Ñù£¬ÒÔÃâÔì³Éʱ¼äµ¢¸é¡£ [D?RL `ZF  
Óʼĸå¼þµÄÐÎʽÔø¾­ÊÇSCIÂÛÎÄͶ¸å½üºõΨһµÄ·½Ê½£¬ÏÖÔÚ²ÉÓÃÕâÖÖ·½Ê½½ÓÊÜÀ´¸åµÄSCIÆÚ¿¯Ô½À´Ô½ÉÙÁË¡£ *)U=ZO6S  
£¨2£©µç×ÓÓʼþÐÎʽ¡£¼´×÷Õß½«SCIÂÛÎÄE-mail±à¼­²¿¡£ÏÖÔÚÓÐÐí¶àSCIÆÚ¿¯ÒѾ­¸æ±ðÁËÓʼĺ͵ç×ÓÓʼþµÄʱ´ú£¬¿ªÊ¼Ö»ÊÜÀíÍøÉÏͶ¸å¡£Ä³Ð©ÆÚ¿¯½öÔÊÐíһЩûÓÐͼ±íµÄ¶ÌÎÄ¡¢ÌØÑûÂÛÎÄ£¨reviewer£¬book chapter£©»ò¡°¸ø±à¼­µÄÐÅ¡±Í¨¹ýE-mailͶ¸å¡£¼¸ºõËùÓеÄSCIÆÚ¿¯¾ù²»½ÓÊÜfaxͶ¸å¡£ %nP13V]  
£¨3£©ÍøÉÏͶ¸å£¨online submission£©¡£ÍøÉÏͶ¸å·½Ê½Ëٶȸü¿ì£¬¶øÇÒ¸å¼þ²»»á¶ªÊ§¡£ÍøÉÏͶ¸å³£ÐèÒª×÷Õßonline×¢²á¡£Ò»µ©×÷ÕßÔÚÍøÉϵǼÇ×¢²áͶ¸å£¬Ã¿¸öÖ÷Òª²½Ö趼ÓмǼ£¬ºÜÊÜSCIÆÚ¿¯×÷ÕߵĻ¶Ó­¡£ vXRfsv y  
4.ÍøÉÏͶ¸å x>;! `}x  
£¨1£©ÍøÉÏ×¢²á£¨online registration£©£¬Ò²½Ð×÷Õß×¢²á¡£ÍøÉÏͶ¸å£¨online submission£©Ê±£¬Òª°Ñ×Ô¼ºµÄÐÕÃû¡¢µ¥Î»¡¢ÁªÏµµØÖ·£¬°üÀ¨µç»°¡¢´«ÕæºÍµç×ÓÓÊÏäµÈµÇ¼Ç׼ȷÎÞÎó¡£×¢²á³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ zpiqJEf|'"  
×¢²á³É¹¦ÊÂÀý avykg(  
Dear Dr .XXX, 2\lUaC#E  
Thank you for registering for the Elsevier Editorial System online submission and peer review tracking system for Neurobiology of Disease. TR5"K{WDx  
Here is your username and confidential password, which you need to acess the Elsevier Editorial System :http://ees.elsevier.com/ynbdi/ M8:gHjwsx  
Your username is: XXX and Your password is: XXX ^zO%O653  
You can change your password and other personal information at: http://ees.elsevier.com/ynbdi/ 9eH(FB  
info_update.asp UP 75}h9  
Editorial Office 2YdMsu~  
£¨2£©°´²¿¾Í°àµÄÊäÈëÂÛÎĵĸ÷¸öÖ÷Òª²¿·Ö¡£ÈçÌâÄ¿¡¢×÷Õß¡¢ÕªÒª¡¢¹Ø¼ü´Ê¡¢ÕýÎÄ¡¢Í¼±íµÈ¡£ÔÚÊäÈëÿ¸ö²¿·ÖµÄʱºò£¬Ò»ÊÇҪͨ¹ý¸Ã²¿·ÖµÄÓйØÒªÇó£¬ÔÙ´ÎҪȷÈÏ×Ô¼ºÊäÈëµÄÎļþÊÇ·ñ·ûºÏÒªÇó¡£ÕâÌýÆðÀ´²¢²»ÄÑ£¬µ«Êµ¼ÊÉÏ×÷ÕßÔÚÕâ·½ÃæµÄÊèºöÈ´ºÜ¶à¡£ /R b`^n#  
£¨3£©È·ÈÏÿ¸ö²¿·ÖÊäÈëµÄÍêÕûÐÔ¡£ÓÐЩ×÷ÕßÔÚÊäÈëÎļþʱ¹ýÓÚ´Ò棬ʮ¸öͼֻÊäÈëÒ»°ë£¬ÕâÑùµÄ¸å¼þ¼´Ê¹Äܵ½Á˱༭²¿Ò²²»ÄÜËÍÉó£¬Ö»ÄÜ·µ»Ø×÷Õß²¹Â©¡£Èç¹ûÉóУԱһʱÊèºö»òÖ÷±àûÓвì¾õ£¬½«ËùÓÐǷȱµÄÎÄÕ·¢³öËÍÉó£¬ÔòÉó¸åÈËÒòΪȱͼ£¬²»ÄÜÕý³£ÉóÔÄÎÄÕ¡£ÕâÑùÔì³ÉµÄÂé·³Ëùµ¢ÎóµÄʱ¼ä»á¸ü¶à¡£ j#9p 0[  
£¨4£©ÊäÈëÎļþÍê±Ïºó£¬Ò²¾ÍÊÇËùÓеIJ¿·Ö³É¹¦µØÊäÈëºó£¬²»ÒªÍü¼Çµã»÷Ͷ¸å·¢Ëͼü£¨¡¾Sending¡¿»ò¡¾submitting¡¿£©¡£·ñÔò£¬¸å¼þÖ»»á´æ´¢ÔÚ×÷Õß×Ô¼ºµÄÎļþ¼ÐÖУ¬¶ø²»ÊÇ·¢Ë͵½±à¼­²¿µÄÎļþ¼ÐÀï¡£ÂÛÎÄÌá½»³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ t+W+f  
Ͷ¸å·¢Ëͳɹ¦Ê¾Àý TfDx> F$  
Dear DrXXX£¬ |\*7J!Liv  
This is confirm that the above-mentioned manuscript has been received for consideration tb/bEy^  
in Neurobiology of Disease. @w[WG:-+  
You will be able to check on the progress of your manuscript by logging on to the Elsevier Editorial System for Neurobiology of Disease as an author. qi.|oL9p  
You will be given a manuscript number shortly and you will soon receive an E-mail cx&jnF#$  
with this number for your reference. W0K&mBu  
Thank you for submitting your manuscript to Neurobiology of Disese. Should you have 6cb;iA  
any questions, please feel free to contact our office. 5Q^ L"&0  
Kind regards, h$_Wh (  
Editorial Office !r,ZyJU  
Ä¿Ç°£¬Ðí¶àSCIÆÚ¿¯ÍøÉÏͶ¸å£¬Ðè°ÑÎļþÓÐÒ»ÖÖ´æ´¢ÐÎʽת»»µ½ÁíÍâÒ»ÖÖ´æ´¢ÐÎʽ£¬±ÈÈçWordÎļþ±ä³ÉPDFÎļþ¡£ÔÚÕâ¸öת»»¹ý³ÌÖУ¬¼ÆËã»úÆÁÄ»ÉÏ»áÏÔʾͣÖÍ״̬£¬¿´ÉÏÈ¥ºÃÏñËÀ»úÁË¡£Æäʵ²»È»£¬Ö»ÐèÄÍÐĵȴý¡£Èç¹ûÓÐÎÊÌ⣬ÆÁÄ»ÉÏÔò»á³öÏÖÎÊÌâÔ¤¾¯»ò½â¾öÎÊÌâµÄÌáʾ¡£Èç¹û×÷Õß²»ÄÜ×ÔÐнâ¾ö¹ÊÕÏ»òÎÊÌâ·´¸´³öÏÖ£¬×÷Õß¿ÉÓë³ö°æÉçµÄÔÚÏßͶ¸åÖ§³ÖϵͳµÄÏà¹Ø²¿ÃÅ£¨online submission support team £©ÁªÏµ£¬ÇóµÃ°ïÖú¡£´ËÍâÖµµÃÒ»ÌáµÄÊÇ£¬²¿·ÖÖøÃû³ö°æÉçµÄÍøÒ³Éϳý¸½ÓÐͶ¸åÐëÖªÍ⣬»¹ÓÐרÃÅÉè¼ÆÁËÕë¶ÔÍøÉÏͶ¸åµÄÖ¸µ¼Ê¾·¶Îļþ£¨£©¡£×ÜÖ®£¬ÍøÉÏͶ¸å²¢²»ÄÑ£¬¹Ø¼üÊÇ×¼±¸³ä·Ö£¬¶øÇÒÔÚʵ¼ÊÉÏ»ú²Ù×÷ʱ°´²¿¾Í°à£¬²»Äܵ¥´¿Çó¿ì£¬·ñÔòÓûËÙ¶ø²»´ï¡£ g(7htWr4  
ÍøÉÏͶ¸åºó£¬±à¼­²¿»¹»á¸øÄãÒ»¸öÕýʽµÄ»ØÖ´ºÍ¸å¼þ±àºÅ¡£ cwlXb!S$  
£¨5£©¸å¼þ±àºÅ¿ÉÓÃÓÚ¸å¼þ×·×Ù£¨following-up£©¡£Òò´Ë£¬Òª±£´æºÃ¡£ _~d C>`K  
Ͷ¸åÊÕÌõʾÀý BBm.;=8@ ^  
Dear Authors£¬ 3x#=@i  
This is to inform you that the following manuscript has been submitted to the JCB. qN1(mxa.?  
Manuscript Number: F-00555-2008 `Yn^ -W  
Manuscript Title: X X£Ø.Author list:XXX K8$Hg:Ky-/  
You can track the status of the manuscript in your author center at http://mc.manuscriptcentral.com/JCN. l[.*X  
If you have received this message in error, or if one of your co-authors did not receive this message, please contact the corresponding author:Dr.XXX. gEcVQPD@  
Regards, C eNpJ  
Peer Review Manager #r `hK)  
5.ÍøÉÏͶ¸å³£¼ûÎÊÌâ IpXg2QbN  
ÍøÉÏͶ¸åͨ³£ÊÇ¿ìËÙ²¢Ïà¶ÔµØÈÝÒס£È»¶ø£¬Èç¹û×÷ÕßÊèºö×ñÊØÆÚ¿¯µÄÒªÇ󣬿ÉÄÜÑÓ³Ù»òÍ£Ö¹·¢ËͺÍÉó¸å¹ý³Ì£¨The submission and peer-review process£©¡£ÍøÉÏͶ¸å³£¼ûµÄÎÊÌâÓУº 3Wrl_V  
£¨1£©ÂÛÎÄ×ÖÊdz¬¹ý¹æ¶¨µÄÒªÇó¡£ xAMj16ZF  
±ÈÈç°´ÒªÇó£¬Ô­¸å²»Äܳ¬¹ý3000×Ö£¬¿ÉÓеÄÔ­¸å³¤´ï3200×Ö£¬ÉõÖÁ¸ü¶à¡£ `zAV#   
£¨2£©Í¼²»¹æ·¶¡£ f#pT6  
¨SµÝ½»Í¼Îļþ£¨Figure file£©·½Ê½²»ÕýÈ·¡£¶àÊýSCIÆÚ¿¯ÒªÇóÿµ¥¶Àͼ×÷Ϊһ¸öµ¥¶ÀÎļþµÝ½»£¬¶ø²»ÊÇ°ÑËùÓеÄfigure fileºÏ³ÉÒ»¸öÎļþÔٵݽ»¡£ =iC5um:  
¨SͼµÄ·Ö±æÂÊÌ«µÍ¡£Ó¦¸ÃÓø߷ֱæÂʵÄͼ£¨300dots per inch£©¡£ z%Ywjfn'  
¨SͼµÄ¸ñʽ£¨format£©²»¶Ô¡£³£ÓÃͼµÄÖ¸¶¨¸ñʽΪGIF¡¢JPEG¡¢TIFF¡£²»ÒªÓ÷ÇÖ¸¶¨¸ñʽ£¬ÀýÈ磬PDF¡¢WBMP¡¢Word.doc¡¢RLEºÍPowerPoint¡£ w1F7gd  
¨SûÓÐͼ½â£¨Figure legend£©¡£ $g$~TuA w  
£¨3£©Ã»Óеݽ»¡°A conflict of interest disclosure¡±¡£ 2mP| hp?  
ÓÐЩSCIÆÚ¿¯ÒªÇó×÷ÕßÔÚͶ¸åµÄͬʱ£¬ÒªµÝ½»¡°A conflict of interest disclosure¡±¡£ =i~/.Nu&  
£¨4£©È±Title page¡£ *YZ' Uy?  
£¨5£©È±ÕªÒª¡£ X&0m$x  
£¨6£©È±Í¶¸åÐÅ¡£ yHLc lv  
£¨7£©¶¯ÎïºÍÈËÌåÊÔÑéûÓб»Â×ÀíίԱ»áÅú×¼¡£ A0# K@  
£¨8£©ÂÛÎĵĸñʽ²»·ûºÏËùͶSCIÆÚ¿¯µÄÒªÇó¡£

kaobook 2011-08-17 22:39
µÚ20ÕÂSCIÂÛÎÄÉó¸å¹ý³Ì -20 o%t  
1.±à¼­²¿³õÉó PwQW5,,h0  
³õÉó°üÀ¨£º .FK[Y? ci#  
£¨1£©×î»ù±¾µÄ¼¼Êõ¼ì²é¡£Ö÷ÒªÊǼì²ìÔ­¸åÊÇ·ñ°üº¬ÁËÓ¦¸ÃÓеĻù±¾ÄÚÈÝ¡£°üÀ¨ÎļþÐÎʽ¡¢ÄÚÈÝ¡¢×÷ÕßÁªÏµ·½Ê½ÒÔ¼°ÂÛÎÄÊÇ·ñÊôÓÚÖظ´ÐÔͶ¸åµÈ¡£ HAEgR  
£¨2£©ÂÛÎĵÄÓ¢ÎÄÊÇ·ñ»ù±¾¹ý¹Ø£¨·ÇÓ¢Óï¹ú¼Ò£©¡£ MB" uJUk  
£¨3£©ÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ ji? 0;2Y  
£¨4£©ÂÛÎĵÄˮƽÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ N(vzxx^  
2.±à¼­²¿³õÉóºóµÄ½á¹û i:Pg&474f  
£¨1£©½øÒ»²½ËÍÉó¡£ 7'S/hV%  
£¨2£©Ðè²¹³äºÍÐ޸ġ£Ò»µ©¼¼Êõ·¢ÏÖÎÊÌ⣬±ÈÈçÔ­¸å¹ý³¤µÈ£¬Ô­¸å»áÂíÉÏ·µ»Ø×÷Õߣ¬½øÐбØÒªµÄ²¹³äºÍÐ޸ġ£Ô­¸æÒ»µ©ÍË»Ø×÷Õߣ¬Îļþ±ã»áÖØлص½×÷Õß×Ô¼ºÔÚÍøÉϵÄͶ¸åÎļþ¼ÐÀµÈºòÐ޸ġ£Óë´Ëͬʱ£¬×÷Õߵĵç×ÓÐÅÏäÄÚͬÑù»áÊÕµ½Ò»·â±à¼­²¿µÄÀ´ÐÅ£¬Ã÷È·¸æÖª¸å¼þÓ¦¸Ã½øÐÐÐ޸Ļò²¹³äµÄµØ·½¡£×÷ÕßÖ»ÐèÉÏÍø´Ó×Ô¼ºµÄÎļþÖе÷³öÎļþÐ޸ļ´¿É¡£Ò»µ©ÎļþÐÞ¸ÄÍê±Ï£¬×÷ÕßÓÖÒª¸ù¾Ý³ö°æÉçÐź¯µÄÌáʾ£¬ÉÏÍø°´²½Öè»á×ßÔÙ½«Ô­¸å·¢»ØSCIÆÚ¿¯µÄ±à¼­²¿¡£Õâ¸ö²Ù×÷¹ý³ÌÓë×î³õµÄͶ¸å³ÌÐò´óͬСÒì¡£ 9vWKyzMi  
£¨3£©Ö±½Ó±»¾Ü¾ø¡£ e &^BPzg  
Ö±½Ó±»¾Ü¾øµÄÔ­ÒòÖ÷ÒªÓУº g_G?gO  
µÚÒ»£¬ÂÛÎĵÄˮƽûÓзûºÏ¿¯ÎïÒªÇó¡£ÀýÈ磬Nature´óÖµÄÆÀÑ¡»úÖÆ£º±à¼­Ê×ÏȾö¶¨ÕâƪÂÛÎĵ½µ×ÓжàÉÙ·ÖÁ¿£¬Õâ¸ö¾ö¶¨ÒªÔÚ¼¸ÌìÄÚ¾ÍÍê³É£¬Èç¹û·ÖÁ¿²»¹»£¬¾ÍÖ±½Ó¾Ü¾ø£¬Ã¿ÄêÈ«Çò´óÔ¼ÓÐ1ÍòƪÂÛÎÄÌá½»£¬60%-70%µÄÂÛÎĵ±¼´·ñ¾öµô£¬´ËºóÇëרҵÆÀÉóÍÅÆÀ¹À£¬´óÔ¼3¸ö×óÓÒ£¬¶¼ÊÇÏàͬÁìÓòµÄר¼Ò£¬Í¨¹ýÆÀÉóÂÊ´óÔ¼ÊÇ20%£»ÔÚÌýÈ¡ÆÀÉóÍÅÒâ¼ûºóÔÙ·ñ¾ö´óÔ¼2000-3000ƪ£¬×îºóֻʣÏÂ1000ƪ·¢±í£¬×îºóµÄ×Ü·¢±íÂÊÊÇ10%¡£ #x1AZwC  
µÚ¶þ£¬ÂÛÎĵÄÄÚÈݲ»·ûºÏ¸ÃÆÚ¿¯µÄµÄ°ì¿¯×ÚÖ¼ºÍ·¶Î§ÒªÇó¡£ @^a6^*X>  
ÂÛÎÄÖ±½Ó±»¾ÜʾÀý O_K@\<;~  
Dear Dr.XXX \#1!qeF  
I am writing to you on behalf of the Journal of Clinical Investigation,s Editorial Board to thank you for submitting your manuscript,¡°Xxxx¡± (our reference 5555-RG-1).The Broad has now had a chance to carefully consider your manuscript, but I regret to inform you that we feel the manuscript would not be appropriate for publication in the Journal of Clinical Investigation. z}.!q{Q  
More than 4,000 manuscripts are submitted annually to the JCI,of which only a small percentage can be published. To facilitate the review process, we submit all manuscripts to a review by the Editorial Board to determine their appeal to the Journal¡¯s general readership. @g9j+DcU  
Although the Board regrets that it cannot offer to publish your manuscript, I would stress that this decision was based on issues relating to the priority assigned to your work relative to the other submissions under consideration. "Ol;0>$  
Thank you for allowing us to review this work.We hope that you will continue to consider sending your work to the Journal in the future. -}%'I ]R=  
Sincerely, Kv:UQdnU[  
Editor-in-Chief ehtiu!Vk  
3.±à¼­²¿ËÍÉó <89@k(\ /  
¡òÆÀÉóÈ˵ÄÑ¡Ôñ Ictc '#y  
SCIÆÚ¿¯µÄÉó¸åÈË´ó¶àÊǸ÷ÁìÓòר¼Ò£¬ÔÓÖ¾³ö°æÕß¾­³£Õ÷ѯ±àίÒâ¼û£¬Ñ¡Ôñ×î¼ÑÉó¸å¶ÓÎé¡£Éó¸åÈ˵ÄÔðÈÎÊǶÔÂÛÎĵĴ´ÐÂÐÔºÍÕþÈ·¶¨½øÐÐÉó²é£»Éó¸åÒâ¼ûÒ»°ãÓ¦°üÀ¨ÎªÌá¸ß¸å¼þÖÊÁ¿¶øÓ¦×öµÄÐ޸ĵĽ¨Òé¡£Éó¸åÈËÊÇÎÞ±¨³êµÄ£¬Éó¸åÈ˵Ä̬¶È´ó¶à¼«ÆäÈÏÕ档ÿһÂÛÎÄÓÉ2-4λÆÀÉóÈËÀ´ÅжÏÆä¼ÛÖµ£¬²¢½¨Òé±à¼­ÊÇ·ñ½ÓÊÜ»ò¾Ü¾ø¸ÃÂÛÎÄ¡£µ«±à¼­×ö³ö×îºóµÄ¾ö¶¨£¬Ò»°ã²»»áÒòΪ±à¼­¸öÈ˵ĺöñ»òÆäËû·Ç¿ÆѧÒòËضøÓ°ÏìÂÛÎĵĽÓÊÜ¡£ÒòΪ£¬±à¼­À´×Ô²»Í¬µÄ¹ú¼ÒºÍµØÇø£¬ÓÐ×Ų»Í¬¿ÆѧµÄרҵ±³¾°£¬×Ô¼ºÊ×ÏȾÍÊǸÃÁìÓòµÄר¼Ò£¬ËûÃǵÄÖ°Ôð¾ÍÊǾ¡×Ô¼º×î´ó¿ÉÄÜ£¬Ñ°ÕÒ×îÓÅÐãµÄÂÛÎÄ¡£ 1B'i7  
EditorÑûÇëReviewerÉó¸åµÄÑù¸åÐÅʾÀý vVc:[i  
MS TITLE£ºXXX Y:&1;`FBZ  
Dear Dr.XXX ]w]Swt2n  
I would appreciate your expert opinion as a reviewer of the above manuscript recently submitted for publication to Science. Given your knoeledge and expertise in the subject areas upon which this manuscript is focused, I hope you will agree to participate in the reviewer process. Bjml%  
Please advise the editorial office in your reply of any relevant relationship that might be reasonably perceived as a real or potienial conflict of interest that could potentially influence or bias your review of this manuscript. %=/Y~ml?  
While most relationships are not disqualifyin, if you believe that you have a disqualifying conflict of interest, financial or otherwise, please contact the editorial office immediately. A relationship is ¡°relevant¡± if the relationship or interest relates to the topic of the manuscript in terms of any of the following: the same or similar subject matter or topic; the same, similar or competing drug or device, product or service, intellectual property or asset; a drug or device company or its competitor; or has the reasonable potential to result in financial, professional or other personal gain or loss for you, members of your household or employer. 6T< ~mn  
To view the abstract and accept/decline this invitation, please go to: http://submit-science.org SOb17:o3|  
Enter your ¡®Reviewer Area¡¯ and click on ¡®Requests for Review¡¯. Please accept or decline via the appropriate alternative reviewers, giving their name(s),institution(s), and E-mail address(es). |(}uagfrd  
Sincerely, po*s  
Editor KD$P\(5#  
Èç¹ûͬÒ⣬Editor»á¸øReviewerÒ»·âÐŲ¢¸æËßReviewerÈçºÎÏÂÔØÂÛÎĺÍÆÀÉó¡£ Q}^ n  
Editor¸øReviewerµÄÑù¸åÐÅʾÀý (*&6XTV (  
Dear Dr.XXX *D~@xypy  
Thank you for agreeing to review Manuscript ID-07-555 entitled ¡°XXX¡± for Cell. E?y0UD[8J  
In your review, please answer all questions. On the review page, there is a space for ¡°Comments to Editor¡± and a space for ¡°Comments to the Author¡±.Please be sure to put your comments to the author in the appropriate space. fdho`juFa  
To access the manuscript, login to Cell-Manuscript Central site at http://mc.manuscriptcentral.com/cell. Once you are logged in, the Main Menu will be displayed.Please click on the Reviewer Centre, where you will find the manuscript listed under ¡°Review and Score¡±.You can click on the ¡°View Details¡± button to begin reviewing the manuscript. It is essential that you click the ¡°Save¡± button if you wish to exit the review before you submit it to the Editor. Otherwise, none of the information that your have completed your review and are ready to submit it to the Editor, click on ¡°Submit¡±. d`StBXG!  
Thank you for evaluating this manuscript. ~Cks)mJs  
Best regards, ?@|1>epgd  
Executive Editor ]SBv3Q0D7  
¡òÂÛÎĽøÈëSCIÆÚ¿¯µÄ×î»ù±¾ÒªÇó N TXT0:  
Ô­´´ÐÔÊǺܶàSCIÆÚ¿¯ÊÇ·ñ¼ÓÃÂÛÎĵÄ×îÖ÷Òª³ö·¢µã¡£ÈκÎÆÚ¿¯¶¼²»Ï£Íû·¢±íÒѾ­¼ûÓÚÆäËûÔÓÖ¾£¬»òÓÉÆäËûÓïÑÔ·¢±í¡¢»òÒÔÉÔÓв»Í¬µÄÐÎʽ·¢±íµÄÂÛÎÄ£¬SCIÆÚ¿¯Ò²ÊÇÈç´Ë¡£ÒªÏëÔÚSCIÆÚ¿¯·¢±íÂÛÎÄ£¬Ô­´´ÐÔ×î»ù±¾µÄÒªÇó¡£ }tft@,dIC  
¡òÂÛÎÄÆÀÉó±ê×¼ x?:WR*5w  
ÏÖ½éÉÜÂÛÎÄÆÀÉó±ê×¼ÈçÏ£º ex'd^y  
¨SÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯µÄ·¶Î§£¨aims and scope£©¡£ >G' NI?$  
¨SÂÛÎÄÊÇ·ñÌá³öÁËÒ»¸öеÄÎÊÌâ»òÕ߶ÔÒÑÓÐÎÊÌâÌá³öÁËÒ»¸öеĽâ¾ö·½°¸¡£ j2qDRI  
¨SÂÛÎĵÄÔ­´´ÐÔÖÊ£¨°üÀ¨¸ÅÄî¡¢ÖÎÁÆ¡¢·½·¨¡¢Êý¾Ý¡¢½âÊͺÍ/»òÓ¦Óã©»ò½ñºóµÄ¼ÛÖµ»òÒâÒå¡£ =)Ew6} W6  
¨SÂÛÎĵÄÖ÷Òª½á¹û»ò½áÂÛÊÇʲô£¿ÊµÑé½á¹û»ò½áÂÛÊÇ·ñ³ä·Ö£¿ _ H$ Cm  
¨SÂÛÎÄËùʹÓõķ½·¨µÄÆÀ¼Û£¿ÂÛÎļ¼Êõº¬Á¿ÈçºÎ£¿ |1g2\5Re  
¨S½á¹û»ò½áÂÛÊÇ·ñ¾ßÓÐÐÂÓ±ÐÔ£¿½áÂÛÊÇ·ñÓëÌá³öµÄ¼Ù˵»òÎÊÌâ¹ØÁª£¿½áÂÛÊÇ·ñ±»Ö¤Ã÷Çå³þ£¿  Xe=@I*  
¨SÖ÷Òª½á¹û»ò½áÂÛÊÇ·ñÕýÈ·£¿ UbC)X iO  
¨SÂÛÎÄÊÇ·ñ¶ÔËùÌá³öµÄ¼¼Êõ/½á¹ûµÄÓÐЧÐԺ;ÖÏÞÐÔ½øÐÐÁËÆÀ¼Û£¿ n+zXt?{u  
¨SÂÛÎÄд×÷ÊÇ·ñÇåÎú£¬ÊÇ·ñÄÜÈñ¾ÐÐÒµÄÚ¶àÊýÑо¿ÈËÔ±¶Á¶®£¿ +/\.%S/  
¨SÎÊÌâ¡¢¸ÅÄî¡¢¶¨ÒåºÍ/»ò¼Ù˵µÄ³ÂÊöÊÇ·ñÇå³þ£¿ .w$v<y6C  
¨SÂÛÎÄÊÇ·ñÊʵ±µØÒýÓúͽéÉÜÁËÓëÖ®Ïà¹ØµÄÀúÊ·ÎÄÏ×£¿ÒýÓÃÎÄÏ×ÊÇ·ñ³ä·Ö£¿ eX?o 4>  
¨SÊÇ·ñ¾ßÓÐÒ»ÖÂÐÔ£¨Ç°/ºó£¬ÂÛÊö/½á¹û£©£¿ sN-5vYfC*  
¨SÂÛÎĵÄÓ¢ÎÄÊÇ·ñ¹ý¹Ø£¿ n9bX[+#d  
¡ò¸å¼þ×·×Ù 3WPMS/  
Ͷ¸åºó¸å¼þ×·×Ù£¨follow-up£©¡£Èç¹ûͶ¸å2ÖܺóÈÔÎÞÈκÎÓйظå¼þÊÕµ½µÄÐÅÏ¢£¬¿ÉÒÔ´òµç»°¡¢·¢E-mail»òдПø±à¼­²¿ºËʵ¸å¼þÊÇ·ñÊÕµ½¡£ÏÖÔÚµÄÓʼþ¶ªÊ§Êdz£ÓеÄÊ£¬¼´Ê¹Í¨¹ýE-mail×÷Ϊ¸½¼þ·¢µÄ£¬Ò²ÓзþÎñÆ÷´íÈÏΪ²¡¶¾¶øɾµôÄãµÄͶ¸å¡£E-mail×îºÃÒԻظ´µÄÐÎʽ£¬±£ÁôÔ­Ðżþ£¬ÌáÐѱ༭²¿ÉÏ´ÎͨÐŵÄʱ¼ä¡¢ÄÚÈݺ͸å¼þ±àºÅ¡£Ñ¯ÎÊÎÄ×ÖÒª¼ò½à£¬¿ªÃżûɽ£¬²»ÓÿÍÌ×»°¡£ &9o @x]) @  
¸å¼þ×·×ÙÑù¸åÐÅʾÀý ]a _;*Xq8d  
Dear Dr.XXX JB+pd_>5  
I am just writing to enquire if you have received our manuscript (MS#:55555)? CFul_qZ/e  
Best bGK&W;Myk  
(your name here) {:6VJ0s\  
ËùÓÐͨÐÅÓ¦±£³Ö¼Í¼£¬±ÜÃâÎʵĹýÇÚ¡£¿ÉÒÔÔÚÍøÉϲéѯ¸å¼þ״̬¡£

kaobook 2011-08-17 22:40
µÚ21Õ ÈçºÎÕýÈ·¶Ô´ýÉó¸åÒâ¼ûºÍÍ˸å  M/UJb1<  
1.Ͷ¸åºóµÄ½á¹û ~JC``&6E=}  
ͨ³£ÔÚÁ½Öܵ½Á½¸öÔ£¬Äã»áÊÕµ½±à¼­µÄ»Ø¸´£¬°üÀ¨Éó¸åÈ˵ÄÒâ¼û£¨Reviewers, comments£©ºÍÒ»·â±à¼­²¿µÄ¸ÅÀ¨ÐÅ£¨Covering letter£©¡£Ò»°ãÓÐÏÂÁпÉÄÜÐÔ£º fD,#z&  
£¨1£©Ô­¸æ½ÓÊÜ£¬ÎÞÐèÐ޸ģ¨Publish without changes£©¡£º±¼û¡£ E_ mgYW*5  
Dear XXX *ArzXhs[  
On the basis of reviewer¡¯s comments on your manuscript, I am pleased to inform you that your manuscript has been accepted for publication in the ¡°XXX iournal¡±. Yv"uIj+']  
For the pre-publication preparation, please read carefully the document of ¡°name of document¡± at ¡°XXX website¡± to access the resources you need for preparing the reference styles and the final complete package. When you same your manuscript into an MS-Word file, please use your Paper ID as the file name. For our production schedule, please submit your complete package to me within 14 calendar days. Jb ;el*,K  
Normally, the pre-publication process takes up to three months. During this period, galley proofs will be sent to you for checking and corrections purposes.The galley proofs must be returned to the production office within 7 callendar days. Furthermore, you are responsible for any error in the published paper due to your oversight. guwnYS  
I look forward to receiving the electronic file of your final manuscript. "DRp4;  
Best Regards, )x(  *T  
Editor i]Kq  
£¨2£©¸å¼þÍËÐÞ£¬ÐèÇá΢Ð޸ģ¨Publish with minor changes£©¡£²»¶à¼û¡£ -(:BkA  
Dear Dr. XXX ?:U6MjlQ"{  
Your manuscript, entitled ¡°title of the paper¡±, has been subjected to a double-blind review process by the reviewers who are experts in the related fields. Enclosed please find the reports from these reviewers. v+Mt/8  
Based on the reviewers, recommendations, I am delighted to inform you that your manuscript has been ACCEPTTED WITH MINOR REVISIONS for the ¡°name of the journal¡±. :M=!MgD3w  
Please note that it is imperative for you to revise the manuscript according to reviewers, comments and guidelines. Once you have revised the manuscript, please E-mail it in an MS-Word format to me at ¡°Your E-mail Address¡± on or before MM DD,YYYY, with a cover letter outlining point-by-point the revisions you have made in regards to the reviewers comments and guidelines.  vtL)  
Thank you very much for submitting your article to ¡°the name of the journal¡±. I look forward to receiving the revised version of your manuscript. y99G3t  
Sincerely, i& _sbQ^  
Editor ^~(bm$4r  
Enclosures: Referees reports. .Ta$@sPh}  
£¨3£©¸å¼þÍËÐÞ£¬ÐèÖØ´óÐ޸ģ¨Publish with major changes£©¡£ºÜ³£¼û¡£ 4{fi=BA   
Dear Dr. XXX P_b00",S  
We have now received the reviews of your manuscript referenced above. While the reviewers believe that this paper would ultimately make a significant contribution to the literature and could be acceptable for publication in The Journal of Neuroscience, they have also raised a number of serious concerns. These concerns are outlined in their reviews which have been included below. We invite you to revise and resubmit the manuscript. ^]aD LjD  
Please carefully address the issues raised in the attached comments, points by points, and make appropriate changes in the manuscript, or provide a suitable rebuttal to any specific request for change that you believe is unwarranted. When the revised manuscript is received, it will be sent for re-review. ?5/Sa  
When submitting your revised paper, please include a separate document called ¡°Response to Reviews¡± detailing your responses to the comments of the reviewers, we request that your manuscript text, tables and figure legend be submitted in an editable format(Word or La Tex only), and all figures uploaded individually. TIF or EPS files are the preferred formats for figures; however, Power point, Word, and Excel files will also be accepted. DPI minimums are as follows: 2H]&3kM3X  
-Line art must be at least 1000dpi. &<!I]:Y  
-Line/tone(combination of photographs and lines or labels )must be at least 500dpi. kP [ Y  
Thank you and we look forward to receiving yopur revised manuscript. :=~([oSNW"  
Kind regards, R \`,Q'3  
Associate Editor Dm4\Rld{  
£¨4£©ÂÛÎÄÐèÒªÖØ´óÐ޸ģ¬ÖØͶ²¢µ±×÷иå¼þ´¦Àí£¨not publish in its present form, but resubmit after major modifications to then be treated like a new submission£©¡£³£¼û¡£ !sR`]0  
Dear Dr. XXX @x{;a9y  
Your manuscript has been reviewed by referees who specialize in the subject matter addressed by the submitted material. The general and specific comments of the referees are below. I regret to inform you that the reviewers raised serious concerns about the manuscript and submitted low priority ratings. In particular the concern was raised that the work was only a minor advance of the field and that several of the findings are already well established. Accordingly, I must reject your manuscript for publication in The Journal of Clinical Investigator. I hope that the reviewers comments will be of assistance to you if you decide to submit your work elsewhere. *7-uQKp  
If you choose to rewrite your manuscript and resubmit it to The Journal of Clinical Investigator, you must resubmit it online as a de novo manuscript where it will be assigned an Associate Editor and expert reviewers. You must be complete all required submission forms and pay the $50 submission fee. No exceptions will be made. z` gR*+  
Yours sincerely, C9bf1ddCW&  
Associate Editor ZYL]|/"J9  
£¨5£©ÍêÈ«¾Ü¾ø(Reject)¡£×î³£¼û¡£ ~~yo& ]  
SCIÆÚ¿¯±à¼­²¿³ýÁ˸ø×÷Õ߻ظ´ÒÔÍ⣬ͬʸæËßreviewer±à¼­¶ÔÂÛÎĵÄ×îºó´¦ÀíÒâ¼û¡£ @$~%C) %u  
±à¼­Ð´¸øreviewerÑù¸åÐÅ d_]MqH>R\  
Dear Dr. XXX \idg[&}l}  
Thank you for reviewing manuscript Cell-07-o555 entitled XXX for Cell. jUjQ{eT  
On behalf of the Editors of Cell, we appreciate the voluntary contribution that each reviewer gives to the Journal. We thank you for your participation in the online review process and hope that we may call upon you again to review future manuscripts. 5ue{&z @T  
To read the Editors decision on this paper, go to your Reviewer Centre an click on View Decision Letter. &4B N9`|:  
Sincerely, UHR)]5Lt  
Editor NCl={O9<j  
2.×î³£¼ûÍ˸åÔ­Òò c()F%e:n  
£¨1£©Ö÷ÌâÔ­Òò£¨Subject£©£º \mv7"TM  
¨SÄÚÈݲ»ÊʺϸÃÆÚ¿¯£¨Not suitable for journal£©¡£ 2;6p2GNSh  
¨S²»ÊÊʱ£¨Not time£©¡£ h^[K= J  
£¨2£©ÂÛÎÄÄÚÈÝ£¨coverage£©£º <\yM{ V\  
¨SÒâÒå²»´ó£¨Questionable significance£©¡£ Q*U$i#,  
¨S²»¿ÉÐÅ£¨Questionable validity£©¡£ W~DY-;  
¨SÉî¶È²»¹»£¨Too shallow£©¡£ rY($+O@a<  
¨S¹ýÓÚÏ꾡£¨Too exhaustive£©¡£ {mueP6Gz@J  
£¨3£©ÂÛÎij¤¶ÈµÄÔ­Òò£¨Length£©£º N5oao'7|A  
¨SÂÛÎĹý³¤£¨Too long£©¡£ / <y-pFTg  
¨SÂÛÎĹý¶Ì£¨Too short£©¡£ rEZa%)XJ  
£¨4£©ÂÛÎĵıí´ïÔ­Òò£¨Presentation£©£º $7PFos%@  
¨S¿ò¼Ü²»ºÃ£¨Bad organization£©¡£ WO_cT26Y  
¨S±í´ï²»ÐУ¨Ineffective expression£©¡£ 6)DYQ^4y  
¨S²åͼÓÐÎÊÌ⣨Ineffective or unusable illustrations£©¡£ I_eYTy-a`1  
£¨5£©ÂÛÎĵĸñʽÎÊÌ⣨Failure to follow style guide£©¡£ })s s.  
3.ÈçºÎ´¦Àí±»¾ÜµÄÂÛÎÄ .cle^P  
£¨1£©ÒªÀí½â±»SCIÆÚ¿¯¾Ü¸åÊÇÒ»¼þÕý³£µÄÊÂÇ飨70%ÒÔÉϱ»¾Ü£©¡£Òò´Ë£¬Òª±£³ÖÁ¼ºÃÐÄ̬¡£ 3!ulBiMh  
£¨2£©¶ÔÍêÈ«¾Ü¾øµÄÂÛÎÄ£¬±à¼­Í¨³£»á±í´ï²»Ô¸ÔÙ¿´µ½¸ÃÎÄ£¬ÔÙ¼ÄËÍÕâÀàÎÄÕÂÊÇûÓÐÒâÒåµÄ¡£Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ V^.~m;ETu]  
£¨3£©Éó¸åÈËÓÐʱҲ»á·¸´íÎ󣬲»½ö½öÊDZÊÎó£¬Ò²ÓÐרҵ֪ʶÉϵĴíÎó£¬ÒòΪ±à¼­ÈËÕÒµÄÉó¸åÈËδ±ØÊÇÄãÏàͬÁìÓòµÄר¼Ò¡£Èç¹û×÷Õ߶Էñ¶¨µÄÔ­ÒòÓÐÒìÒ飬¿ÉÒÔÏò±à¼­²¿»òÖ÷±àÌá³ö×Ô¼ºµÄÒâ¼û£¬¾ÝÀíÁ¦Õù¡£Ö»Òª×Ô¼ºÊÇÕýÈ·µÄ¾ÍÒª¼á³Ö¡£Ôڻظ´ÖÐίÍñµØ±í´ïÒ»ÏÂÄãµÄÒâ¼û£¬ÂÛÎÄ¿ÉÒÔÖØнøÈëеÄÒ»ÂÖÉó¸å³ÌÐò¡£ÕâÖÖÇé¿öºÜÉÙ¼û¡£³É¹¦µÄ¿ÉÄÜÐԺܵ͡£ G|X1c}zAL  
£¨4£©Èç¹ûÎÄÕ±»¾ÜµÄÔ­ÒòÊÇÒòΪÊý¾Ý»ò·ÖÎöÓÐÑÏÖØȱÏÝ£¬ÕâÖÖÎÄÕ²»·ÁÏÈ·ÅÒ»·Å£¬µÈÕÒµ½¸ü¹ã·ºµÄÖ¤¾ÝÖ§³Ö»òÓÐÁ˸üÃ÷ÎúµÄ½áÂÛºó£¬ÔÙ½«¾­¹ýÐ޸ĵġ°Ð¡±ÎÄÕ¼ĸøͬһSCIÆÚ¿¯£¬±à¼­Í¨³£»á¿¼ÂÇÖØÐÂÊÜÀí¡£ L42C<  
£¨5£©Èç¹û±»¾ÜÂÛÎIJ»ÊÇÓÉÓÚÎĸåÖеĴíÎ󣬶øÊÇÖØÒªÐÔ»ò´´ÐÂÐÔ²»¹»£¬×÷Õß×Ðϸ¿¼ÂÇÉó¸åÈ˵ÄÒâ¼û²¢ÈÏÕæÐÞ¸ÄÎĸåºó£¬¿ÉÒԼĸøÓ°ÏìÒò×ӽϵ͵ÄÆäËûSCI¿¯Îï¡£ f*kT7PJG  
4.ÈçºÎÐÞ»ØSCIÂÛÎÄ _X;5ORH"  
¸å¼þÍËÐÞ£¨revised manuscript£©¡£¼¸ºõËùÓеľ­Éó²éѧÊõˮƽ´ïµ½³ö°æÒªÇóµÄSCIÂÛÎÄ£¬ÔÚ·¢±íÇ°¶¼ÐèÒªÍ˸ø×÷ÕßÐÞ¸ÄÆä±í´ï·½Ê½¼°±à¼­¸ñʽ£¬ÈçѹËõÎÄÕÂƪ·ù¡¢ÖØÐÂÉè¼Æ±í¸ñ¡¢¸ÄÉƲåͼÖÊÁ¿¡¢ÏÞÖƲ»¹æÔòËõд´ÊʹÓõȡ£È»¶øÍ˸ø×÷Õߵĸå¼þ²¢²»´ú±íÎÄÕÂÒѾ­±»½ÓÊÜ¡£Óеĸå¼þ¸Ä¶¯Ò»´Î¼´¿É±»¿¯Îï²ÉÄÉ£¬µ«Ò²ÓеÄÒª·´¸´Ð޸Ķà´Î²ÅÄܱ»Í¨¹ý¡£ÎÄÕÂ×îÖÕ½ÓÊÜÓë·ñÈ¡¾öÓë×÷Õ߶ÔÎÄÕ¹ؼüÐÔÖØÒªÄÚÈݺͱíÊö·½Ê½µÄÐÞ¸ÄÄÜ·ñ´ïµ½Éó¸åÈ˼°±à¼­µÄÒªÇó¡£È»ºóÓ¦¿¼ÂÇÄÜ·ñ»òÔ¸Òâ½ÓÊÜÉó¸åÈË»ò±à¼­µÄÒâ¼û¡£ 1kTJMtZG~  
´ÓÖ÷±à»ò±à¼­µÄ»ØÐźÍÉó¸åÈËÐÞ»áÒâ¼û¿É¿´³öÎÄÕ¼ÓõĿÉÄÜÐÔ¡£Ö÷±àµÄ»ØÐÅ»áÌرðÌáµ½ÄãÎÄÕµĿÆѧ´´ÐÂÐÔ£»Éó¸åÈ˶ÔÎÄÕÂ×ܵÄÆÀ¼ÛÖлáÌáµ½¶ÔÎÄÕÂÊÇ·ñ¸ÐÐËȤµÈ£»Ðݻ᲻Ҫ²Ö´Ù£¬·´¸´ÔĶÁ¡¢Àí½âÉó¸åÈ˵ÄÎÊÌâ¡£ 7uxy<#Ar  
Èç¹û×÷ÕßÔÚ½Óµ½Ö÷±à»ò±à¼­²¿×ªÀ´µÄÉó¸åÈËÒâ¼ûºó£¬¶ÔÆäÆÀ¼ÛÓкܴóÒìÒé»ò²»Ô¸Òâ¸Ä¶¯×Ô¼ºµÄÂÛÎÄ£¬±ã¿ÉÒÔÖ÷¶¯ÒªÇóÍ˸塣ÊÖÐøºÜ¼òµ¥£¬Ö»ÐèÒªÏò±à¼­²¿·¢¸öE-mail¼´¿É£¬»ò×Ô¼ºÉÏÍø³·¸å¡£Èç¹û×÷ÕßÔ­Òâ¸ù¾ÝÉó¸åÈ˵ÄÒâ¼û¸Ä¶¯ÂÛÎÄ£¬ÔòÐèÈ«Ãæ³¹µ×£¬²¢ÇÒ¶ÔÉó¸åÈËÌá³öµÄÒÉÎÊÒªÒ»Ò»×÷´ð¡£ J;'?(xO3\  
5.¸å¼þÍËÐÞʱעÒâÊÂÏî R-hqaEB  
£¨1£©¶ÔÉó¸åÒâ¼ûҪʮ·Ö×ðÖØ£¬¶ÔÓÚÿһÌõÅúÆÀºÍ½¨Ò飬¶¼ÒªÈÏÕæ·ÖÎö¡£ËùÓÐÎÊÌâ±ØÐëÖðÌõ»Ø´ð£¨Response to reviewer¡¯s comments1,2,3£©¡£ #!9aTp).AL  
£¨2£©¶ÔÐ޻ظåÖÐÒÑÐ޸ĵĵط½Òª¾ßÌå±êÃ÷£¨pages, line£©¡£ CWt,cwFW  
£¨3£©¾¡Á¿Âú×ãÒâ¼ûÖÐÐèÒª²¹³äµÄʵÑé¡£ O,:ent|  
£¨4£©Éó¸åÈËÓÉÓÚ֪ʶÏÞÖƺÍijÖֳɼû£¬ÉõÖÁѧÊõ¹Ûµã²»Í¬£¬ÅжϴíÎó²¢½¨ÒéÍ˸峣·¢Éú¡£Òª¼«ÆäÉ÷ÖغÍÈÏÕæµØ»Ø´ð£¬ÓÐÀíÓоݵØÓëÉó¸åÈË̽ÌÖ¡£µ«ÒªÎ¯ÍñµØÀñòµØ±í´ïÄãµÄ¹Ûµã¡£ 4z[Z3|_V  
ÀýÈ磬 PX(Gx%s|  
[²»ÍƼö]¡°The reviewer¡¯s comments was wrong, ¡­¡± >iWl-hI-  
[²»ÍƼö]¡°The referee¡¯s idea is bad, but mine is good.¡± r~TiJ?8I  
[ÍƼö]¡°The reviewer¡¯s comments is very interesting. However, we found that ¡­¡± y&9v0&o  
[ÍƼö]¡°It would be very interesting to see ¡­ .However, ¡­¡± %E~4Ur  
[ÍƼö]¡°The referee has an interesting notion, but the proposed idea is also good, particularly in light of this or that fact.¡± [-1Nn}  
£¨5£©²»ÄÜ×öµÄÒ²²»Òª»Ø±Ü£¬ËµÃ÷ºÏÀíÀíÓÉ¡£ 1 dI  
£¨6£©Éó¸åÈËÊÇÂÛÎĵĵÚÒ»¶ÁÕߣ¬Èç¹ûËû¶¼Ã»ÓжÁ¶®Äã˵µÄijһ·½Ã棬×÷ÕߵĿ¼ÂÇ×Ô¼ºµÄÎÄÕÂÓÐʲôÎÊÌâÈÃÈ˼Ҳ»¶®£¬·ñÔò·¢±íºóÈçºÎÃæ¶Ô¸ü¶àµÄ¶ÁÕߣ¿ÄãÐè¸ÄµÃ¸üÇå³þ¡£ wxr93$v  
£¨7£©Èç¹ûÄãµÄÂÛÎÄÓÖ±»¾Ü¾øÊÇÒòΪÓÐÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÓкܺõÄÆÀ¼Û£¬µ«ÁíÍâÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÆÀ¼ÛºÜ²î¡£´Ëʱ£¬Èç¹ûÓÐÀíÓÉÈÏΪÉó¸åÈ˲»ºÏÀí¶Ô´ýÄãµÄÂÛÎÄ£¬Äã¿ÉÒÔдПø±à¼­²¿ÒªÇó¸ü»»Éó¸åÈË¡£Èç¹ûÕâλÉó¸åÈËÒ²ÆÀ¼ÛºÜ²î£¬ÄÇô£¬Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ mNm 8I8  
£¨8£©¸ø±à¼­»ØÐÅ£¬¸Ðл¸øÂÛÎÄÌá³öµÄÐÞ¸ÄÒâ¼û£¬²¢Ö¸³ö°´Ð޸Ľ¨ÒéÒÑ×öµÄÐ޸ģ¬Î´×÷Ð޸ĵĵط½ÒªËµÃ÷ÀíÓÉ¡£ h Sr#/dw&  
6.³£¼ûÎÊÌâ <k/'mBDk  
¨SǧÍò²»ÒªÒ»¸å¶àͶ¡£Ò²²»Òª°ÑÒѾ­·¢±íµÄÖÐÎÄ°æµÄÂÛÎĸijÉΪӢÎÄÔÙͶSCIÆÚ¿¯¡£·´Ö®£¬Ò²²»ÐС£µ«ÊÇһƪ»áÒéÂÛÎľ­¹ýÐ޸ĺó¿ÉÒÔÔÚͶSCIÆÚ¿¯¡£ %^gT.DsX-  
¨SÂÛÎı»Ò»¼ÒSCIÆÚ¿¯¾Ü¾øºó²»¾­Ð޸ģ¬ÓּĸøÁíÒ»¼ÒSCIÆÚ¿¯¡£ =@V4V} ?  
7.ÂÛÎı»½ÓÊÜ t3v*P6  
ÐÞ»ØÂÛÎĸåºó£¨´óÔ¼1¸öÔº󣩣¬×÷Õß»áÊÕµ½±à¼­²¿µÄÐÅ£¬Ò»°ãΪ½ÓÊÜͬÒâ·¢±í¡£ #j iQa"  
SCIÂÛÎı»½ÓÊÜÑù¸åÐÅʾÀý e +4p__TmZ  
Dear Dr. XXX LQNu]2  
We are pleased to inform you that the PNAS Editorial Board has given final approval of your article for publication. The Editor who conducted the initial review of your manuscript [MS#2007-XXX],will also bo informed of the decision. [ ,|KVc=&H  
If you have not done so already, please complete and sign the Copyright Assignment from <http: //www.pnas.org/ misc/ copyright. pdf>. If practical, all authors are not available, the corresponding author may sign on their behalf. The form should be faxed to the PNAS office(202-555555).Proofs for your article will not be sent to you until the copyright form is received in our office. :#I8Cf  
You will receive reprint order details and an invoice for publication fees with your proofs. Payment of the page charge of $70 per printed page will be assessed from all authors who have funds available for that purpose. Payment by authors of the following additional costs is expected: $325 for each color figure or table and $150 for each replacement or deletion of a color figure or table. Proofs should be returned within 48 hours. m'oVqA&  
Sincerely yours, 8+v6%,K2  
Editor-in-Chief fx%'7 /+  
ͬʱ£¬×÷ÕßÒ²»áÊܵ½°æȨǩ×Ö±í¸ñ£¨copyright assignment form£©¡£×÷ÕßÐèÒªÔÚ°æȨǩ×Ö±í¸ñÉÏÇ©×Öºó£¬ÂÛÎIJÅÄÜ·¢±í¡£Ò»°ãÇé¿öÏ£¬Öйú×÷ÕßÐèÒªÔÚÀ¸Ä¿ºÍµ×²¿Ç©×Ö¾ÍÐС£ M1Od%nz3  

kaobook 2011-08-17 22:44
µÚ22Õ ÈçºÎÐÞ¸ÄSCIÂÛÎĵÄÑù¸å I)_072^O  
SCIÂÛÎı»½ÓÊܺó£¬×÷Õß²»¾Ã»áÊܵ½ÂÛÎÄÑù¸å£¨proof£©¡£Ò»°ãÅÅ°æΪPDFÎĵµ£¬»¹ÓÐTIFFÎĵµ¡£ &Vvy`JE  
1.ÂÛÎĵÄÑù¸å (RWZ [-;)  
ÂÛÎĵÄÑù¸åÐÅʾÀý P}DrUND  
Dear Author _ CXKJ]m4  
We are pleased to inform you that your paper is nearing publication. The page proofs are available at : http://www.spsspitech.com/springer/XXX zP rT0  
The proof shows the paper as it will appear later in print except that: V\ !FD5%  
-The pages are not numbered but the lines are, to ease reference to any passage to be corrected. xm/v :hl=  
-This proof has been optimized for online presentation. Please note that color figures will appear in color in the online version, but not necessarily in the printed edition. See the comment on the proof as to whether they will be printed in black and white. ruB&&C6)v  
You can help us facilitate rapid publication by returning the corrected proof of this paper within 2 working days. Please first read about the proof produre to learn how to proceed and also to obtain information about online publication. x #BUIi  
Thank you very much. We hope you are pleased with the publication. ^dYFFKQ  
Sincerely, H Y.,f_m  
Springer `$G7Ia_ $]  
2.ÓÃproof correction marks½øÐÐÑù¸åÐÞ¸Ä k[A=:H1"  
Ñù¸å»á¾­³£·¢ÏÖÓм¸´¦´íÎó£¬ÐèÒªÐ޸ġ£Äã¿ÉÒÔÁгöÑù¸åÖÐÒªÐ޸ĵĵط½£¬Ö±½ÓE-mail¸ø±à¼­²¿£¬ËûÃÇ»á°ïÄãÐ޸ĵġ£µ«Ðí¶àÔÓÖ¾ÒªÇó½«ÕýÈ·µÄÎÄ×Ö±êÔÚÑù¸åµÄÁ½±ß£¬¼´Ö±½Ó±ê×¢ÔÚPDFÎļþÉÏ¡£ÕâÊÇÄãÒªÓùú¼ÊͨÓõġ°proof correction marks¡±½øÐбê×¢¡£Ð޸ĺóµÄÑù¸åÖ±½Ó´«Õæ»òÕ߼ĸø±à¼­²¿£¬Ò²¿ÉÒÔɨÃèºó£¬E-mail¸ø±à¼­²¿¡£Ò»°ãÇé¿öÏ£¬SCIÂÛÎĵÄÑù¸åÒªÇóÔÚ24¡ª72СʱÄڼĻء£ @UkcvhH  
3.Ö±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸Ä E I)Pfx"0  
ÏÖÔÚÓÐЩSCIÆÚ¿¯ÒªÇóÖ±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸ÄPDFÎļþÊǶÀÁ¢ÐÔµÄÎļþ¡£°üº¬ËùÓÐÊʵ±µÄ¸ñʽ»¯ºÍËùÓÐ×ÖÌ壬¿ÉÒÔÏÔʾÔÚ¼ÆËã»úÆÁÄ»ºÍ´òÓ¡Ö½ÉÏ¡£Òª²é¿´ºÍÐÞ¸ÄÄãµÄÑù¸å£¬ÐèÒªAdobe Reader°æ±¾7£¨»ò¸ü¸ß£©¡£¸ÃÈí¼þ¿ÉÓÃÓÚPC¡¢MacºÍUNIX¼°Æ䣬ÊÇÈ«ÃæÃâ·ÑµÄ£¬²¢¿ÉÒÔ´Óhttp://www.adobe.com/products/acrobat/readstep2.htm ÏÂÔØ¡£ j=PQoEtU'<  
4.ÈçºÎÓÃAdobe ReaderÈí¼þ½øÐÐÐÞ¸Ä >(`|oD`,Y  
£¨1£©´ò¿ªPDFÎļþ£¨open the PDF file£©¡£Òª°ÑPDFÎļþµÄÑù¸å×÷×¢ÊÍ»òÕßÐ޸ģ¬ÏÈ´ò¿ªAdobeÖ÷Òª¹¤¾ßÀ¸¡¾Toolbar¡¿¡£Ò»°ãÀ´Ëµ£¬µ±ÓÃAdobe Reader´ò¿ªPDFÎļþ£¬Ó¦¸Ã×Ô¶¯µØÏÔʾ¡¾Commenting toolbar¡¿¡£Èç¹ûûÓУ¬µã»÷¡¾Tool¡¿£¬Ñ¡¡¾Commenting¡¿£¬È»ºóµã»÷¡¾Commenting toolbar¡¿¡£Èç¹ûÕâЩѡÔñ¶¼²»ÐУ¬ÄÇôÄãµÄAdobe°æ±¾±È°æ±¾7µÍ¡£È»ºó´ò¿ªÄãÒªÐ޸ĵÄPDFÎļþ¡£ P,_GTs3/G  
£¨2£©²åÈëÎÄ×Ö£¨insert text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£½«Êó±êλÖÃÒƵ½ÐèÒªÐ޸ĵĵط½£¬È»ºó¿ªÊ¼¼üÈëÒªÐ޸ĵÄÎÄ×Ö¡£Í¨¹ýµã»÷ÓÒÉϽǡ¾X¡¿¹Ø±Õ¡¾box¡¿¡£Ò²¿ÉÒÔͨ¹ýµã»÷Êó±êÓÒ¼üÑ¡Ôñ¡¾Delete¡¿À´É¾È¥ÊäÈëµÄÎÄ×Ö¡£ D@>P%k$$s>  
£¨3£©Ìæ»»ÎÄ×Ö£¨replace text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£È»ºóhighlightÒªÌæ»»µÄÎÄ×Ö£¬½«Êó±êÒƵ½ÒªÌæ»»µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºóÊäÈëÌæ»»ÎÄ×Ö¡£Èç¹ûÒªÌ滻ijЩ¸ñʽ»¯µÄÎÄ×Ö£¨ÈçµÈʽ£©£¬Ç븽Îļþ¡£ >pG]#Z g  
£¨4£©Ïû³ýÎÄ×Ö£¨remove text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£³¶×§£¨drag over£©Òª±»É¾³ýµÄÎÄ×Ö²¢µã»÷¡£È»ºó°´É¾³ý¼ü¡£ = Ky1v$<  
£¨5£©HighlightÎÄ×Ö/ÆÀ¼Û£¨highlight text/make a comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Highlight¡¿¼ü¡£È»ºóHighlightÏàÓ¦µÄÎÄ×Ö¡£Òª×öÆÀÂÛ£¬Ë«»÷¡¾Highlight¡¿µÄÎÄ×Ö£¬È»ºó¼üÈëÄãµÄcomments¡£ EG7ki0  
£¨6£©¸½¼þ£¨attach a file£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Attach a File¡¿¼ü¡£µã»÷Òª±»Ì滻ͼ£¬ÖƱí»òÕßÎÄ×Ö¡£´°¿Ú½«×Ô¶¯µØ´ò¿ª£¬ÔÊÐí¸½ÓÐÎļþ¡£ $hg W>e  
£¨7£©ÆÀÂÛ£¨leave a note /comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Note Tool¡¿¼ü¡£½«Êó±êÒƵ½ÏàÓ¦µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºó¿ªÊ¼¼üÈëÎÄ×Ö¡£µ«²»ÒªÊ¹ÓÃÕâ¸öÌصã×öÔ­Îı༭¡£ P ,xayy  
£¨8£©¸´ÔÄ£¨review£©¡£Òª¸´ÔÄÒÑÓеı䶯£¬µã»÷¡¾Commenting toolbar¡¿Öеġ¾Show¡¿¼ü¡£Ñ¡Ôñ¡¾Show Comments List¡¿¡£ 0Q]x[;!k  
5.ʵÀý·ÖÎö s@^GjA[6+  
¹ú¼ÊÉϳ£ÓõÄproof correction mark xfos>|0N  
Ö÷Òª°üÀ¨Instruction£¬Textual markºÍMargin markÈý²¿·Ö¡£ pc^(@eD  
Ïà¹ØͼÎÄ·ûºÅÂÔÈ¥¡£¿ÉÒԲο¼ÍøÖ·Á´½Ó£º http://www.jaggercreative.co.uk/proofingmarks.pdf

kaobook 2011-08-17 22:46
µÚ23Õ SCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ Ju)2J?Xs5  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËƵÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£  i\},  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ JAmv7GL'6  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº (+CB)nV0IA  
¡òººÓïÓ²Òë 7KuTC%7  
ʾÀýÈçÏ£º 7!<cU  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) [AE ]0cO@  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿)  6>Lr  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) g2:^Z==  
¨SWatch sister(±í½ã) G80d!*7  
¡ò ººÓïÖ±Òë )h2wwq0]  
ʾÀýÒ» QOy+T6en  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ niqiDT/  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ 4=*VXM/  
·ÇÓ¢ÓïÏ°¹ßÐÔ±í´ïʾÀý jP@H$$-=wH  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º Kn=P~,FaG3  
°´×ÊÅű² to assign priority according to seniority 5a5 I+* c  
°ÚÍÑƶÀ§ shake off poverty; lift oneself from poverty w KXKc\r  
°ëÀ­×Ó¹¤³Ì uncompleted project wEQV"I  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs B07(15y]  
±ÆÉÏÁºÉ½ be driven to drastic alternatives %I&Hx<H j  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas VISNmz2P  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency xwTN\7f>  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul vZhN% DfY  
¶ÀÉú×ÓÅ® the only child in one¡¯s family \iSa xwU_  
·´¸¯³«Á® combat corruption and build a clean government h&NcN-["  
»§¿Ú²¾ residence booklet C;G~_if4PR  
T AwA)Zg  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£ najd~%?Rs  
1.SCIÂÛÎÄд×÷ʱ̬ z<sf}6q  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê ~y$B #.l  
3.Ó¢Îıêµã·ûºÅ -9.S?N'T>;  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ D(@#Gd\Z@  
a^,6[  

kaobook 2011-08-17 22:48
µÚ23ÕÂSCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ ns}"[44C}l  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËƵÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£ x/]]~@:  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ WVkJ=r0Ny  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº ]R7zvcu&  
¡òººÓïÓ²Òë j{: >"6  
ʾÀýÈçÏ£º -A3>+G3[  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) nLjc.Z\Bl  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿) 4.o[:5'  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) U|YIu!^  
¨SWatch sister(±í½ã) +^tw@b  
]$xN`O4W{  
ººÓïÖ±Òë $ri 'tJ+  
ʾÀýÒ» h}@)oSX }  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ D@ R>gqb  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ Kulh:d:w  
·ÇÓ¢ÓïÏ°¹ßÐÔ±í´ïʾÀý rZSX fgfr  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º Q?7:Xb N  
°´×ÊÅű² to assign priority according to seniority 0oU;Cmw.  
°ÚÍÑƶÀ§ shake off poverty; lift oneself from poverty "JBTsQDj!  
°ëÀ­×Ó¹¤³Ì uncompleted project 1}>uY  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs }ki}J>j|f  
±ÆÉÏÁºÉ½ be driven to drastic alternatives MRZ/%OZ.  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas 'V-_3WWxU  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency r1o_i;rg  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul =m6yH_`@  
¶ÀÉú×ÓÅ® the only child in one¡¯s family &8^ch,+pD  
·´¸¯³«Á® combat corruption and build a clean government m=.}}DcSs  
»§¿Ú²¾ residence booklet SGUu\yS&s  
[Dou%\  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£ <6L=% \X{*  
1.SCIÂÛÎÄд×÷ʱ̬ <xpHlLc  
£¨1£©ÃèÊö×÷Õß×Ô¼ºµÄ¹¤×÷ͨ³£Ê¹Óùýȥʽ£¬ÈçÔÚ¡°Material and Methods¡±ºÍ¡°Results¡±²¿·Ö¡£µ«ÊÇÓÃÏÖÔÚʱ̬ÐðÊö×÷Õß½áÂÛ¡£ ( /):  
£¨2£©ÃèÊöËûÈ˵Ť×÷ʱͨ³£Ê¹ÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£¬ÔÚ¡°Introduction¡±ÖеÄÎÄÏ׻ع˺͡°Discussion¡±ÖеĴ󲿷֣¨×¢£ºÔÚ¡°Discussion¡±ÖУ¬ÓùýȥʱÃèÊöËûÈ˵Ť×÷²»ÄÜËã´í£©¡£ e9e7_QG_-  
ÏÂÁÐÇéÀýÍ⣺ JLZ=$d  
¨SÈç¹ûÄ㻳ÒÉËûÈ˵Ť×÷ÊÇ·ñÕýȷʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ LG6k K G  
¨S×÷Õß×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ w\PCBY=  
ÀýÈçGreenberg showed that streptomycin inhibits S. nocolor. y5AJ1A6?E  
¨S±í¸ñ»òͼ±í×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹ÓÃÏÖÔÚʱ¡£ LNR~F_64Q  
ÀýÈçTable 2 shows the percent of districts in Oklahoma that have individuals identified as filling particular primary positions. SSh=r  
¨SÃèÊö¼ÆËã½á¹ûºÍͳ¼Æ½á¹ûʱʹÓÃÏÖÔÚʱ̬ÐðÊö¡£¼´Ê¹¸Ãʼþ·¢ÉúÔÚ¹ýÈ¥£¬Ò²Ó¦¸ÃʹÓÃÏÖÔÚʱ¡£ v!b 8_0~u6  
These values are significantly greater than those of those of the females of the same age, indicating that the males grew more rapidly. vs|_l!n3  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê IC:wof "  
£¨1£©¶¯´Ê£¨verbs£©¡¢¶¯Ãû´Ê£*****erund£©ºÍÏÖÔÚ·Ö´Ê£¨present participle£©¡£ÏÖÔڷִʺͶ¯Ãû´ÊÒ»Ñù£¬¶¼ÊÇÔÚ¶¯´ÊβÉϼÓing¹¹³É£»¶ø¹ýÈ¥·Ö´Ê£¨past participle£©ÔòÊÇÔÚ¶¯´ÊβÉϼÓed¡¢en¡¢d¡¢tËù¹¹³É¡£ËäÈ»ÈÝÒ×Çø·Ö£¬µ«ÓÐʱºòÒ²¿ÉÄÜ»ìÏý¡£ Uq8=R)1<|d  
Ò»°ãÀ´Ëµ£¬¿ÉÓö¯´ÊµÄÇé¿öÓ¦¾¡Á¿±ÜÃâʹÓö¯´ÊµÄÃû´ÊÐÎʽ£»ÄÜÓÃÃû´Ê×÷¶¨ÓïµÄ²»ÒªÓö¯Ãû´Ê×÷¶¨ÓÄÜÓÃÐÎÈÝ´Ê×÷¶¨Óï²»ÒªÓÃÃû´Ê×÷¶¨Óï¡£ c'8a)j$$+  
ÓÐЩ¶¯Ãû¼È¿ÉÊǼ°Îﶯ´ÊÒ²¿ÉÒÔÊDz»¼°Îﶯ´Ê£¬Ó¦¸ÃÓÅÏÈʹÓò»¼°Îﶯ´ÊÔì¾ä£¬¶ø²»ÒªÓü°Îﶯ´ÊµÄ±»¶¯Óï̬³É¾ä¡£ J|D$  
£¨2£©²»¶¨¹Ú´Ê£¨the indefinite article£©ºÍ¶¨¹Ú´Ê£¨the definite article£©¡£¹Ú´ÊÊÇÐé´Ê£¬±¾Éí²»Äܵ¥¶ÀʹÓã¬Ò²Ã»ÓдÊÒ壬ËüÓÃÔÚÃû´ÎµÄÇ°Ã棬°ïÖúÖ¸Ã÷Ãû´ÊµÄº¬Òå¡£²»¶¨¹Ú´Êa(an)ÓëÊý´ÊoneͬԴ£¬ÊÇ¡°Ò»¸ö¡±µÄÒâ˼¡£aÓÃÓÚ¸¨ÒôÒôËØÇ°£¬¶øanÔòÓÃÓÚÔªÒôÒôËØÇ°¡£¶¨¹Ú´ÊtheÓëָʾ´ú´Êthis¡¢thatͬԴ£¬ÓС°Õ⣨ÄÇ£©¸ö¡±µÄÒâ˼£¬¿ÉÒÔºÍÒ»¸öÃû´ÊÁ¬Óã¬ÓÃÀ´±íʾij¸ö»òij¸öÌض¨µÄÈË»ò¶«Î÷¡£Ó¢ÓïÖеĶ¨¹Ú´ÊÓ÷¨¸´ÔÓ£¬´ÊÒåÖڶ࣬¶øÇÒººÓïÖÐûÓж¨¹Ú´ÊµÄ¸ÅÄÒò´ËÔÚʹÓÃÊÊӦעÒâ¶à·½ÃæÎÊÌâ¡£¶¨¹Ú´ÊÓ÷¨³£¼ûÓÚÏÂÁÐÇé¿ö£º 3>I   
¨SÖ¸ÊÀÉ϶ÀÒ»ÎÞ¶þµÄÊÂÎï¡£ AHA4{Zu[  
¨SÓÃÔÚµ¥ÊýÃû´ÊÇ°Ã棬ÒÔ´ú±íͬÀàµÄÈË»òÎï¡£µ«µ±Éæ¼°manºÍwomanÕâÁ½¸öÃû´Êʱ£¬Ò»°ã²»±ØÓá°the¡±¡£ _P]!J~$5  
¨SÓÃÔÚÐòÊý´ÊºÍÐÎÈÝ´Ê×î¸ß¼¶¼°ÐÎÈÝ´Êonly¡¢very¡¢someµÈÇ°¡£ xQetAYP`  
¨SÓ븴ÊýÃû´ÊÁ¬Óã¬Ö¸Õû¸öȺÌå¡£ .}V&*-ep  
¨S±íʾËùÓУ¬Ï൱ÓÚÎïÖ÷´ú´Ê£¬ÓÃÔÚ±íʾÉíÌ岿λµÄÃû´ÊÇ°¡£ hDf|9}/UQd  
¨SÓÃÔÚijЩÓÐÆÕ±éÃû´Ê¹¹³ÉµÄ¹ú¼ÒÃû³Æ¡¢»ú¹ØÍÅÌåµÈרÓÐÃû´ÊÇ°¡£ nHB=*Mj DV  
¨SÓÃÔÚÊýÄ¿×ÖÇ°¡£ ~^GY(J'  
¨SÓÃÔÚÐÎʽµÄ¸´ÊýÃû´Ê֮ǰ£¬±íʾһ¼ÒÈË¡£ 1>!wm0;x  
¨SÓÃÔÚ¹ßÓÃÓïÖС£ x`# |8  
ÓÐЩÇé¿öÊDZØÐëÊ¡ÂÔ¹Ú´Ê£º clwJ+kku@  
¨S±íʾ²»ÌØÖ¸µÄ¡¢½Ï³éÏóµÄ¸ÅÄîʱ¿É²»¼Ó¡£ rq.S0bzH  
¨SĿ¼¡¢±êÌâÖÐͨ³£Ê¡ÂÔ¹Ú´Ê¡£ MGmUgc  
¨Sͼ¡¢±íµÄÌâÄ¿ÖÐÓÐʱ¿ÉÊ¡ÂÔ¹Ú´Ê¡£ 3Q@HP;<  
¨S»¯Ñ§Ò©Æ·¡¢»¯Ñ§ÎïÖÊǰͨ³£²»¼Ó¹Ú´Ê¡£ }uTe (Rf  
¨SͼÖеĺᡢ×Ý×ø±êµÄÃû´ÊÇ°²»¼Ó¹Ú´Ê¡£ ,VM)ZK=Tr  
£¨3£©´ú´Ê£¨pronouns£©.´ú´ÊʱÓÃÀ´´úÌæÃû´ÊµÄ´Ê¡£ÔÚSCIÂÛÎÄÖУ¬×î³£ÓõĴú´ÊÊÇ¡°this¡±¡£Òª×¢Òâ´ú´Ê¡°this¡±µÄÓ÷¨¡£Ò»°ãÀ´Ëµ£¬ÌᳫÔÚ¡°this¡±ºóÃæ±ØÐëÁ¬½ÓÃû´Ê£¬ÕâÑù¡°this¡±ËùÖ¸µÄ¶ÔÏó¾Í»á¸ü¼ÓÇå³þ¡£ÀýÈ磺This problem was resolved in update 887742 for Windows XP. !w[io;  
£¨4£©¸±´Ê£¨adverbs£©¡£Ò»°ãÀ´Ëµ£¬Ðí¶à¸±´ÊÓ¦¸ÃÔÚ¶¯´ÊС×éÖ®ÄÚ¶ø²»ÊÇÔÚ×î³õ»ò×îºóµÄλÖá£ÔÚ·ÇÕýʽӢÓ¸±´Ê³£Î»ÓÚ¾ä×Ó¿ªÊ¼»ò½áβµÄ¾ä×Ó¡£ -p:X]Ov  
ÀýÈ磺[·ÇÕýʽ]Then the solution was replaced¡£ RNJUA^{  
[Õýʽ]The solution was then replaced¡£ DjX*2O  
£¨5£©½é´Ê£¨preposition£©¡£½é´ÊÊÇÓÃÀ´±íʾһ¸öÊÂÎïÓëÁíÒ»¸öÊÂÎïÖ®¼ä¹ØϵµÄÐé´Ê£¬Ëü²»µ¥¶ÀʹÓ㬶ø³£ºÍºóÃæµÄÃû´Ê»ò´ú´Ê¹¹³É½é´Ê¶ÌÓï¡£½é´ÊÌáʾµØ·½£¨where£©£¬Ê±¼ä£¨since, when£©ºÍÈË£¨who, whose£©Ê±Ó¦×¼È·Ê¹Óá£ÀýÈ磺 v .ftfL!  
[²»ÍƼö]Since all tumours are visible at bronchoscopy, this is the investigation of choice. J"x M[c2  
[ÍƼö]As all tumours are visible at bronchoscopy, this is the investigation of choice. SgOn:xg;3L  
£¨6£©Ãû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ơ£Òª×¢ÒâÃû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ÆÅäºÏ¡£ÀýÈ磺 'Si 1r%'m#  
[Îó]The new group of drugs were associated with many adverse reactions. c QjzI#  
[Õý]The new group of drugs was associated with many adverse reactions. AV0C9a/td  
£¨7£©Ãû´ÊÐÞÊΣ¨modifiers of noun£©¡£±ÜÃâʹÓó¤ÏµÁÐÐÎÈÝ´Ê»òÃû´ÊÀ´ÐÞÊÎÃû´Ê¡£ $1CAfSgKw  
[ÍƼö]a modified test of cognitive function ~\ 9bh6%R  
[²»ÍƼö] a modified cognitive-function test _Vs\:tygs  
£¨8£©ÙµÓ¿ÚÓïºÍÍâÀ´Óï¡£²»Ê¹ÓÃÙµÓ¿ÚÓïºÍÍâÀ´Óï×÷ΪÕýʽ±í´ï¡£ÀýÈ磺 +U%U3tAvs  
[·ÇÕýʽ]Retirement is something most of us must face sooner or later. k]n=7vw;  
[Õýʽ] Retirement is inevitable. f8Xe%"<  
£¨9£©ÂÛÎÄÖеÄÓôÊÓ¦¸Ã±È½ÏÕýʽ¡£²»ÒªÊ¹ÓôʵļòÂÔÐÎʽ£¬Èç¡°don¡¯t¡±£¬¡°can¡¯t¡±ºÍ¡°won¡¯t¡±¡£Ó¦¸Ãдȫ³Æ¡°do not¡±£»¡°can not ¡±ºÍ¡°will not¡±¡£¾ä×ÓÒ²Òª±ÜÃâʹÓá°and so forth¡±¡¢¡°and so on¡±µÈ¡£ -'tgr6=|w"  
£¨10£©Êý×Ö¡£Èç¹ûÊý×ÖλÓÚ¾äÊ×£¬Ó¦¸ÃÓÃÓ¢ÎĵÄÍêÕû±í´ï£¬²»Óð¢À­²®Êý×Ö¡£ÀýÈ磺 ' Vp6=,P  
[²»ÍƼö]¡°30 patients were performed operation.¡± 39W6"^q"o  
[ÍƼö]¡°Thirty patients were performed operation.¡± Q &Rj)1!  
£¨11£©Ó¢ÓïÓôÊÔ­Ôò£º s ^/<6kwO  
¨SÓÃÊìϤµÄÎÄ×ÖÓÅÓÚǣǿµÄÎÄ×Ö¡£ EcA@bZ0  
¨SÓþßÌåÎÄ×ÖÒªÓÅÓÚ³éÏóµÄÎÄ×Ö¡£ $?l?  
¨SÓõ¥Ò»µÄÎÄ×ÖÓÅÓڶݴÊÎÄ×Ö¡£ {5f? y\Z  
¨SÓö̵ÄÎÄ×ÖÒªÓÅÓÚ³¤µÄÎÄ×Ö¡£ ? U:LAub  
¨SÓô¿ÆÓÎÞ»ªµÄÎÄ×ÖÓÅÓÚ¶à×˶à²ÊµÄÎÄѧÐÔÃèÊöÎÄ×Ö¡£ K#=)]qIk  
3.Ó¢Îıêµã·ûºÅ x+}6qfc$9k  
¡òÖÐÎÄÌØÓеıêµã·ûºÅ QES[/i +  
¨S¶ÙºÅ£¨¡¢£©£º¶ÙºÅÔÚººÓïÖÐÆð·Ö¸î¾ä×ÓÖеIJ¢ÁгɷÖ×÷Óã»Ó¢ÓïÖÐûÓжٺţ¬·Ö¸î¾ä×ÓÖеIJ¢ÁгɷֶàÓöººÅ¡£ y7 I')}SC  
¨SÊéÃûºÅ£¨¡¶¡·£©£ºÓ¢ÓïûÓÐÊéÃûºÅ£¬ÊéÃû¡¢ÆÚ¿¯ÃûÓÃбÌå»òÏ»®Ïߵȱíʾ¡£ HR85!S`  
¨S¼ä¸ôºÅ£¨.£©£ºººÓïÓмä¸ôºÅ£¬µ«ÊÇÓ¢ÓïÖÐûÓмä¸ôºÅ£¬ÐèÒª¼ä¸ôʱ¶àÓöººÅ¡£ gJNp]I2R  
¨S×ÅÖغţºÓÐʱººÓïÓÃÔÚÎÄ×ÖϵãʵÐÄÔ²±íʾÐèҪǿµ÷µÄ´ÊÓÕâЩʵÐĵã¾ÍÊÇ×ÅÖغš£¶øÓ¢ÓïÖÐûÓÐÕâÒ»·ûºÅ£¬ÐèҪǿµ÷ijЩ³É·Öʱ¿É½èÖúÎÄ×ÖбÌå¡¢ºÚÌå×ÖºÍÏ»®ÏߵȶàÖÖ·½·¨¡£ hCX}*  
¡òÓ¢ÎÄÌØÓеıêµã·ûºÅ rNL*(PN}lO  
¨SбÏߺšªforward slash(/):Ö÷Òª¹¦ÄÜÊÇ·Ö¸ô×÷ÓᣠU$J l5[`F^  
¨SƲºÅ¡ªapostrophe£¨£¬£©:¹¹³ÉÃû´ÊËùÓиñ£»±íʾ´Ê¡¢×Öĸ¡¢ÊýÂëµÈµÄ¸´ÊýÐÎʽ£¬»¹±íʾһ¸ö»ò¼¸¸ö×ÖĸºÍÊý×ÖµÄÊ¡ÂÔ£¬È磺I¡¯ve got it¡£ H1PW/AW  
¨SÁ¬×ֺšªhyphen£¨--£©£ºÖ÷ÒªÓÃÓÚijЩǰ׺£¨È磺self-¡¢ex-ºÍall-£©¹¹³É¸´ºÏ´Ê¡£ -Bqn^ E  
¡òººÓ¢¹²Óе«ÐÎʽ²»Í¬µÄ±êµã·ûºÅ t@Qs&DZ7k  
¨SÖÐÎĵľäºÅ£¨periods£©ÊÇ¡°Ô²È¦¡±£¨¡££©£¬¶øÓ¢ÎÄÖÐÊǸöʵµã£¨.£©¡£ 1;p'2-x  
¨SÓ¢Óï¾äÖеÄÊ¡ÂԺţ¨ellipsis£©ÊÇÈý¸öµã£¨¡­£©£¬Èç¹ûÊ¡ÂÔºÅÔÚ¾äÄ©¼ÓÉϾäºÅ¾ÍÊÇËĸöµã£¨ ¡­ .£©£¬Î»Öö¼ÔÚÐеף»ÖÐÎĵÄÊ¡ÂÔºÅΪÁù¸öµã£¨¡­¡­£©£¬¾ÓÓÚÐÐÖС£ $1N_qu  
¨SÓ¢ÓïµÄÆÆÕۺţ¨dash£©ÊÇ£¨-£©£¬¶øÖÐÎÄÊÇ£¨¡ª¡ª£© <;d? E%`  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ ;4E0%@R  
£¨1£©SCIÂÛÎÄÖоä×ÓÁ¬¹áÓëÂß¼­£º´ÓÓïÑÔÄÚ²¿À´Ëµ£¬Óï¾ä»ò¶ÎÂ䶼ÊÇһЩÒâÒåÏà¹ØµÄ¾ä×Óͨ¹ýÒ»¶¨µÄ³Ð½ÓÊֶκϺõÂß¼­µÄ×éÖ¯ÆðÀ´µÄÓïÒåÕûÌ塣ͨ¹ýÒ»×éÒâÒåÏà¹ØµÄ¾ä×Ó²»Í¨¹ýÒ»¶¨µÄתÕÛ´Ê»òÁ¬½Ó´ÊºÏºõÂß¼­µÄÁªÏµÆðÀ´£¬Õâ×é¾ä×Ó¾ÍÄÑÒÔ¹¹³ÉƪÕ¡£Á¬½Ó´ÊÊÇÖ¸ÔÚÂÛÎÄÖÐÓÃÀ´ËµÃ÷ÉÏϾä»òÇ°ºó¾äÁ½¸öÒâ˼֮¼ä¹ØϵµÄ´Ê»ò´Ê×é¡£Á¬½Ó´Êͨ³£ÓÃÓÚ¿ªÆª£¬Òý³öÀ©Õ¹¾ä£»Ò²¿ÉÓÃÓÚ¾äÖУ¬ÓÈÆäÊÇÓÃÓڽϳ¤µÄ¸´ÔÓ¾ä×ÓÖУ¬ÒÔ×÷ΪÉÏÏÂÎĵÄŦ´ø£»»¹¿ÉÓÃÓÚÎÄÄ©»ò¶ÎÄ©£¬ÓÃÓÚ×ܽáÉÏÎÄ»ò½áÊø±¾¶ÎÄÚÈÝ¡£ÓÐÁËÊʵ±µÄתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾äÓë¾äÖ®¼äÂöÂçÇåÎú¡¢ÌõÀí×ÔÈ»£¬°ïÖú¶ÁÕßÀí½âÂÛÎĵÄ˼·¡£³£¼ûµÄתÕ۴ʺÍÁ¬½Ó´Ê¿ÉÒÔÓÃÀ´±íʾ£º V4GcW|P4y  
¨SƽÐлòµÝ½ø¹Øϵ %3ecV$  
and; furthermore; & p 1Et  
also; in addition(to); I=VPw5"E  
as well(as); likewise; (m[] A&u  
at the same time; moreover; uj$b/I>.'  
besides; similarly; ,z1X{  
both ¡­ and ¡­ ; still; dZ&/Iz  
¨SתÕÛ¹Øϵ [-cYFdt"V  
although; otherwise; C,R_` %b%  
but; to the opposite; /JL2dBy#z  
however; while; @ oE [!  
nevertheless; yet; O $uXQ.r  
on the contrary q<rB(j-(  
¨SÄ¿µÄ»òÒò¹û¹Øϵ $-m`LF@  
as; since; *5iNw_&  
as a result; so; F8km8lPQl  
because(of); so¡­that ¡­; =& ~*r  
consequently; such¡­that¡­; v V:eU-a  
due to; therefore; UBp0;)-  
for; thus; +(VHnxNQs  
now that; p%_#"dkC7  
¨S¾ÙÀý¹Øϵ `d, hP"jBc  
For example; for another; [ "}0umt  
For instance; such as; <4,>`#NEo  
For one thing; b>AFhj:  
¨S²ã´Î¡¢Ë³Ðò¹Øϵ >h/J{T(P>h  
first, second, third, last [)|P-x-<  
firstly, secondly, thirdly, finally(²»ÍƼö) QT/ TZ:  
the first, the second, the third, the last FA ?xp1E  
in the first place , in the second place , in the third place ,lastly 8 M3Q8&  
to begin with , then , furthermore, finally rxQn[  
to start with, next, in addition, finally A {lzQO  
first and foremost, besides, last but not least |D%i3@P&ZR  
most important of all, moreover , finally /w{DyHT  
on the one hand, on the other hand(ÊÊÓÃÓÚÁ½µãµÄÇé¿ö) >bWsUG9  
¨S½âÊÍ˵Ã÷¹Øϵ£º ,JyE7h2%i  
in other words vRYQ4B4o  
that is ^EE 3E'  
¨S¹éÄÉ¡¢×ܽ᣺ x]lv:m\)jT  
as a result; on the whole; S P)$K=  
briefly; to sum up; _H(m 4~ M  
in a word ; in summary; l@nkR&4[  
in brief; collectively; j8 nG Gx  
in short; taken together D+d\<":  
ÕýÈ·´îÅäתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­ÐÔÇ¿¡£ nY"9"R\.=  
£¨2£©SCIÂÛÎÄÖжÎÂä²¼¾ÖµÄÕûÌåÂß¼­£º¾­³£ÎÒÃÇÒªÐðÊöÒ»¸öÎÊÌâµÄ¼¸¸ö·½Ãæ¡£ÕâÖÖÇé¿öÏ£¬Ò»¶¨Òª×¢Òâ¶ÎÂäÖ®¼äµÄÂß¼­½á¹¹¡£°ÑÄãµÄÏë·¨°´ÕÕÂß¼­Ë³Ðò×éÖ¯£¬»òÕßÖÁÉÙÓ¦°´ÖÈÐòÅÅÁУ¬Ê¹¸÷¶ÎÂäÓлúµØÁ¬½ÓÔÚÒ»Æð¡£ 8 ZD1}58U4  
³ý´ËÖ®Í⣬»¹Òª×¢Òâ¾ä×ÓÖ®¼äÁ¬¹áÓëÂß¼­¡£×ܶøÑÔÖ®£¬ÓúÃתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­¡¢ÎÄÕ²ã´ÎÇå³þ¡¢Òâ˼Ã÷È·¡£ x F7C1g(  

kaobook 2011-08-17 22:49
µÚ24ÕÂSCIÂÛÎĵÄд×÷Ô­Ôò LF?83P,UJ#  
1.SCIÂÛÎĵÄд×÷ÓïÑÔ±í´ï×ÜÌåÔ­Ôò 2628 c`  
£¨1£©ÕýÈ·£¨correctness£©£ºÑ¡ÔñÕýÈ·´Ê»ò´Ê×é¡£ )h&s.k  
£¨2£©Çå³þ£¨clarity£©£º¿ÆѧÂÛÎĵÄд×÷ÍêÈ«²»Í¬ÓÚÎÄÒÕ×÷Æ·£¬ÒªÇó¾«È·¡¢Çå³þºÍºÁ²»º¬ºý¡£ h" cLZM:6  
±ÜÃâË×ÓïºÍÄѶ®µÄ»°Ê¾Àý gP1~N^hke]  
¨SAs already state \](IBI:  
¨SIt has been found that [R-4e; SRh  
¨SIt has long been known that 5f PYtVm  
¨SIt is interesting to note that ivsp):W  
¨SIt is worth mentioning at this point @kC>+4s!  
¨SIt may be said that i X qB-4"  
¨SIt was demonstrated that s`M[/i3Nm  
£¨3£©¼ò½à£¨concision£©£ºÎÄ×ÖÒª¼ò½à£¬É¾·±´Ó¼ò¡£ 3Vj uk7  
ʾÀý I <`9ANe  
¡°There is ample evidence indicating that smoking is a risk factor for cancer¡±Ó¦¸Ã¼ò»¯Îª¡°Smoking is a risk factor for cancer¡±¡£ 8WK%g0gm  
Óüò½à´Ê¡¢¶Ì¾ä×ÓÀ´±í´ïʾÀý p*)RP2  
¨Sa majority of = most + c#:;&Gs  
¨Sat the present time = now |&+g,A _w  
¨Sgive rise to = cause pe=Ou0  
¨Sin some cease = sometimes LyO, ]  
¨Sis defined as = is ~(kIr? ^  
¨Sit is believed that = I think j$<uE{c  
¨Son the basis of = by Va,M9)F  
¨Spooled together = pooled }c(".v#  
¨Ssubsequent to = after w_|R.T\7  
¨Swith the result that = so that =\.Oc+p4  
È¥µô¶àÓàµÄ´Ê£¬ÀýÈç D"_~Njf  
[δÐÞ¸Ä]We plan additional studies in the future in order to confirm previous experiments where replicate determinations consistently showed the pool sizes to essentially increase. E;\XZ<E  
[Ð޸ĺó]We plan studies to confirm experiments where replicate determinations showed an increase in pool size. |E$Jt-'  
[ÔÙÐÞ¸Ä] We plan to confirm the experiments showing an increase in pool size. jV)!9+H#  
£¨4£©ÍêÕûÐÔºÍÂß¼­ÐÔ£¨completion and logic£©¡£Ð´ÂÛÎľÍÏñ½²¹ÊÊ£¬²»½öҪעÒâ¾ä×ÓÍêÕû£¬ÂÛÊö¡°¹ÊÊ¡±Ò²ÒªÍêÕû¡£ÌرðҪעÒâÂß¼­ÐÔ±í´ï¡°¹ÊÊ¡±¡£ HVaWv].  
(5)Ò»ÖÂÐÔ£¨consistency£©¡£ (v(!l=3  
2.Ìá¸ßÂÛÎÄд×÷ÄÜÁ¦µÄ;¾¶ V_jVVy30Ji  
£¨1£©¶à¶Á¡£Ñ§Ï°ÈκÎÓïÑÔ¶¼ÐèÒª´óÁ¿ÔĶÁ¡£Ñ§Ï°Ó¢ÓïÒ²ÐèÒª´óÁ¿ÔĶÁ¡£Èç¹ûҪ׫д¸ßˮƽÂÛÎÄ£¬Æä¹Ø¼üµÄÊǶÁºÜ¶àÎÄÏס£Õâ¸öµÀÀíºÜ¼òµ¥£¬µ«²»ÉÙѧÕßȴδ±ØÍêÈ«Ã÷°×¡£Ê±Ï£¬ºÜ¶àÈ˶¼ÈÈÖÔÓÚ×öÌâÄ¿£¬ÒÔΪÕâÊÇѧϰӢÓïµÄÕýȷ;¾¶¡£½á¹û×öµÄÁ·Ï°²áÒ»±¾ÓÖÒ»±¾£¬ÊÔÌâ×öÁËÒ»Ì×ÓÖÒ»Ì×£¬×öµÃÍ·»èÑÛ»¨£¬ÐËȤȫÎÞ£¬Ó¢Óïˮƽȴ²¢Ã»ÓÐʵÖÊÐÔÌá¸ß¡£ÔÚÔĶÁʱ£¬ÒªÓÃÓ¢Óï˼¿¼£¬²»±Ø°ÑÓ¢ÎÄ·­Òë³ÉÖÐÎÄ£¬·ñÔò½«´ó´óµØ½µµÍÔĶÁËٶȣ¬´Ó¶øÓ°Ïì¶ÔÔĶÁ²ÄÁϵÄÈ«ÃæÀí½â¡£½¨ÒéÈÏÕæµØÑжÁÓ°ÏìÒò×ӸߵĹúÍâÎÄÏ×£¬×îºÃÓ°ÏìÒò×Ó´óÓÚ5ÒÔÉÏ¡£Ðí¶à¿Æ¼¼ÈËÔ±²»ÉÆÓÚ±í´ï×Ô¼ºµÄ¿ÆÑгɹû£¬Ö÷ÒªÊÇÕë¶Ô±¾ÁìÓò֪ʶÕÆÎյıȽÏÉÙ¡£ÒªÌرðÖØÊÓÂÛÎĵıí´ï£¬Ðû´«×Ô¼º£¨sell yourself£©¡£ÒªËµÃ÷ÂÛÎĵÄÖØÒªÐÔ£¬¾ÍÐèÒª¶à¶ÁÎÄÏס£ 1><\3+8  
£¨2£©¶àд¡£¾ÍÊÇÒª×Ô¼º¶¯ÊÖд×÷¡£ÓÉÓÚSCIÂÛÎĵÄд×÷ÎÊÌⲻͬÓÚÆäËüÎÄÕµÄд×÷£¬¸ü²»Í¬ÓÚÎÄÒÕд×÷£¬ËûÔÚд×÷¸ñʽ¡¢±í´ï·½Ê½ºÍÒªÇóÉ϶¼ÓÐ×Ô¼ºµÄÌص㡣 G%~=hEK0  
£¨3£©¶à¸Ä¡£Îĸå³õ¸åÍê³ÉÖ®ºó£¬Òª°´ÕÕSCIÂÛÎĵÄд×÷ÒªÇó·´¸´Ð޸ġ£ e\ i K  
¨S¿ò¼Ü·½ÃæµÄ·´¸´Ð޸ġ£×öµ½¾«µñϸ×Á¡¢¾«²ÊºÏÀí¡£°üÀ¨£º  {n }6  
¡¤ÂÛÎÄÖ÷Ìâ¡¢Â۾ݺÍÂÛÖ¤·½·¨ÊÇ·ñ¿Æѧ£» d&'z0]mOe  
¡¤¶ÔÎÄÕµĽṹ¡¢ÓïÑÔÒª×ÐϸÍÆÇ㬶àÓàµÄÄÚÈݹû¶Ïɾ³ý¡£ <cG .V |B  
¨SÄÚÈÝ·½ÃæµÄÐÞ¸ÄÓëУºË 2Cn^<(F^4I  
¡¤ÄÚÈݵÄÔö²¹¡¢É¾³ýºÍµ÷Õû¡£ [tDUR  
¡¤ÌáÁ¶¡£Ê¹ÎÄÕ´ﵽÎÄ×Ö¼òÁ·£¬ÓôÊ׼ȷ£¬ÄÚÈݾ«´â¡£  b<v\  
¡¤Ð£ºË¡£¶ÔԭʼÊý¾Ý£¬ÔËËã¹ý³ÌºÍ×îºó½á¹û£¬¶¼Òª½øÐÐÈÏÕæµÄУºË£¬ÓÈÆäÊǶÔÊýѧʽµÄÍƵ¼ÒªÈÏÕæÉóºË£¬¿´ÆäÊÇ·ñ´æÔÚ´íÎó¡£ Cd)e_&  
¨SÐÎʽ·½ÃæµÄÐ޸ģº mN3}wJ}J  
¡¤ÂÛÎĸñʽÊÇ·ñ·ûºÏSCIÆÚ¿¯¹æ¶¨µÄд×÷¸ñʽ¡£ iJ_`ZM.w  
¡¤ÓÃ×ÖÊÇ·ñÕýÈ·¡£ L;30 & a  
¡¤¼ÆÁ¿µ¥Î»ÊÇ·ñ·ûºÏ·¨¶¨¼ÆÁ¿µ¥Î»¡£ tdg.vYMDPC  
¡¤±êµã·ûºÅ¼°¸÷ÖÖÈ˹¤ÓïÑÔ·ûºÅµÄʹÓÃÓëÊéдÊÇ·ñÕýÈ·¡¢Çå³þ¡£ +4^XFPq~  
3.дSCIÂÛÎÄ»¹Òª¿¼Âǵļ¸µã ,?i^i#Wqzg  
£¨1£©ÔÙдSCIÂÛÎÄ֮ǰ£¬Ó¦¸Ã¼ì²éÊÇ·ñ±ðÈËÒѾ­Ð´ÁËÀàËƵÄÎÄÕ¡£ AH`D&V  
£¨2£©Ë¼Â·µÄ´´ÐÂÐÔ¡£ d{+ H|$L`  
£¨3£©ÂÛÎĵÄÄÚÈÝÒªÕæʵ¡¢ÕýÈ·¡£ÕâÒ»µãÊǺÜÖØÒªµÄ£¬²»ÅªÐé×÷¼ÙÊÇÁ¼ºÃµÄ¿ÆѧµÀµÂ¡£ M>J8J*  
£¨4£©ÎªÊ¹ÎÄÕÂÇå³þ£¬µÚÒ»´ÎÌá³ö¸ÅÄîʱ£¬ÒªÒÔÀ¨ºÅ¸ø³ö½ÏÏêϸµÄ½âÊÍ¡£ ;AKtb S;H  
£¨5£©ÂÛÎĵÄд·¨Ò»¶¨ÒªÍ»³öÖص㡣 q]q(zUtU  
£¨6£©ÓÅ»¯Ó¢Óï¡£

kaobook 2011-08-17 22:51
¸½Â¼ ³£ÓüìË÷ÍøÖ· : Ey  
1.ISIÖ÷Ò³ (Z.K3  
http://www.isinet.com btw_k+Fh  
2.Web of Knoeledge JI )+  
http://www.isiwebofknowledge.com $;7?w-.  
3.Journal Citation Report ~b5aT;ObR  
http://scientific.thomson.com/product/jcr J5k \R+\H  
4.SCIÎÄÏ×¼ìË÷½çÃæ Q`g0g)3w  
http://isiknowledge.com T*\'G6e  
5.EIÖ÷Ò³ kP%'{   
http://www.ei.org MR%M[SK1  
6.ElsevierϵÁÐÆÚ¿¯ Kr=DoQ."d8  
http://www.sciencedirect.com 8U\;N  
http://elsevier.lib.tsinghua.edu.cn 0@, ,YZ f  
http://elsevier.lib.sjtu.edu.cn 1mL--m'r  
7.IEEE(ÃÀ¹úµçÆøµç×Ó¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ &of %;>$>M  
http://www.ieee.org/web/publications/journmag/index.html m^U\l9LE  
8.IEEE»áÒéÂÛÎÄ !OPK?7   
http://www.ieee.org/web/publications/confproc/index.html ho#] ?Z#  
9.ACM(ÃÀ¹ú¼ÆËã»úЭ»á)ÂÛÎÄ Ha$|9li`  
http://www.acm.org/pubs ^o!K0 t*  
10.ASME(ÃÀ¹ú»úе¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ V;=SncUb  
http://www.asme.org/Publications/Journals/View_Journals_Online.cfm -}2q-  
11.NIH(ÃÀ¹úÈ«¹úÎÀÉúÑо¿Ëù) #$ K\:V+ 4  
http://www.nih.gov -{pcb7.xuv  
12.ҽѧË÷Òý 3RscuD&  
http://www.pubmed.gov ub}t3#  
13.Academic Press V.'EP  
http://www.idealibrary.com | g> K$m^  
14.kluwer fbNVmjb$)  
http://kluwer.calis.edu.cn R JnRbaC  
15.springer S`K8e^]  
http://link.springer-ny.com qQ/j+  
16.Öйú¿ÆѧÔÚÏß b,D+1'  
http://china.sciencemag.org 2<fG= I8  
17.Öйú¿ÆѧԺÑо¿ËùͼÊé¹ÝÊÕ²Ø r@"Vbq%  
http://www.las.ac.cn/subpage/subframe_detail.jsp?Sub-FrameID=1003 rxIfatp^  
u` `FD  
ÔÙ´ÎÏòÂÃÃÀ»ªÒáѧÕß½ðÀ¤ÁÖ½ÌÊÚÖÂÒÔ³ç¸ßµÄ¾´Ò⣬¸ÐлËûΪ¹ã´óÖйúѧÕß·¢±íSCIÂÛÎÄËù×÷µÄ·îÏ×£¡ pHni"i T  
PS`v3|d}}}  
¾´Àñ£¡ ~k+-))pf  

chqu 2011-11-15 21:25
лл·ÖÏí

mengliuhe 2011-11-16 01:55
ºÃÂ鷳Ŷ

xielei0409 2011-11-16 03:09
²»´íµÄÎÄÕ£¡£¡

chqu 2011-11-21 11:08
·Ç³£Ïêϸ£¬Ð»Ð»

haoyl123 2012-01-09 01:35
ѧϰһͨ£¬¸Ð¾õÊǾÞÂé·³µ½¶«¶«

2013Ä꿼²© 2012-05-08 13:47
лл¥Ö÷

2013Ä꿼²© 2012-05-18 18:03
лл¥Ö÷£¬¿¼²©£¬µ¼Ê¦ºÜ¿´ÖÐÎÄÕ£¿

y691935503 2012-05-25 15:14
¶àл

lunwen365 2014-10-06 10:53
SCI£¬Ïë±Ø´ó¼Ò¶¼ÄܱíÏÖ³ö¶úÊìÄÜÏêµÄÑù×Ó£¬ËüÊÇÃÀ¹ú¡¶¿ÆѧÒýÎÄË÷Òý¡·µÄÓ¢Îļò³Æ£¬´´¿¯ÓÚ1961Ä꣬ËüÊǸù¾ÝÏÖ´úÇ鱨ѧ¼Ò¼Ó·Æ¶ûµÂ(Engene Garfield) 19 5 3ÄêÌá³öµÄÒýÎÄ˼Ïë¶ø´´Á¢µÄ¡£ <S6|$7{1  
       SCIÊÇÒ»²¿¹ú¼ÊÐԵļìË÷¿¯Î°üÀ¨ÓУº×ÔÈ»¿Æѧ¡¢ÉúÎҽѧ¡¢Å©Òµ¡¢¼¼ÊõºÍÐÐΪ¿ÆѧµÈ£¬Ö÷Òª²àÖØ»ù´¡¿Æѧ¡£ 0{@E=}}h  
SCIÑ¡ÔñÆÚ¿¯±È½Ï¿Æѧ£¬ËüÔËÓÃÒýÎÄÊý¾Ý·ÖÎöºÍͬÐÐÆÀ¹ÀÏà½áºÏµÄ·½·¨£¬³ä·Ö¿¼ÂÇÁËÆÚ¿¯µÄѧÊõ¼ÛÖµ£¬ÔÚÑ¡ÓÃµÄ 3 400ÓàÖÖÆÚ¿¯Àï°üº¬Á˹ú¼ÊÉϽÏΪÖØÒªµÄÆÚ¿¯¡£ËüËùÔñÈ¡µÄ80ÍòÌõÂÛÎÄ£¬¿ÉÒÔ˵ÊǼ¯¸÷ѧ¿ÆÖ®¾«ÝÍ¡£SCI¼ìË÷ϵͳÀúÀ´³ÉΪÊÀ½çѧÊõ½çÃÜÇÐ×¢ÊÓµÄÖÐÐÄ£¬ÕùÏà½ÇÖðµÄ½¹µã£¬ÊÀ½ç¹«ÈϵÄÎÄÏ×ͳ¼ÆÔ´¡£ x!tCK47Yq  
       È»£¬SCI¾ÍÆä±¾Éí¶øÑÔ£¬×îÖØÒªµÄ¹¦ÄÜÊÇ°ïÖú¿Æ¼¼ÈËÔ±»ñÈ¡×îÐèÒªµÄÎÄÏ×ÐÅÏ¢¡£ÕâÒ²ÊDZ༭¸Ã²¿Ë÷ÒýµÄÖ÷ÒªÒâͼ¡£ 7$\;G82_  
       SCI×î´óµÄÓŵãÊÇÒýÎŦÄÜ£¬ÔÚÕâÀï¶ÁÕßÄܺܿìµØÁ˽⵽ijһ×÷ÕßµÄijƪÂÛÎÄÊÇ·ñ±»ËûÈËÒýÓùý£¬Í¨¹ýÒýÎÄ´ÎÊý¿ÉÒÔÁ˽âijһѧ¿ÆµÄ·¢Õ¹¹ý³Ì¡£Í¬Ê±£¬SCIÒ²¾ßÓз´Ó³¿Æ¼¼ÂÛÎÄÖÊÁ¿ºÍѧÊõˮƽµÄ¹¦ÄÜ¡£ p3\F1](Z  
i?A4uyYwS  
k,0JW=Vh>|  
ϲѶ´«À´¹úÄÚÊ×¼ÒÓµÓÐ×Ô¼ºSCI SSCI ¶ÀÁ¢ÔËÓª×ÊÖÊ×Éѯ¹«Ë¾ Wepa;  
          Ò»¡¢SCI SSCI ´Óҵǰ¾°£º [_^K}\/+  
ÎÒÃǵÄÓÅÊÆÊÇ ¡¢Ä¿Ç°¹úÄÚÄÜÏñÎÒÃÇÕâÑù²Ù×÷SCI/SSCIÊDZȽÏÉٵģ¬ÎÒÃÇÓÐ×Ô¼ºSCI/SSCIÆÚ¿¯×ÊÔ´ÒÔ¼°ºÍºÜ¶à¹ú¼ÊSCI/SSCIÔÓÖ¾´ï³ÉÕ½ÂÔºÏ×÷µ¥Î»£¬ÌØƸÇëÁ˹ú¼ÊÖªÃûѧÕßר¼Ò×öѧÊõÖ¸µ¼£¬ÆÀ¹À ¡¢ÈóÉ«¡¢ ÐÞ¸Ä ¡¢ÍƼö·¢±í¡¢¼Û¸ñµÍ¡¢²ã´Î¸ß¡¢ÔÚ¹úÄÚ 211 ¡¢985¡¢´óÖÐרԺУ¿ÆÑÐÔºËù¡¢¼°Ïؼ¶ÒÔÉÏÒ½ÔºÓкܴóµÄÐèÇó¡£¹úÄÚ¸÷´óѧҽԺ¿ÆÑÐÔºËù¶¼°ÑSCI SSCIÆÚ¿¯ÂÛÎÄÁÐΪ×î¸ß¼¶±ðµÄѧÊõ³É¾Í¡£ÕâЩÊÇÄ¿Ç°¹ú¼ÊÖ÷Á÷ÆÀ¼Û»úÖÆ¡£ E-MEMran4  
ÀýÈç ¹þÒ½´óϵÁе¥Î»¾ùÒªÇó·¢±íSCI¼ìË÷ÂÛÎÄΪְ³ÆÆÀ¶¨µÄÓÐЧÂÛÎÄ¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×ÓСÓÚ1£¬Ôò±ØÐëͬʱÓÐÁ½ÆªÒÔÉϱ±´óºËÐÄÂÛÎIJÅÄܲÎÓëÖ°³ÆÆÀ¶¨¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×Ó´óÓÚ1£¬Ôòһƪ¼´¿É¡£ÕâÖ»ÊÇÀýÍâ±íÏÖ£¬¹úÄÚÖ÷Á÷ԺУ²»ÏÞÖÆÓ°ÏìÒò×Ó£¬ÓÈÆäÊǶþ±¾ Èý±¾ ְҵԺУ¾Í¸ü²»ÒªÇóÓ°ÏìÒò×ÓÁË£¬ÉõÖÁºÜ¶àµ¥Î»»¹¸ø¸ß¶î½±Àø£¬×÷ÕßÒ»¾ÙÊýµÃ¡£ *FQrmdwb]L  
ÀýÈç½­ËÕ»´°²ÊÐÈËÃñÒ½Ôº ·¢±íһƪSCI ҽѧÎÄÕ½±ÀøÎåÍò »¹ÔÚµ±µØ»´°²ÈÕ±¨¿¯µÇÕû°æ±íÑĿǰ¶øÑÔSCI SSCIÔÚ¹úÄÚ»¹ÊǾø¶ÔÊÜ»¶Ó­µÄ¡£  Z yu4!  
           ¶þ¡¢ ÐÐÒµ¸Å¿ö ido'< ;4>  
Ä¿Ç°£¬¹úÄÚÆÚ¿¯ÖÊÁ¿ÐÐÒµ½ÏÂÒ£¬¼Ù¿¯¡¢ÀÄ¿¯µ½´¦¶¼ÊÇ£¬Õý¹æ¿¯ÎïÒ²¶¼´ò²Á±ßÇò£¬ÒÔÖÂ×·Çó¾­¼ÃÀûÒ棬ÂÛÎÄÖÊÁ¿¡¢Ñ§Êõˮƽ ¡¢ÖðÄêϽµ¡¢ºËÐÄÆÚ¿¯ÓÉÓÚ¹Øϵ¸åÌ«¶à ÖÊÁ¿ÁîÈ˵£ÓÇ£¬¹úÄÚÏÖÔڸ߶ËÖ÷Á÷ԺУ¿ÆÑÐÔºËù ¶¼Ïò¹ú¼Ê¿´Æë Óùú¼Ê¿Æѧ±ê×¼£¬Ñ§ÊõÆÀ¼Û»úÖÆΪ׼ ¡£¹úÄÚ¿¯ÎïÂÒÏó»¹»á³ÖÐø3-5Äê»ò¸ü¶Ì£¬ÓÉÓÚÊܹú¼ÒÕþ²ßÓ°Ï죬Ëæʱ¶¼Óм±É²³µÎ£ÏÕ¡£¹ú¼Ê¿¯ÎïSCI SSCI ²»ÊÜÕþ²ßÏÞÖÆÓ°Ïì¡¢²»ÊÜÖ°³Æ ¡¢Ñ§Àú¡¢ ѧλ¡¢¿ÉÒÔÓÀÔ¶³¤ÆÚºÏ×÷¡£ËùÒÔÎÒÃÇץסÆõ»úÓ­ÈжøÉÏ £¬Ç°¾°²»¿ÉÏÞÁ¿ ¡£Í¬Ö¾Ãǹ²Ãã¡£ TXv3@/>ZlG  
~Z=Q+'Hu0  
^$FHI_  
»¶Ó­Ë÷È¡Ïêϸ×ÊÁÏ QQ:1046245582ÓÊÏ䣺wuk223@163.com  18611667875 СÎâ ^{DXin 1O`  


²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us